Quarterlytics / Financial Services / Asset Management / Albion Venture Capital Trust PLC

Albion Venture Capital Trust PLC

aavc · LSE Financial Services
Claim this profile
Ticker aavc
Exchange LSE
Sector Financial Services
Industry Asset Management
Employees 51-200
← All annual reports
FY2022 Annual Report · Albion Venture Capital Trust PLC
Sign in to download
Loading PDF…
Albion Venture Capital Trust PLC

Albion Venture Capital Trust PLC

Annual Report and Financial 
Statements for the year 
ended 31 March 2022

l

i

A
b
o
n
V
e
n
t
u
r
e
C
a
p
i
t
a

A member of the Association 
of Investment Companies

This report is printed on Amadeus offset a totally recycled paper 
produced using 100% recycled waste at a mill that has been 
awarded the ISO 14001 certificate for environmental management. 
The pulp is bleached using a totally chlorine free (TCF) process. 

l

T
r
u
s
t

P
L
C

2
0
2
2

2022

 
 
 
 
 
 
 
 
263764 Albion Capital pp01-pp08.qxp  29/06/2022  15:44  Page 1

Contents 

Page 

2        Company information 

3        Investment policy and financial calendar 

4        Financial highlights 

6        Chairman’s statement 

9        Strategic report 

19      Environmental, Social and Governance (“ESG”) report 

22      The Board of Directors 

23      The Manager 

25      Portfolio of investments 

27      Portfolio companies 

33      Directors’ report 

38      Statement of Directors’ responsibilities 

39      Statement of corporate governance 

45      Directors’ remuneration report 

48      Independent Auditor’s report 

54      Income statement 

55      Balance sheet 

56      Statement of changes in equity 

57      Statement of cash flows 

58      Notes to the Financial Statements 

72      Notice of Annual General Meeting 

Albion Venture Capital Trust PLC 

1
1

 
263764 Albion Capital pp01-pp08.qxp  29/06/2022  15:44  Page 2

Company information

Company name 
Albion Venture Capital Trust PLC (the “Company”) 

Company number 
03142609 

Directors 
Richard Glover, Chairman 
John Kerr ACMA 
Ann Berresford ACA 
Richard Wilson 

Country of incorporation 
United Kingdom 

Legal form 
Public Limited Company 

Manager,  company  secretary,  AIFM  and 
registered office 
Albion Capital Group LLP 
1 Benjamin Street 
London, EC1M 5QL 

Registrar 
Computershare Investor Services PLC 
The Pavilions 
Bridgewater Road 
Bristol, BS99 6ZZ

Auditor 
BDO LLP 
55 Baker Street 
London, W1U 7EU 

Corporate broker 
Panmure Gordon (UK) Limited 
One New Change 
London, EC4M 9AF 

Taxation adviser 
Philip Hare & Associates LLP 
6 Snow Hill 
London, EC1A 2AY 

Legal adviser 
Bird & Bird LLP 
12 New Fetter Lane 
London, EC4A 1JP 

Depositary 
Ocorian Depositary (UK) Limited 
Level 5, 20 Fenchurch Street 
London, EC3M 3BY 

Albion Venture Capital Trust PLC is a member of The Association of Investment Companies (www.theaic.co.uk). 

Shareholder information 
For help relating to dividend payments, shareholdings and share certificates please contact Computershare 
Investor Services PLC: 
Tel: 0370 873 5849 (UK National Rate call, lines are open 8.30am – 5.30pm; Mon – Fri, calls are recorded) 
Website: www.investorcentre.co.uk 

Shareholders  can  access  holdings  and  valuation  information  regarding  any  of  their  shares  held  with 
Computershare by registering on Computershare’s website. 

Shareholders can also contact the Chairman directly on: AAVCchair@albion.capital 

Financial adviser information 
For enquiries relating to the performance of the Company, and information for financial advisers, please contact 
the Business Development team at Albion Capital Group LLP: 

Email: info@albion.capital 
Tel: 020 7601 1850 (lines are open 9.00am – 5.30pm; Mon – Fri; calls are recorded) 
Website: www.albion.capital 

Please note that these contacts are unable to provide financial or taxation advice.

2

Albion Venture Capital Trust PLC 

263764 Albion Capital pp01-pp08.qxp  29/06/2022  15:44  Page 3

Investment policy

Albion Venture Capital Trust PLC (the “Company”) is a Venture Capital Trust and the investment policy is intended to produce a regular 
dividend stream with an appreciation in capital value. 

Investment policy 
The Company will invest in a broad portfolio of smaller, unquoted growth businesses across a variety of sectors including higher risk 
technology companies. Investments may take the form of equity or a mixture of equity and loans. 

Allocation of funds will be determined by the investment opportunities which become available but efforts will be made to ensure that 
the portfolio is diversified both in terms of sector and stage of maturity of company. Funds held pending investment or for liquidity 
purposes will be held as cash on deposit. 

Risk diversification and maximum exposures 
Risk is spread by investing in a number of different businesses within Venture Capital Trust qualifying industry sectors. The maximum 
amount which the Company will invest in a single portfolio company is 15% of the Company's assets at cost, thus ensuring a spread 
of investment risk. The value of an individual investment may increase over time as a result of trading progress and it is possible that 
it may grow in value to a point where it represents a significantly higher proportion of total assets prior to a realisation opportunity 
being available. 

Gearing 
The Company's maximum exposure in relation to gearing is restricted to 10% of the adjusted share capital and reserves.

Financial calendar 

Record date for first interim dividend

Payment of first interim dividend

Annual General Meeting

Announcement of Half-yearly results for the six months ending 30 September 2022

Payment of second interim dividend (subject to Board approval)

8 July 2022 

29 July 2022 

Noon on 6 September 2022 

December 2022 

31 January 2023 

Albion Venture Capital Trust PLC 

3

263764 Albion Capital pp01-pp08.qxp  29/06/2022  15:44  Page 4

Financial highlights 

242.72p

Total shareholder value – being net asset 
value plus dividends paid per Ordinary share 
since launch†

7.6%

25.30p

53.38p

Shareholder return for the year ended 
31 March 2022†

Total tax-free dividend per share paid during 
the year ended 31 March 2022

Net asset value per share as at 
31 March 2022

Total shareholder value relative to the 
FTSE All-Share Index total return 
(in both cases with dividends reinvested)

250

200

150

100

50

)
e
r
a
h
s

r
e
p
e
c
n
e
p
(
n
r
u
t
e
R

0

Mar
2012

Mar
2013

Mar
2014

Mar
2015

Mar
2016

Mar
2017

Mar
2018

Mar
2019

Mar
2020

Mar
2021

Mar
2022

Total shareholder value

FTSE All-Share Index total return

Methodology: The total shareholder value including original amount invested from 1 April 2012 (rebased to 100) assuming that dividends were reinvested at the 
net asset value of the Company at the time that the shares were quoted ex-dividend. Transaction costs are not taken into account. 
† These are considered Alternative Performance Measures, see notes 2 and 3 on page 11 of the Strategic report for further explanation.

4

Albion Venture Capital Trust PLC 

 
 
 
263764 Albion Capital pp01-pp08.qxp  29/06/2022  15:44  Page 5

Financial highlights  continued

                                                                                                                                   31 March 2022             31 March 2021 
                                                                                                                                (pence per share)          (pence per share) 

Opening net asset value                                                                                                          73.13                                70.13 
Capital return                                                                                                            5.38                                     5.64 
Revenue return                                                                                                          0.39                                     1.46 
Total return                                                                                                                                   5.77                                  7.10 
Dividends paid                                                                                                                         (25.30)                               (4.24) 
Impact from share capital movements                                                                                (0.22)                                 0.14 
Net asset value                                                                                                                          53.38                                73.13 

Ordinary shares 
(pence per share) 
Total dividends paid to 31 March 2022                                                                                                                   189.34 
Net asset value on 31 March 2022                                                                                                                                               53.38 

Total shareholder value to 31 March 2022                                                                                                              242.72 

A  more  detailed  breakdown  of  the  dividends  paid  per  year  can  be  found  at  www.albion.capital/funds/AAVC  under  the  ‘Dividend 
History’ section. 

The financial highlights above are for Albion Venture Capital Trust PLC Ordinary shares only. Details of the financial performance of the 
C shares and Albion Prime VCT PLC, which have been merged into the Company, can be found at www.albion.capital/funds/AAVC 
under the ‘Financial summary for previous funds’ section. 

In addition to the dividends summarised above, the Board has declared a first dividend for the year ending 31 March 2023 
of 1.33 pence per share to be paid on 29 July 2022 to shareholders on the register on 8 July 2022. 

Albion Venture Capital Trust PLC – performance data 

1 year return

3 year return

5 year return

10 year return

0%

10%

20%

30%

40%

50%

60%

70%

Increase in shareholder value

1 year average 7.6% p.a.

3 year average 3.8% p.a.

5 year average 6.0% p.a.

10 year average 5.8% p.a.

The graph above shows the one year, three year, five year and ten year total return to shareholders. This return comprises dividends 
paid and the change in net asset value over the relevant periods. 

Albion Venture Capital Trust PLC 

5

 
 
 
263764 Albion Capital pp01-pp08.qxp  29/06/2022  15:44  Page 6

Chairman’s statement  

Introduction 
I  am  delighted  to  announce  that  your  Company  has  achieved  a 
positive  total  return  in  total  shareholder  value  of  5.55  pence  per 
share, a 7.6% shareholder return for the year ended 31 March 2022 
on the opening net asset value. The Company continues to benefit 
from the resilience of its portfolio companies, many of whom have 
shown growth over the past year, despite the ongoing uncertainty of 
the  Covid-19  pandemic,  the  high  levels  of  inflation  both  in  the  UK 
and  across  the  world,  and  the  war  in  Ukraine.  There  is  still  much 
uncertainty on how the economy and the markets will be affected by 
these  ongoing  disruptions.  I  am  optimistic  that  our  portfolio 
companies will continue to add value over the longer term, and we 
can  still  find  new  investment  opportunities  which  will  increase 
shareholder value, but inevitably there will be disruption ahead. 

Richard Glover 
Chairman

Results and dividends 
As  at  31  March  2022,  the  Net  Asset  Value  (“NAV”)  was  £63.9 
million or 53.38 pence per share, compared to £72.7 million or 
73.13 pence per share as at 31 March 2021. The large decrease 
in the NAV was a result of the payment of total tax-free dividends 
of 25.30 pence per share during the year. The total return before 
taxation  was  £6.0  million  compared  to  £7.3  million  for  the 
previous  year.  The  positive  progress  in  several  of  our  portfolio 
companies  is  discussed  later  in  this  statement  and  in  the 
Strategic report on page 9. 

In line with the variable dividend policy targeting around 5% of 
NAV  per  annum,  the  Company  paid  interim  dividends  totalling 
3.30 pence per share during the year ended 31 March 2022 (31 
March 2021: 4.24 pence per share). As a result of the successful 
sale  of  the  Company’s  three  care  homes,  which  generated 
substantial  cash  proceeds,  the  Company  also  paid  special 
dividends totalling 22.00 pence per share during the year ended 
31 March 2022 (31 March 2021: nil). 

The  Board  has  declared  a  first  dividend  for  the  year  ending 
31  March  2023  of  1.33  pence  per  share  to  be  paid  on  29  July 
2022 to shareholders on the register on 8 July 2022. 

Investment performance and progress 
During  the  year,  the  Company  completed  the  sale  of  Credit 
Kudos generating proceeds of £3.0 million and a return on cost 
of  5.2  times.  The  Company  also  sold  Phrasee  generating 
proceeds of £1.7 million and a return on cost of 3.2 times. These 
are both excellent results for the Company. 

The  results  for  the  year  showed  net  valuation  gains  on 
investments of £6.6 million. The key contributors were the uplifts 
on Cantab Research (T/A Speechmatics) and Elliptic Enterprises, 
both  of  which  have  been  revalued  after  further  externally  led 

funding rounds. Phrasee and Credit Kudos also contributed to the 
valuation  gain,  due  to  their  sales  which  completed  during  the 
year. However, our investments in Concirrus and Avora have seen 
write-downs following difficult trading conditions, in part because 
of  the  Covid-19  pandemic.  We  have  also  written-off  our 
investment in Xperiome which went into administration. 

The three largest investments in the Company’s portfolio, being 
Chonais  River  Hydro,  Cantab  Research  (T/A  Speechmatics)  and 
Elliptic  Enterprises,  are  valued  at  £9.8  million  and  represent  15 
per cent. of the Company’s NAV. 

The  Company  has  been  an  active  investor  during  the  year 
investing a total of £7.8 million. Of this, £3.2 million was invested 
into  six  new  portfolio  companies,  all  of  which  are  expected  to 
require  further  investment  as  the  companies  prove  themselves 
and grow: 

•         £0.9  million  into  NuvoAir  Holdings  a  provider  of  digital 
therapeutics and decentralised clinical trials for respiratory 
conditions; 

•         £0.8 million into Gravitee TopCo (trading as Gravitee.io) an 
application  programming  interface  (API)  management 
platform; 

•         £0.6 million into Brytlyt which uses patented software and 
artificial  intelligence  (AI),  combined  with  the  superior 
computation power of graphics processing units (GPUs), to 
derive  insights  thousands  of  times  faster  than  legacy 
systems; 

•         £0.5 million into PerchPeek, a digital relocation platform; 

•         £0.3 million into Accelex Technology, a data extraction and 
analytics technology for private capital markets; and 

6

Albion Venture Capital Trust PLC 

‘

Achieved a positive 
total return in total 
shareholder value 
of 5.55 pence per 
share, a 7.6% 
shareholder  
return

’

263764 Albion Capital pp01-pp08.qxp  29/06/2022  15:44  Page 7

Chairman’s statement  continued

•         £0.1  million  into  Regulatory  Genome 
Development,  a  provider  of  machine 
readable structured regulatory content. 

adverse  events  arising  out  of  the  increasingly 
volatile geopolitical backdrop  remain a major 
risk factor. 

A  detailed  analysis  of  the  other  risks  and 
uncertainties  facing  the  business  is  shown  in 
the Strategic report on pages 9 to 18. 

Sunset Clause 
In 2015 a VCT “sunset clause” was introduced 
as a requirement of a EU state aid notification. 
This  provides  that  income  tax  relief  will  no 
longer  be  given  to  subscriptions  made  on  or 
after  6  April  2025,  unless  the  legislation  is 
amended  to  make  the  scheme  permanent  or 
the “sunset clause” is extended. Our Manager, 
Albion  Capital,  is  working,  alongside  the  VCT 
industry,  to  demonstrate  to  Government  the 
importance of VCTs as a source of early-stage 
capital  to  support  entrepreneurs  creating 
innovative  growth  businesses  employing 
thousands of people throughout the UK. Given 
its importance, the Board expects that the VCT 
scheme  will  continue  to  attract  Government 
support. 

Share buy-backs 
It  remains  the  Board’s  policy  to  buy-back 
shares  in  the  market,  subject  to  the  overall 
constraint  that  such  purchases  are  in  the 
the 
Company’s 
maintenance  of  sufficient  cash  resources  for 
investment  in  new  and  existing  portfolio 
companies  and  the  continued  payment  of 
dividends to shareholders. 

interest.  This 

includes 

A  further  £4.6  million  was  invested  into 
existing portfolio companies, the largest being: 
£1.3  million  into  Seldon  Technologies;  £0.7 
million into TransFICC; £0.7 million into Elliptic; 
and  £0.7  million  into  Speechmatics.  Software 
and  other  technology  now  accounts  for  39% 
of our portfolio (excluding cash), an increase of 
6% from last year. 

A  full  list  of  the  Company’s  investments  and 
disposals,  including  their  movements  in  value 
for  the  year,  can  be  found  in  the  Portfolio  of 
investments section on pages 25 to 26. 

Board Composition 
the 
After  serving  as  a  Director  since 
Company’s launch in 1996, and subsequently 
as  Audit  Committee  Chairman,  John  Kerr  will 
be  retiring  from  the  Board  at  the  AGM  on  6 
September  2022.  We  have  valued  his 
contributions  and  wish  him  well  in  the  future. 
Ann  Berresford  will  succeed  him  as  Audit 
Committee Chairman. 

Following  a  formal  selection  process,  Neeta 
Patel CBE will be appointed as a non-executive 
Director  with  effect  from  1  July  2022.  Neeta 
will be bringing over 35 years of experience in 
the  technology  sector  to  the  Board  and  is 
currently  a  non-executive  director  of  Allianz 
Technology  Trust,  CEO  of  the  Centre  for 
Entrepreneurs, a board advisor for Tech London 
Advocates  and  an  entrepreneur  mentor-in-
residence at London Business School. 

Principal and emerging risks 
In addition to the risks around Covid-19, which 
have been a major factor for the past 2 years, 
the  UK  is  experiencing  its  highest  level  of 
inflation in decades, as well as the uncertainty 
over  the  future  course,  and  global  impact,  of 
Russia’s  invasion  of  Ukraine.  Our  investment 
portfolio,  while  concentrated  mainly  in  the 
technology  and  healthcare  sectors,  remains 
diversified  in  terms  of  both  sub-sector  and 
stage of maturity and, importantly, we believe 
it to be appropriately valued. While we would 
expect these valuations to be robust within the 
tolerance  of  normal  market  fluctuations,  the 
potential  but,  unknown,  scale  of  any  further 

It is the Board’s intention that such buy-backs 
should  be  at  around  a  5%  discount  to  net 
asset value, in so far as market conditions and 
liquidity permit. The Board continues to review 
the use of buy-backs and is satisfied that it is 
an  important  means  of  providing  market 
liquidity for shareholders. 

Details  of  the  Company’s  share  buy-backs 

during the year can be found in note 15.  ‘

The Company has 
been an active 
investor during the 
year investing a 
total of £7.8 
million

’

Albion Venture Capital Trust PLC 

7

263764 Albion Capital pp01-pp08.qxp  29/06/2022  15:44  Page 8

Chairman’s statement  continued

Albion VCTs Prospectus Top Up Offers 
Your Board, in conjunction with the boards of 
the other five VCTs managed by Albion Capital, 
launched  a  prospectus  top  up  offer  of  new 
Ordinary shares on 6 January 2022. The Board 
announced  on  16  February  2022  that, 
following  strong  demand,  the  Company  had 
reached  its  £10  million  limit  under  the  Offer 
and was fully subscribed and closed to further 
applications. 

The  proceeds  are  being  used  to  provide 
support  to  our  existing  portfolio  companies 
and  to  enable  us  to  take  advantage  of  new 
investment  opportunities.  The  first  allotment 
of  the  shares  under  the  Offer  was  on  25 
February 2022 and the second allotment was 
on 13 April 2022. Further details can be found 
in notes 15 and 19 respectively. 

Annual General Meeting (“AGM”) 
Based on the success of last year’s live webcast 
AGM, the Board has decided to adopt a virtual 
format for the AGM again this year. The AGM 
will be held at noon on 6 September 2022 via 
the  Lumi  platform.  Information  on  how  to 
participate in the live webcast can be found on 
the Manager’s website www.albion.capital/vct-
hub/agms-events. 

shareholders  can  email  their  questions  to 
AAVCchair@albion.capital  prior 
the 
Meeting. 

to 

Shareholders'  views  are  important,  and  the 
Board encourages shareholders to vote on the 
resolutions. 

Further  details  on  the  format  and  business  to 
be conducted at the AGM can be found in the 
Directors’  report  on  pages  36  and  37  and  in 
the Notice of the Meeting on pages 72 to 75. 

longer-term 

Outlook and prospects 
The  positive  results  for  the  year  just  ended 
demonstrate  the  resilience  of  our  portfolio 
during  what  were  challenging  times.  I  am 
confident that our portfolio companies are well 
positioned  to  grow,  despite  the  uncertainty 
around  the 
impact  of  the 
pandemic, the current cost of living in the UK 
and  across  the  world,  and  an  increasingly 
volatile  geopolitical  and  economic  backdrop. 
The Board believes the Company is well placed 
to  continue  to  deliver  long  term  value  to  our 
shareholders,  though  remains  mindful  of  the 
considerable  uncertainty  over  the  Global 
economy. 

The  Board  welcomes  questions 
from 
shareholders at the AGM and shareholders will 
be  able  to  ask  questions  using  the  Lumi 
platform  during  the  AGM.  Alternatively, 

Richard Glover 
Chairman 
29 June 2022

‘

The Company 
completed the sale 
of Credit Kudos 
generating 
proceeds of £3.0 
million and Phrasee 
generating 
proceeds of £1.7 
million

’

‘

The results for the 
year showed net 
valuation gains on 
investments of £6.6 
million

’

8

Albion Venture Capital Trust PLC 

 
 
263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 9

Strategic report 

Investment policy 
The Company will invest in a broad portfolio of smaller, unquoted growth businesses across a variety of sectors including higher risk 
technology companies. Investments may take the form of equity or a mixture of equity and loans. 

Allocation of funds will be determined by the investment opportunities which become available but efforts will be made to ensure that 
the portfolio is diversified both in terms of sector and stage of maturity of company. Funds held pending investment or for liquidity 
purposes will be held as cash on deposit. 

The full investment policy can be found on page 3. 

Current portfolio analysis 
The following pie charts show the split of the portfolio valuation as at 31 March 2022 by: sector; sector (excluding cash and net assets); 
stage of investment; and number of employees. This is a useful way of assessing how the Company and its portfolio is diversified across 
sector, portfolio companies’ maturity measured by revenues and their size measured by the number of people employed. Details of 
the principal investments made by the Company are shown in the Portfolio of investments on pages 25 and 26. 

Split of portfolio by sector

Split of portfolio by sector 
(excluding cash and net assets)

Software & other 
technology
23% (13%)

Cash and 
net assets
41% (61%)

Software & other 
technology 
39% (33%)

Business services
and other
4% (2%)

Renewable energy
16% (14%)

Healthcare 
(including digital 
healthcare)
18% (15%)

Education
9% (11%)

Education
5% (4%)

Healthcare (including 
digital healthcare)
11% (6%)

Business services 
and other
7% (6%)

Renewable energy
27% (35%)

Portfolio analysis by stage of investment

Portfolio analysis by number of employees

Scale up (revenue 
over £5 million)
48% (26%)

Early stage (revenue less 
than £1 million)
15% (26%)

Renewable 
energy*
27% (35%)

Under 20
7% (9%)

21 - 50
23% (23%)

Growth (revenue between 
£1 million and £5 million)
37% (48%)

101+
24% (11%)

51 - 100
19% (22%)

*Renewable energy companies have no employees 
Comparatives for 31 March 2021 are shown in brackets 

Albion Venture Capital Trust PLC

9

       
 
 
       
 
 
263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 10

Strategic report  continued

investments 

Direction of portfolio 
The cash balance has decreased mainly due to the two special 
dividends totalling £22 million that were paid out to shareholders 
into  higher  growth  technology 
and  further 
companies during the year. The percentage of cash remains high 
at the year end, however this is largely a result of the allotment 
of £9 million of shares under the Top Up Offers in February 2022, 
as  well  as  an  additional  £5  million  from  the  disposals  of  Credit 
Kudos  and  Phrasee  which  both  completed  in  March  2022.  The 
shift  away  from  asset-based  companies  continues,  and  the 
Company will continue to invest these funds into higher growth 
including  digital  healthcare.  The 
technology  companies, 
Manager  has  a  significant  speciality  in  software  and  other 
technology investing, which can be seen as a growing part of the 
portfolio,  represented  by  a  10%  increase  this  year.  Healthcare 
technology  is  another  area  of  particular  strength,  which  has 
increased by 5%. 

Further  details  on  portfolio  companies  can  be  found  in  the 
Portfolio of investments on page 25. 

Results and dividends 

Ordinary shares 
£’000 

Net capital return for the year 
ended 31 March 2022
Net revenue return for the year  
ended 31 March 2022

Total return for the year  
ended 31 March 2022
First interim and first special dividend 
of 16.83 pence per share paid on 
30 July 2021
Second special dividend of 7.00 pence 
per share paid on 31 December 2021
Second interim dividend of 1.47 pence 
per share paid on 31 January 2022
Unclaimed dividends returned  
to the Company

Transferred from reserves

Net assets as at 31 March 2022

Net asset value as at 31 March 2022 
(pence per share)

5,554 

407 

5,961 

(16,728) 

(7,141) 

(1,523) 

10 

(19,421) 

63,937 

53.38

The  Company  paid  dividends  totalling  25.30  pence  per  share 
during  the  year  ended  31  March  2022  (2021:  4.24  pence  per 
share).  This  included  two  special  dividends  of  15.00  pence  per 
share and 7.00 pence per share paid to shareholders on 30 July 

10

Albion Venture Capital Trust PLC

2021  and  31  December  2021,  respectively.  The  Board  has 
declared a first dividend for the year ending 31 March 2023, of 
1.33 pence per share to be paid on 29 July 2022 to shareholders 
on the register on 8 July 2022. 

As shown in the Company’s Income statement on page 54, the 
total return for the year was 5.77 pence per share (2021: 7.10 
pence  per  share).  The  total  investment  income  decreased  to 
£1,037,000 (2021: £2,467,000), which was primarily due to the 
care homes sale in March 2021. The Company will continue to 
receive  income  from  its  renewable  energy  portfolio  for  the 
foreseeable  future,  however  investment  income  is  expected  to 
be  much  lower  over  the  next  few  years.  The  revenue  return  to 
equity holders has subsequently decreased to £407,000 (2021: 
£1,468,000). 

The  capital  return  on  investments  for  the  year  of  £6,553,000 
(2021:  £6,508,000),  has  been  discussed  in  the  Chairman’s 
statement  on  pages  6  and  7.  The  net  asset  value  of  the 
Company has decreased to 53.38 pence per share (2021: 73.13 
pence  per  share),  which  was  primarily  due  to  the  two  special 
dividends totalling 22.00 pence per share paid to shareholders 
during  the  year.  Whilst  this  reduced  the  Company’s  assets,  it 
provided a significant return to shareholders and more detail on 
these special dividends can be found in the Annual Report and 
Financial Statements for the year ended 31 March 2021 and the 
Half-yearly Financial report to 30 September 2021. 

There was a net cash outflow for the Company of £18,894,000 
for  the  year  (2021:  net  inflow  of  £21,782,000),  resulting  from 
the  payment  of  two  special  and  interim  dividends,  the 
investment  in  fixed  asset  investments,  operating  activities  and 
the buy-back of shares, offset by the issue of shares under the 
Albion VCTs Top Up Offers 2021/2022 and the disposal of fixed 
asset investments. 

Review of business and future changes 
A detailed review of the Company’s business during the year is 
contained  in  the  Chairman’s  statement  on  pages  6  to  8.  The 
total  return  before  tax  for  the  year  was  £6.0  million  (2021: 
£7.3 million). 

There is a continuing focus on growing the healthcare (including 
digital  healthcare)  and  software  and  other  technology  sectors. 
The majority of these investment returns are delivered through 
equity and capital gains and therefore we expect our investment 
income to continually reduce in future years. 

Details of significant events which have occurred since the end 
of the financial year are listed in note 19. Details of transactions 
with the Manager are shown in note 5. 

 
263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 11

Strategic report  continued

Future prospects 
The  Company’s  portfolio  remains  well  balanced  across  sectors  and  risk  classes,  and  has  largely  weathered  the  pandemic  so  far. 
Although there remains much uncertainty, the Manager has a strong pipeline of investment opportunities in which the Company’s 
cash can be deployed. The Board considers that the current portfolio and the pipeline of opportunities should enable the Company 
to maintain a predictable stream of dividend payments to shareholders, as well as delivering long term growth for shareholders. 

Key performance indicators (“KPIs”) and Alternative Performance Measures (“APMs”) 
The Directors believe that the following KPIs (some of which are APMs), which are typical for Venture Capital Trusts, used in its own 
assessment of the Company, will provide shareholders with sufficient information to assess how effectively the Company is applying 
its investment policy to meet its objectives. The Directors are satisfied that the results shown in the following KPIs and APMs give a 
good indication that the Company is achieving its investment objective and policy. These are: 

1.    Total shareholder value relative to FTSE All Share Index total return 

The graph on page 4 shows the Company’s total shareholder value relative to the FTSE All-Share Index total return, with dividends 
reinvested.  The  FTSE  All-Share  index  is  considered  a  reasonable  benchmark  as  the  Company  is  classed  as  a  generalist  UK  VCT 
investor, and this index includes over 600 companies listed in the UK, including small-cap, covering a range of sectors. Details on the 
performance of the net asset value and return per share for the year are shown in the Chairman’s statement. 

2.    Net asset value per share and total shareholder value 

Net asset value per share and total shareholder value*

e
r
a
h
s

r
e
p
e
c
n
e
P

250

200

150

100

50

0

242.7

233.8

229.9

237.2

225.8

220.2

211.8

206.4

205.0 204.7

190.1 191.4

195.3

197.9 199.0 201.1

191.3

183.7

171.9

159.2

148.5

136.8

127.8

118.4

110.2

99.9

95.0

1

1

1

1

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

9

9

9

9

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

9

9

9

9

0

0

0

0

0

0

0

0

0

0

1

1

1

1

1

1

1

1

1

1

2

2

2

6

7

8

9

0

1

2

3

4

5

6

7

8

9

0

1

2

3

4

5

6

7

8

9

0

1

2

* Total shareholder value is net asset value plus cumulative dividends paid since launch to 31 March 2022. 

Total shareholder value increased by 5.55 pence to 242.72 pence per share for the year ended 31 March 2022. 

Net asset value

Cumulative dividend

3.    Movement in shareholder value in the year† 

The graph on page 5 shows the Company’s total shareholder return over the previous ten years, five years, three years and the past year, 
and the annual returns for the same period are detailed out below. 

    2013           2014              2015            2016             2017            2018             2019            2020              2021           2022 
     1.4%            2.8%               7.4%             7.5%             11.8%           7.4%             10.5%          (4.9)%             10.3%           7.6% 

† Methodology: Calculated as the movement in total shareholder value for the year divided by the opening net asset value. 
The table above shows that total shareholder value has continued to increase over the last 10 years, with an average return of 6.2% 
per annum. 

Albion Venture Capital Trust PLC

11

 
           
 
 
 
263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 12

Strategic report  continued

4.    Dividend distributions 

The chart that follows shows the dividends paid in each year and the cumulative dividends paid since launch. 

Dividends paid

189.3

164.0

159.8

154.8

149.8

144.8

139.8

134.8

129.8

124.8

119.8

114.8

109.8

104.8

94.8

84.8

74.8

67.8

58.8

50.3

42.3

34.8

27.3

18.8

11.0

5.0

e
r
a
h
s

r
e
p
e
c
n
e
P

200

175

150

125

100

75

50

25

0

1

1

1

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

9

9

9

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

9

9

9

0

0

0

0

0

0

0

0

0

0

1

1

1

1

1

1

1

1

1

1

2

2

2

7

8

9

0

1

2

3

4

5

6

7

8

9

0

1

2

3

4

5

6

7

8

9

0

1

2

Cumulative dividend

Dividends paid in the period

Dividends paid in respect of the year ended 31 March 2022 were 25.30 pence per share (2021: 4.24 pence per share). This included 
the  payment  of  two  special  dividends  amounting  to  22.00  pence  per  share  (2021:  nil).  Cumulative  dividends  paid  since  inception 
amount to 189.34 pence per Ordinary share.

5.    Ongoing charges 

The  ongoing  charges  ratio  for  the  year  ended  31  March  2022 
was 2.44% (2021: 2.37%). The ongoing charges ratio has been 
calculated  using  The  Association  of  Investment  Companies’ 
(“AIC”) 
recommended  methodology.  This  figure  shows 
shareholders  the  total  recurring  annual  running  expenses 
(including  investment  management  fees  charged  to  capital 
reserve) as a percentage of the average net assets attributable to 
shareholders. The Directors expect the ongoing charges ratio for 
the year ahead to increase to approximately 2.50% due to the 
reduction  in  the  net  asset  value  of  the  Company  after  the 
payment  of  the  significant  special  dividends.  The  cap  on  the 
ongoing charges ratio is 2.50%. 

6.    VCT compliance* 

The investment policy is designed to ensure that the Company 
continues to qualify and is approved as a VCT by HMRC. In order 
to  maintain  its  status  under  Venture  Capital  Trust  legislation,  a 
VCT  must  comply  on  a  continuing  basis  with  the  provisions  of 
Section  274  of  the  Income  Tax  Act  2007,  details  of  which  are 
provided in the Directors’ report on page 34. 

12

Albion Venture Capital Trust PLC

The relevant tests to measure compliance have been carried out 
and independently reviewed for the year ended 31 March 2022. 
These showed that the Company has complied with all tests and 
continues to do so. 

* VCT compliance is not a numerical measure of performance and thus cannot be 
defined as an APM. 

Gearing 
As  defined  by  the  Articles  of  Association,  the  Company’s 
maximum exposure in relation to gearing is restricted to 10% of 
the  adjusted  share  capital  and  reserves.  The  Directors  do  not 
currently have any intention to utilise gearing for the Company. 

Operational arrangements 
The  Company  has  delegated  the  investment  management  of 
the portfolio to the Manager, Albion Capital Group LLP, which is 
authorised  and  regulated  by  the  Financial  Conduct  Authority. 
The  Manager  also  provides  company  secretarial  and  other 
accounting and administrative support to the Company. 

 
 
 
263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 13

Strategic report  continued

Management agreement 
Under  the  Management  agreement,  the  Manager  provides 
investment management, secretarial and administrative services 
to  the  Company.  The  Management  agreement  can  be 
terminated  by  either  party  on  12  months’  notice.  The 
Management agreement is subject to earlier termination in the 
event of certain breaches or on the insolvency of either party. The 
Manager is paid an annual fee equal to 1.9% of the net asset 
value  of  the  Company,  and  an  annual  secretarial  and 
administrative  fee  of  £55,000  (2021:  £54,000)  increased 
annually by RPI. These fees are payable quarterly in arrears. Total 
annual expenses, including the management fee, are limited to 
2.5% of the net asset value. 

In line with common practice, the Manager is also entitled to an 
arrangement  fee,  payable  by  each  new  portfolio  company,  of 
approximately  2%  on  each  new  investment  made  and  any 
applicable monitoring fees. 

Management performance incentive 
In  order  to  align  the  interests  of  the  Manager  and  the 
shareholders  with  regards  to  generating  positive  returns,  the 
Manager is entitled to charge an incentive fee in the event that 
the returns exceed minimum target levels. 

The  performance  hurdle  requires  that  the  growth  of  the 
aggregate of the net asset value per share and dividends paid by 
the  Company  compared  with  the  previous  accounting  date 
exceeds  RPI  plus  2%.  The  hurdle  will  be  calculated  every  year, 
based on the previous year’s closing NAV per Share. The starting 
NAV is 79.00 pence per share, being the audited net asset value 
at 31 March 2019. If the target return is not achieved in a period, 
the cumulative shortfall is carried forward to the next accounting 
period and has to be made up before an incentive fee becomes 
payable. 

There was no management performance incentive fee payable 
during the year. As at 31 March 2022 the cumulative shortfall of 
the  target  return  was  5.18  pence  per  share  (31  March  2021: 
shortfall of 2.72 pence per share) and this amount needs to be 
made up in following accounting periods before an incentive fee 
becomes payable. 

Investment and co-investment 
The  Company  co-invests  with  other  Venture  Capital  Trusts  and 
funds managed by the Manager. Allocation of investments is on 
the basis of an allocation agreement which is based, inter alia, on 
the ratio of funds available for investment. 

Evaluation of the Manager 
The  Board  has  evaluated  the  performance  of  the  Manager 
based on: 

•   the returns generated by the Company; 

•   the continuing achievement of the 80% qualifying holdings 

investment requirement for VCT status; 

•   the 

long  term  prospects  of  the  current  portfolio  of 

investments; 

•   a  review  of  the  Management  agreement  and  the  services 

provided therein; and 

•   benchmarking  the  performance  of  the  Manager  to  other 
service  providers  including  the  performance  of  other  VCTs 
that the Manager is responsible for managing. 

The Board believes that it is in the interests of shareholders as a 
whole, and of the Company, to continue the appointment of the 
Manager for the forthcoming year. 

Alternative Investment Fund Managers Directive (“AIFMD”) 
The  Board  appointed  the  Manager  as  the  Company’s  AIFM  in 
2014  as  required  by  the  AIFMD.  The  Manager  is  a  full-scope 
Alternative Investment Fund Manager under the AIFMD. Ocorian 
Depositary  (UK)  Limited  is  the  appointed  Depositary  and 
oversees the custody and cash arrangements and provides other 
AIFMD duties with respect to the Company. 

Companies Act 2006 Section 172 Reporting 
Under Section 172 of the Companies Act 2006, the Board has a 
duty to promote the success of the Company for the benefit of its 
members  as  a  whole  in  both  the  long  and  short  term,  having 
regard  to  the  interests  of  other  stakeholders  in  the  Company, 
such  as  suppliers,  and  to  do  so  with  an  understanding  of  the 
impact  on  the  community  and  environment  and  with  high 
standards  of  business  conduct,  which  includes  acting  fairly 
between members of the Company. 

The Board is very conscious of these wider responsibilities in the 
ways it promotes the Company’s culture and ensures, as part of 
its regular oversight, that the integrity of the Company’s affairs is 
foremost in the way the activities are managed and promoted. 
This includes regular engagement with the wider stakeholders of 
the Company and being alert to issues that might damage the 
Company’s standing in the way that it operates. The Board works 
very  closely  with  the  Manager  in  reviewing  how  stakeholder 
issues are handled, ensuring good governance and responsibility 
in  managing  the  Company’s  affairs,  as  well  as  visibility  and 
openness in how the affairs are conducted. 

The  Company  is  an  externally  managed  investment  company 
with no employees, and as such has nothing to report in relation 
to employee engagement but does keep close attention to how 
the  Board  operates  as  a  cohesive  and  competent  unit.  The 
Company  also  has  no  customers  in  the  traditional  sense  and, 
therefore,  there  is  also  nothing  to  report  in  relation  to 
relationships with customers. 

The  table  below  sets  out  the  key  stakeholders,  details  how  the 
Board has engaged with these key stakeholders, and the effect of 
these considerations on the Company’s decisions and strategies 
during the year. 

Albion Venture Capital Trust PLC

13

263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 14

Strategic report  continued

Stakeholders                     Engagement with Stakeholders                             Outcome and decisions based on engagement 

Shareholders

The  key  methods  of  engaging  with 
Shareholders are as follows: 

•        Annual General Meeting (“AGM”) 

•        Shareholder seminar 

•        Annual  Report  and 

Financial 
Statements,  Half-yearly  financial 
report,  and  Interim  management 
statements 

•        RNS  announcements  for  all  key 
decisions  including  the  publication 
of a Prospectus 

•        Website  redesigned  in  the  year  to 
make it more user accessible 

•      Shareholders’  views  are  important  and  the  Board 
encourages Shareholders to exercise their right to vote on 
the  resolutions  at  the  AGM.  The  Company’s  AGM  is 
typically  used  as  an  opportunity  to  communicate  with 
investors, including through a presentation made by the 
investment management team. In light of the Covid-19 
pandemic,  the  Board  took  the  decision  to  update  the 
Company’s  Articles  of  Association  to  allow  for 
virtual/hybrid events in order for the 2022 AGM to be live 
streamed  for  Shareholders.  The  Board  was  able  to  take 
questions  from  Shareholders  at  the  AGM  enabling 
maximum shareholder engagement in the absence of a 
face-to-face  event.  Following  last  year’s  success  and  the 
overwhelming  positive  feedback  from  shareholders,  the 
Board has decided that this year’s AGM will again be held 
as a virtual event to facilitate shareholder participation. 
•      Shareholders  are  also  encouraged  to  attend  the  annual 
Shareholders’  Seminar.  Last  year’s  event  took  place  on 
12 November 2021. The seminar included Quantexa and 
Healios  sharing  insights  into  their  businesses  and  also 
presentations from Albion executives on some of the key 
factors  affecting  the  investment  outlook,  as  well  as  a 
review of the past year and the plans for the year ahead. 
Representatives  of  the  Board  attend  the  seminar.  The 
Board  considers  this  an  important  interactive  event  and 
invites shareholders to attend this year’s event scheduled 
for 23 November 2022 at the Royal College of Surgeons. 
To reserve a place, email info@albion.capital. 

•      The Board recognises the importance to Shareholders of 
maintaining a share buy-back policy, in order to provide 
market  liquidity,  and  considered  this  when  establishing 
the  current  policy.  The  Board  closely  monitors  the 
discount  to  the  net  asset  value  to  ensure  this  is  in  the 
region of 5%. 

•      The  Board  seeks  to  create  value  for  Shareholders  by 
generating  strong  and  sustainable  returns  to  provide 
shareholders with regular dividends and the prospect of 
capital  growth.  The  Board  takes  this  into  consideration 
when  making  the  decision  to  pay  dividends  to 
Shareholders.  The  variable  dividend  policy  has  been 
enacted, and has resulted in a dividend yield of 4.5% on 
opening  net  asset  value.  In  addition  to  the  regular 
dividend policy, a first special dividend of 15.00 pence per 
share  was  paid  on  30  July  2021  and  a  second  special 
dividend  of  7.00  pence  per  share  was  paid  on 
31 December 2021. A total of 25.30 pence of dividends 
were  paid  during  the  year,  which  was  34.6%  of  the 
opening net asset value. 

•      During the year, the decision to publish a Prospectus was 
taken, in order to raise more funds for deployment into 
new  and  existing  portfolio  companies.  The  Board 
carefully  considered  whether  further  funds  were 
required,  whether  the  VCT  tests  would  continue  to  be 
met,  and  whether  it  would  be  in  the  interest  of 
Shareholders, before agreeing to publish the Prospectus. 
On  allotment,  the  decision  was  made  to  use  an  issue 
price formula on the prevailing net asset value to ensure 
there was no dilution to existing Shareholders. 

14

Albion Venture Capital Trust PLC

 
      
      
263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 15

Strategic report  continued

Stakeholders                     Engagement with Stakeholders                             Outcome and decisions based on engagement 

Shareholders 
(continued)

Suppliers

Manager

•       Cash  management  and  liquidity  of  the  Company  are  key 
quarterly  discussions  amongst  the  Board,  with  focus  on 
deployment of cash for future investments, dividends and share 
buy-backs. 

•       The Board decided to propose a special resolution at the 2021 
AGM to increase the Company’s distributable reserves by way 
of  a  reduction  of  share  premium  account  and  capital 
redemption reserve. This resolution was approved with 99.5% 
of Shareholders voting in favour of the resolution.

•       The  Manager  is  in  regular  contact  with  the  suppliers  and  the 
contractual arrangements with all the principal suppliers to the 
Company  are  reviewed  regularly  and  formally  once  a  year, 
alongside  the  performance  of  the  suppliers  in  acquitting  their 
responsibilities. 

•       The Board reviews the performance of the providers annually in 
line with the Manager, and was satisfied with their performance.

The key suppliers are: 
•       Corporate broker 
•       VCT taxation advisor 
•       Depositary 
•       Registrar  
•       Auditor 
•       Lawyer 

The performance of Albion Capital Group LLP is 
essential  to  the  long  term  success  of  the 
Company,  including  achieving  the  investment 
policy and generating returns to shareholders, as 
well  as  the  impact  the  Company  has  on 
Environment, Social and Governance practice.

•       The Manager meets with the Board at least quarterly to discuss 
the  performance  of  the  Company,  and  is  in  regular  contact  in 
between  these  meetings,  e.g.  to  share  investment  papers  for 
new  and  follow-on  investments.  All  strategic  decisions  are 
discussed in detail and minuted, with an open dialogue between 
the Board and the Manager. 

Portfolio companies

The  portfolio  companies  are  considered  key 
stakeholders,  not 
least  because  they  are 
principal  drivers  of  value  for  the  Company. 
However,  as  discussed  in  the  Environmental, 
Social and Governance (“ESG”) report on pages 
19  to  21,  the  portfolio  companies’  impact  on 
their  stakeholders  is  also  important  to  the 
Company.

Community and 
environment

The Company, with no employees, has no effect 
itself  on  the  community  and  environment. 
However,  as  discussed  above,  the  portfolio 
companies’ ESG impact is extremely important 
to the Board.

•       The performance of the Manager in managing the portfolio and 
in  providing  company  secretarial,  administration  and 
accounting  services  is  reviewed  in  detail  each  year,  which 
includes reviewing comparator engagement terms and portfolio 
performance. Further details on the evaluation of the Manager, 
and the decision to continue the appointment of the Manager 
for the forthcoming year, can be found in this report. 

•        Details  of  the  Manager’s  responsibilities  can  be  found  in  the 

Statement of corporate governance on pages 39 and 40. 

         During  the  year,  the  Board  has  reviewed  the  current 
Management  Agreement,  and  a  new  agreement  was  signed 
which updated the agreement for new regulatory requirements, 
such as GDPR and AIFMD, but did not change any commercial 
terms with the Manager.

•       The Board aims to have a diversified portfolio in terms of sector 
and stage of investment. Further details of this can be found in 
the pie charts on page 9. 

•       In most cases, an Albion executive has a place on the board of a 
portfolio company, in order to help with both business operation 
decisions, as well as good ESG practices. 

•       The Manager ensures good dialogue with portfolio companies, 
and often puts on events in order to help portfolio companies 
benefit from the Albion network. 

•       Albion Capital has a Talent Platform which focuses on aligning 
growth  strategy  with  leadership  team  hiring,  leadership 
development,  and  organisational  scaling  in  our  portfolio 
companies.  By  assessing  their  leadership  potential,  identifying 
and strengthening portfolio company management teams, the 
Talent  platform  helps  early-stage  businesses  accelerate  their 
growth  to  scale  into  category  defining  businesses,  which 
ultimately benefits VCT investors.

•    The Board receives reports on ESG factors within its portfolio from 
the Manager as it is a signatory of the United Nations Principles for 
Responsible  Investment  (“UN  PRI”).  Further  details  of  this  are  set 
out in the ESG report below. ESG, without its specific definition, has 
always  been  at  the  heart  of  the  responsible  investing  that  the 
Company engages in and in how the Company conducts itself with 
all of its stakeholders.

Albion Venture Capital Trust PLC

15

 
                                                                                                   
 
      
      
 
      
      
 
      
      
 
      
      
263764 Albion Capital pp09-pp24.qxp  29/06/2022  16:59  Page 16

Strategic report  continued

Environmental, Social, and Governance (“ESG”) report 
The  Board  and  the  Company’s  Manager,  Albion  Capital  Group 
LLP, take ESG very seriously and more detail can be found on this 
in the ESG report on pages 19 to 21. 

Social and community issues, employees and human rights 
The Board recognises the requirement under section 414C of the 
Act  to  detail  information  about  social  and  community  issues, 
employees  and  human  rights;  including  any  policies  it  has  in 
relation to these matters and effectiveness of these policies. As 
an externally managed investment company with no employees, 
the Company has no formal policies in these matters, however, it 
is  at  the  core  of  its  responsible  investment  strategy  as  detailed 
above. 

General Data Protection Regulation 
The  General  Data  Protection  Regulation  has  the  objective  of 
unifying data privacy requirements across the European Union. 
GDPR  forms  part  of  the  UK  law  after  Brexit,  now  known  as  UK 
GDPR. The Manager continues to take action to ensure that the 
Manager and the Company are compliant with the regulation. 

Further policies 
The  Company  has  adopted  a  number  of  further  policies 
relating to: 

•   Environment 

•   Global greenhouse gas emissions 

•   Anti-bribery 

•   Anti-facilitation of tax evasion 

•   Diversity 

and these are set out in the Directors’ report on page 35. 

Risk management 
The Board carries out a regular review of the risk environment in 
which  the  Company  operates,  together  with  changes  to  the 
environment  and  individual  risks.  The  Board  also  identifies 
emerging  risks  which  might  impact  on  the  Company.  In  the 
period the most noticeable risks have been the global pandemic 
and the invasion of Ukraine which have impacted not only public 
health  and  mobility  but  also  had  an  adverse  impact  on  the 
economy,  the  full  impact  of  which  is  likely  to  be  uncertain  for 
some time. 

The Board has carried out a robust assessment of the Company’s 
principal risks and uncertainties and seeks to mitigate these risks 
through regular reviews of performance and monitoring progress 
and compliance. The Board applies the principles detailed in the 
Financial  Reporting  Council’s  Guidance  on  Risk  Management, 
Internal Control and Related Financial and Business Reporting, in 
the mitigation and management of these risks. More information 
on  specific  mitigation  measures  for  the  principal  risks  and 
uncertainties are explained below:

Risk                         Possible consequence                       Risk assessment during the year    Risk management 

Increased  (due  to  high  levels  of 
inflation  and  the  geopolitical  risks 
following the invasion of Ukraine).

The  Board  places  reliance  upon  the  skills  and 
expertise  of  the  Manager  and  its  track  record  of 
making  successful  investments  in  higher  growth 
technology  businesses.  The  Manager  operates  a 
structured  investment  appraisal  and  due  diligence 
process.  This  includes  a  review  from  one  external 
investment  professional  and  comments  from  non-
executive  Directors  of  the  Company  on  matters 
discussed at the Investment Committee meetings. 

Investments are monitored by the Manager, through 
monthly  portfolio  updates  and 
typically  an 
investment  manager  sitting  on  portfolio  company 
boards. The Board receives detailed reports on each 
investment  and  their  valuation  as  part  of  their 
quarterly board meetings. 

Review and oversight by the non-executive Directors 
ensures  that  the  risk  to  the  Company’s  and 
Manager’s reputation is kept to a minimum. 

Investments  are  valued  in  accordance  with  the 
International  Private  Equity  and  Venture  Capital 
Valuation  Guidelines,  which  represent  current  best 
practice  for  investment  valuation  and  are  reviewed 
by the Manager’s Valuation Committee. 

These  procedures  ensure  that  this  increased  risk 
continues to be mitigated where possible. 

Investment, 
performance and 
valuation risk

Investment  in  smaller  unquoted 
growth  businesses  carries  a  higher 
degree  of  risk  and  is  more  volatile 
than 
long-
established  businesses.  This  could 
negatively 
impact  shareholder 
returns.  

investing 

larger, 

in 

relies  on 

The  Company 
the 
judgement  and  reputation  of  the 
Manager 
strong 
investment  returns  and  valuations 
for shareholders. 

to  provide 

Company’s 

The 
investment 
valuation methodology is based on 
fair  value,  which 
for  smaller 
unquoted  growth  businesses  can 
be difficult to determine due to the 
lack of observable market data and 
the limitation of external reference 
points. 

16

Albion Venture Capital Trust PLC

 
   
   
   
 
263764 Albion Capital pp09-pp24.qxp  29/06/2022  16:59  Page 17

Strategic report  continued

Risk                         Possible consequence                       Risk assessment during the year    Risk management 

VCT approval 
and regulatory 
change risk

No change.

Any  breach  of  section  274  of  the 
Income  Tax  Act  2007,  including 
legislative  changes,  could 
any 
result in the loss of the Company’s 
HMRC  qualifying  status  and  tax 
reliefs for investors.

Regulatory and 
compliance risk

Operational and 
internal control 
risk (including 
cyber and data 
security)

Economic and 
political risk

the 

Companies 

The  Company  is  listed  on  The 
London  Stock  Exchange  and  is 
required to comply with the rules of 
the UK Listing Authority, as well as 
with 
Act, 
Accounting  Standards  and  other 
legislation.  Failure  to  comply  with 
these  regulations  could  result  in  a 
delisting of the Company’s shares, 
or  other  penalties  under  the 
Companies  Act  or  from  financial 
reporting oversight bodies.

The  Company  relies  on  a  number 
of  third  parties,  in  particular  the 
Manager,  for  the  provision  of 
investment  management  and 
administrative functions. Failures in 
key IT systems and controls within 
the  Manager’s  business  could 
place  assets  of  the  Company  at 
inaccurate 
risk, 
information  being  passed  to  the 
Board  or  shareholders.  This  could 
additionally  result  in  losses  for  the 
Company and its shareholders.

resulting 

in 

Events  such  as  the  Covid-19 
pandemic, the impact of Brexit, an 
economic  recession,  fluctuation  in 
inflation  and 
interest  rates,  or 
significant  political  events  could 
adversely  affect  the  companies 
and 
within 
consequently  the  Company’s  net 
asset value.

portfolio 

the 

No change.

No change.

Increased  (due  to  high  levels  of 
inflation  and  the  geopolitical  risks 
from the invasion of Ukraine).

The  Company’s  VCT  qualifying  status  is  monitored 
monthly by the Manager and quarterly by the Board. 
The  Board  has  appointed  Philip  Hare  &  Associates 
LLP  as  its  taxation  adviser,  who  independently 
confirms  compliance,  highlights  areas  of  risk  and 
informs  on  any  legislative  changes,  including  those 
which  may  arise  from  the  withdrawal  from  the 
European Union.

The Board and the Manager receive regular updates 
on  new  regulation,  including  legislation  on  the 
management  of  the  Company,  from  its  auditor, 
lawyers and other professional bodies. The Company 
is  subject  to  compliance  checks  through  the 
Manager’s compliance officer, and any issues arising 
from compliance or regulation are reported to its own 
board  on  a  monthly  basis.  The  Board  ensures  the 
Company is compliant as part of its quarterly Board 
meetings. 

The Board reviews the quarterly reports prepared by 
Ocorian  Depositary  (UK)  Limited  (the  Company’s 
Depositary) to ensure the Manager is adhering to the 
AIFMD requirements. 

The  Company’s  operations  and  IT  systems  are 
subject  to  rigorous  internal  controls  which  are 
reviewed  on  a  regular  basis  and  reported  to  the 
Board.  

The  Audit  Committee  reviews  the  Internal  Audit 
Reports prepared by the Manager’s internal auditors, 
Azets, and has access to their internal audit partner to 
whom it can ask specific detailed questions in order to 
satisfy itself that the Manager has strong systems and 
controls  in  place  including  those  in  relation  to  risk 
management, business continuity and cyber security.  

The  Board  reviews  the  systems  and  processes 
(including  cyber  and  data  security)  in  place  for  the 
Company’s  key  suppliers  to  ensure  that  there  is  an 
appropriate risk mitigation in place. 

The Company invests in a diversified portfolio of c.38 
companies,  predominantly  in  the  United  Kingdom, 
and  has  a  policy  of  minimising  any  external  bank 
borrowings within portfolio companies.  

Exogenous  risks  over  which  the  Company  has  no 
control are always a risk and the Company does what 
it can to address these risks. The inherent long-term 
nature  of  the  portfolio  helps  to  mitigate  these 
exogenous risks. 

The Board and Manager are continuously assessing 
the  resilience  of  the  portfolio  as  a  result  of  the 
ongoing  economic  and  political  risks,  to  ascertain 
where  support 
is  required.  The  Company  has 
sufficient  cash  resources  to  cope  with  any  such 
exigent  and  unexpected  pressures.  Exposure  is 
relatively small to at-risk sectors that include leisure, 
hospitality, retail and travel (3% of NAV). 

The  Company’s  investment  policy  and  the  Board’s 
scrutiny of the investment portfolio ensures that this 
increased  risk  continues  to  be  mitigated  where 
possible. 

Albion Venture Capital Trust PLC

17

 
   
   
   
 
   
   
   
 
   
   
   
 
   
   
   
 
263764 Albion Capital pp09-pp24.qxp  29/06/2022  16:59  Page 18

Strategic report  continued

Risk                         Possible consequence                       Risk assessment during the year    Risk management 

Liquidity risk

No change.

The  Company  may  not  have 
sufficient cash available to meet its 
financial obligations.  

is 
The  Company’s  portfolio 
primarily 
in  smaller  unquoted 
companies,  which  are  inherently 
illiquid  as  there 
is  no  readily 
available  market,  and  thus  it  may 
be difficult to realise their fair value 
at short notice. 

Environmental, 
social and 
governance 
(“ESG”) risk

An insufficient ESG policy could lead 
to an increased negative impact on 
the  environment, 
including  the 
Company’s carbon footprint. 

Non-compliance  with 
reporting 
requirements could lead to a fall in 
demand 
investors, 
from 
reputational damage and penalties. 

to 

(due 

Increased 
the  new 
guidance issued on climate change 
reporting 
increased 
and 
importance to stakeholders).

The  Board  reviews  the  Company’s  three  year  cash 
flow  forecasts  on  a  quarterly  basis.  These  include 
potential  investment  realisations  (which  are  closely 
monitored by the Manager), Top Up Offers, dividend 
payments and operational expenditure. This ensures 
that there are sufficient cash resources available for 
the Company’s liabilities as they fall due. 

The  Manager  is  a  signatory  of  the  UN  PRI  and  the 
Board is kept appraised of the evolving ESG policies 
at quarterly Board meetings.  

Full  details  of  the  specific  procedures  and  risk 
mitigation can be found in the ESG report on pages 
19 to 21. 

These  procedures  ensure  that  this  increased  risk 
continues to be mitigated where possible. 

Viability statement 
In  accordance  with  the  FRC  UK  Corporate  Governance  Code 
published in 2018 and provision 36 of the AIC Code of Corporate 
Governance,  the  Directors  have  assessed  the  prospects  of  the 
Company  over  three  years  to  31  March  2025.  The  Directors 
believe that three years is a reasonable period in which they can 
assess  the  ability  of  the  Company  to  continue  to  operate  and 
meet its liabilities as they fall due. This is the period used by the 
Board  as  part  of  its  strategic  planning  process,  which  includes: 
the  estimated  timelines  for  finding,  assessing  and  completing 
investments;  the  potential  impact  of  any  new  regulations;  and 
the availability of cash. 

The Board has carried out a robust assessment of the principal 
and  emerging  risks  facing  the  Company,  including  those  that 
could threaten its business model, future performance, solvency 
or  liquidity,  and  focused  on  the  major  factors  which  affect  the 
economic,  regulatory  and  political  environment.  The  Board 
carefully assessed, and were satisfied with, the risk management 
processes  in  place  to  avoid  or  reduce  the  impact  of  these  risks. 
The  Board  has  carried  out  robust  stress  testing  of  cashflows 
which  included  assessing  the  resilience  of  portfolio  companies, 
including  the  requirement  for  any  future  financial  support,  and 
evaluating the impact of high inflation, both within the Company 
and within its portfolio. 

The  Board  has  additionally  considered  the  ability  of  the 
Company  to  comply  with  the  ongoing  conditions  to  ensure  it 
maintains its VCT qualifying status under its current investment 

policy.  As  a  result  of  the  Board’s  quarterly  valuation  reviews,  it 
has  concluded  that  the  portfolio  is  well  balanced  and  geared 
towards  delivering  long  term  growth  and  strong  returns  to 
shareholders. 

The Board has concluded that there is a reasonable expectation 
that the Company will be able to continue in operation and meet 
its  liabilities  as  they  fall  due  over  the  three  year  period  to 
31  March  2025.  The  Board  is  mindful  of  the  ongoing  risks  and 
will continue to ensure that appropriate safeguards are in place, 
in  addition  to  monitoring  the  quarterly  cashflow  forecasts  to 
ensure the Company has sufficient liquidity. 

This  Strategic  report  of  the  Company  for  the  year  ended  31 
March  2022  has  been  prepared  in  accordance  with  the 
requirements of section 414A of the Companies Act 2006 (the 
“Act”). The purpose of this report is to provide Shareholders with 
sufficient  information  to  enable  them  to  assess  the  extent  to 
which  the  Directors  have  performed  their  duty  to  promote  the 
success of the Company in accordance with Section 172 of the 
Act. 

Richard Glover 
Chairman 
29 June 2022

18

Albion Venture Capital Trust PLC

 
   
   
   
 
   
   
   
 
 
263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 19

Environmental Social and Governance 
(“ESG”) report

The Company’s Manager, Albion Capital Group LLP, takes the concept of sustainable and responsible investment seriously for existing 
investments and in reviewing new investment opportunities. In turn, the Board is kept appraised of ESG issues in connection with both 
the portfolio and in how Company affairs are conducted more generally as a regular part of Board oversight. 

The Manager is a signatory of the United Nations Principles for Responsible Investment (“UN PRI”). The UN PRI is the world’s leading 
proponent  of  responsible  investment,  working  to  understand  the  investment  implications  of  ESG  factors  and  to  support  its 
international network of investor signatories in incorporating these factors into their investment and ownership decisions. 

The Board and Albion Capital Group LLP recognise that applying the following six Principles for Responsible Investment better aligns 
investors with broader objectives of society: 

Principle 1: to incorporate ESG issues into investment analysis and decision-making processes. 

Principle 2: to be active owners and incorporate ESG issues into our ownership policies and practices. 

Principle 3: to seek appropriate disclosure on ESG issues by the entities in which we invest. 

Principle 4: to promote acceptance and implementation of the Principles within the investment industry. 

Principle 5: to work together to enhance our effectiveness in implementing the Principles. 

Principle 6: to report on our activities and progress towards implementing the Principles. 

The  Board  and  the  Manager  have  exercised  conscious  principles  in  making  responsible  investments  throughout  the  life  of  the 
Company, not least in providing finance for promising companies in a variety of important sectors such as technology, healthcare and 
renewable energy. In making the investments, the Manager is directly involved in the oversight and governance of these investments, 
including ensuring standards of reporting and visibility on business practices, all of which are reported to the Board of the Company. 
By its nature, not least in making qualifying investments which fulfil the criteria set by HMRC, the Company has focused on sustainable 
and longer-term investment propositions, some of which will grow and serve important societal demands. One of the most important 
drivers  of  performance  is  the  quality  of  the  investment  portfolio,  which  goes  beyond  the  individual  valuations  and  examines  the 
prospects of each of the portfolio companies, as well as the sectors in which they operate – all requiring a longer-term view. 

In the nature of venture capital investment, the Manager is more intimately involved in the affairs of portfolio companies than might 
be the case for funds invested in listed securities. As such, the Manager is in a position to influence good governance and behaviour in 
the portfolio companies, many of which are relatively small companies without the support of a larger company’s administration and 
advisory infrastructure. The Company adheres to the principles of the AIC Code of Corporate Governance and is also aware of other 
governance  and  corporate  conduct  guidance  which  it  meets  as  far  as  practical,  including  in  the  constitution  of  a  diversified  and 
independent Board capable of providing constructive challenge. 

The Manager incorporates ESG considerations into its investment process. These form part of its process to create value for investors 
and develop sustainable long-term strategies for portfolio companies. The Manager reports ESG criteria to the UN PRI when required 
and to the Board quarterly. The Manager is a member of VentureESG steering committee, a global network of fund managers that 
drives application of ESG principles for early stage technology investors and companies. 

ESG  principles  are  integrated  at  the  pre-investment,  investment  and  exit  stages.  This  is  reflected  in  transparency  of  reporting, 
governance principles adopted by the Company and the portfolio companies, and increasingly in the positive environmental or socially 
impactful nature of investments made. The Manager, where relevant, considers climate-specific issues in its investment policies and 
activities. 

Albion Venture Capital Trust PLC

19

263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 20

Environmental Social and Governance 
(“ESG”) report  continued

The  Manager  has  long  held  the  belief  that  returns  are  optimised  by  investing  in  sustainable  businesses  with  positive  societal  and 
environmental outcomes, which forms an important aspect of the investment process: 

* The ESG BSC contains sustainability metrics against which a portfolio company is assessed in order to determine sustainability risks and opportunities, and track progress 

over time. As the Company is a minority investor in early stage technology companies, the Manager has not set ESG Key Performance Indicators for its portfolio companies. 

The Manager's role is to guide portfolio company leadership and share best practice methods across the venture capital industry. 

Pre-investment stage 

An exclusion list is used to rule out investments in unsustainable areas, or in areas which might be perceived as socially detrimental. 
ESG due diligence is performed on each potential portfolio company to identify any sustainability risks associated with the investment. 
Identified sustainability risks are ranked from low to high and are reported to the relevant investment committee. The investment 
committee  considers  each  potential  investment.  If  sustainability  risks  are  identified,  mitigations  are  assessed  and,  if  necessary, 
mitigation plans are put in place. If this is not deemed sufficient, the committee would consider the appropriate level and structure of 
funding to balance the associated risks. If this is not possible, investment committee approval will not be provided, and the investment 
will not proceed. 

The Manager’s standard copy of the investment deal documents includes a sustainability clause that reinforces individual portfolio 
company’s commitment to driving principles of ESG as it scales. 

Investment stage 

An  ESG  clause  is  integrated  into  the  shareholders  agreement  for  all  new  investments.  The  clause  outlines  the  portfolio  company’s 
commitment to combine economic success with ecological and social success. 

All  new  and  existing  portfolio  companies  are  asked  to  report  against  an  ESG  BSC  annually.  The  ESG  BSC  contains  a  number  of 
sustainability  factors  against  which  a  portfolio  company  is  assessed  in  order  to  determine  the  potential  sustainability  risks  and 
opportunities arising from the investment. The ESG BSCs form part of the Manager’s internal review meetings alongside discussions 
around  other  risk  factors,  and  any  outstanding  issues  are  addressed  in  collaboration  with  the  portfolio  companies’  senior 
management. 

Exit stage 

The  Manager  aims  to  ensure  that  good  ESG  practices  remain  in  place  following  exit.  For  example,  by  ensuring  that  the  portfolio 
company creates a self-sustaining ESG management system during our period of ownership, wherever feasible. 

20

Albion Venture Capital Trust PLC

 
263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 21

Environmental Social and Governance 
(“ESG”) report  continued

The Manager’s ESG initiatives 
The Manager incorporates ESG for its internal operations, a breakdown of its ESG considerations are as follows: 

Environmental – The Manager is committed to ensuring that the environmental impacts of its business operations are positive 
and as far as possible, any negative impact is mitigated. 

Social – The Manager aims to conduct its business in a socially responsible manner, to contribute to the communities in which it 
operates and to respect the needs of its employees and all of its stakeholders. 

Governance – The Manager seeks to conduct all of its business activities in an honest, ethical and socially responsible manner and 
these values underpin its business model and strategy. 

Overview of the Manager's ESG activity in 2021: 

Albion Venture Capital Trust PLC

21

263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 22

The Board of Directors 

The following are the Directors of the Company, all of whom operate in a non-executive capacity: 

Richard Glover (appointed 8 November 2017), Chairman 
Richard Glover spent 15 years in industrial relations and HR management roles in the 1970s and 1980s first with ICI and then with 
Grand Metropolitan. Since 1990 he has been involved with two private equity backed businesses in the service sector: first, in 1990 the 
British School of Motoring (BSM), where, as MD and later CEO, he took the company through flotation and then sale to RAC; and in 
2000, the accountancy training company ATC International, where he became the majority shareholder in 2003, running the business 
in Eastern Europe until it was sold in 2011. He has also held a number of non-executive director positions in the service sector and 
remains extensively involved with the Worshipful Company of Haberdashers and its education activities. 

John Kerr ACMA (appointed 9 February 1996) 
John Kerr has worked as a venture capitalist and also has experience in manufacturing and service industries. He held a number of 
finance and general management posts in the UK and USA, before joining SUMIT Equity Ventures, an independent Midlands based 
venture capital company, where he was managing director from 1985 to 1992. He then became chief executive of Price & Pierce 
Limited, which acted as the UK agent for overseas producers of forestry products, before leaving in 1997 to become finance director 
of Ambion Brick, a building materials company bought out from Ibstock PLC. Since retiring in 2002, he has worked as a consultant. 

Ann Berresford BSc (Hons), ACA (appointed 8 November 2017) 
Ann Berresford is a chartered accountant with a background in the financial services and energy sectors. She holds a degree in Organic 
Chemistry and trained as an accountant with Grant Thornton. After a period in audit, she moved into industry and spent over 20 years 
working in financial management and treasury roles, initially with Clyde Petroleum plc and then with the Bank of Ireland Group. Since 
2006, she has had a number of non-executive roles, including positions at Bath Building Society, the Pensions Protection Fund, Triodos 
Renewables  plc,  Hyperion  Insurance  Group  and  the  Pensions  Regulator.  She  is  currently  a  non-executive  director  of  Secure  Trust 
Bank plc. 

Richard Wilson, (appointed 1 May 2020) 
Richard Wilson is highly experienced in the asset management sector and was CEO of BMO Global Asset Management and previously 
CEO of F&C Asset Management plc, where he led the company’s acquisition by BMO Financial Group and subsequent integration into 
BMO  Global  Asset  Management.  He  began  his  asset  management  career  in  1988  as  a  U.K.  equity  manager  with  HSBC  Asset 
Management (formerly Midland Montagu). He then joined Deutsche Asset Management (formerly Morgan Grenfell), where he rose 
to  managing  director,  global  equities.  From  Deutsche,  he  moved  to  Gartmore  Investment  Management  in  2003  as  head  of 
international  equity  investments  before  joining  F&C  in  2004.  He  is  an  independent  non-executive  director  of  Insight  Investment 
Management. 

All Directors are members of the Audit Committee and John Kerr is Chairman. 

All Directors are members of the Nomination Committee and Richard Glover is Chairman. 

All Directors are members of the Remuneration Committee and Ann Berresford is Chairman. 

Ann Berresford is the Senior Independent Director. 

As part of the Board’s succession planning, John Kerr will retire as a Director at the Annual General Meeting on 6 September 2022, 
Ann  Berresford  will  take  over  as  Audit  Committee  Chairman  and  Richard  Wilson  will  take  over  as  Chairman  of  the  Remuneration 
Committee. From 1 July 2022, Neeta Patel CBE will be appointed as a Director. 

22

Albion Venture Capital Trust PLC

263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 23

The Manager

Albion Capital Group LLP is authorised and regulated by the Financial Conduct Authority and is the Manager of Albion Venture Capital
Trust PLC. Albion Capital Group LLP is a leading independent investment manager with a long term record of backing change and
growth. The wider Albion Group has funds of around £925m under management, expected commitment or administration.

The  following  are  specifically  responsible  for  the  management  and  administration  of  the  Venture  Capital  Trusts  managed  by
the Manager:

Will  Fraser-Allen  BA  (Hons),  FCA, is the managing partner of Albion Capital and chairs the investment committee. He is deputy
chairman of the VCT Association, chairing its Public Policy Committee and sits on the Venture Capital Committee of the BVCA. He
joined Albion in 2001, became deputy managing partner in 2009 and managing partner in 2019. He has over 20 years’ experience
investing  in  healthcare,  leisure,  media  and  technology  enabled  businesses.  Prior  to  joining  Albion,  he  qualified  as  a  chartered
accountant and has a BA in History from Southampton University.

Patrick Reeve MA, FCA, was formerly the managing partner of Albion Capital and became chairman on 1 April 2019. He is a director
of Albion Development VCT, Albion Technology & General VCT and Albion Enterprise VCT. Patrick is on Albion’s Valuation Committee
and its Risk Management Committee. He is also a director of the Association of Investment Companies. He joined Close Brothers
Group plc in 1989 before establishing Albion Capital (formerly Albion Ventures LLP) in 1996. Prior to Close he qualified as a chartered
accountant before joining Cazenove & Co. He has an MA in Modern Languages from Oxford University.

Dr. Andrew Elder MA, FRCS, initially practised as a neurosurgeon before starting his career in investment. He now focuses on medical
technologies, digital health and the life-science sector. He is head of healthcare investing and became deputy managing partner of
Albion Capital in 2019. He graduated with an MA plus Bachelors of Medicine and Surgery from Cambridge University and practised as
a surgeon for six years. He is a Fellow of the Royal College of Surgeons (England).

Lauren  Apostolidis,  takes  responsibility  for  driving  the  growth  and  engagement  of  the  Talent  X  platform.  In  this  impactful  brand
ambassadorial  role,  Lauren  focuses  on  continuously  expanding  the  value  of  AlbionVC  networks  to  increase  the  success  of  our
companies.  Previously,  as  Platform  Lead  for  workspace  accelerator,  Huckletree,  Lauren  built  and  managed  the  support  network  of
ambassadors  and  investors  to  help  connect  founders  across  the  workspaces  to  key  individuals  in  the  ecosystem.  She  built  relevant
programming and connection opportunities for the start ups and also ran an in-house accelerator for underrepresented founders who
were looking to raise their Seed round. Prior to this, Lauren managed FinTech partnerships at Thomson Reuters (Refinitiv, now part of
LSEG).

Adam Chirkowski MA (Hons), is responsible primarily for investments in the asset-based portfolio. He is an investment director at
Albion Capital and invests across a number of sectors including digital infrastructure, healthcare and renewable energy. He graduated
from Nottingham University with a first class degree in Industrial Economics and a Masters in Corporate Strategy and Governance.
Prior to joining Albion in 2013, he spent five years working in corporate finance at Rothschild.

Emil  Gigov  BA  (Hons),  FCA,  has  been  an  early-stage  investor  for  over  20  years,  supporting  more  than  30  companies  spanning
software  technology,  advanced  manufacturing,  education  and  healthcare.  More  recently  he  has  focused  on  B2B  SaaS  businesses
across a range of sectors including data management, FinTech and marketing technologies. He joined Albion Capital in 2000 and
became a partner in 2009. He graduated from the European Business School, London, with a BA (Hons) Degree in European Business
Administration.

Dr. Molly Gilmartin BA, joined Albion Capital from McKinsey & Company where she focused on healthcare systems, services and
technologies. Prior to McKinsey, Molly was Chief Commercial Officer of Induction Healthcare Group which completed an IPO on AIM
in  2019  and  provided  digital  tools  for  healthcare  professionals  and  patients  to  deliver  care  more  efficiently  and  effectively.  Before
Induction, Molly was a founding team member of Pando, a messaging and workflow tool for doctors, and an NHS Clinical Entrepreneur
as a medical doctor. As part of the Albion investment team, Molly focuses on health technology investing with a focus on digital tools
and technologies that can drive better outcomes for patients through more efficient delivery of care and better clinical research.

Albion Venture Capital Trust PLC

23

263764 Albion Capital pp09-pp24.qxp  29/06/2022  15:46  Page 24

The Manager  continued

Vikash Hansrani BA (Hons), FCA, is the operations partner of Albion Capital and oversees the finance and administration of all the
funds under Albion’s management. He qualified as a chartered accountant with RSM and latterly worked in its corporate finance team,
before  joining  Albion  in  2010  and  becoming  a  partner  in  2017.  Vikash  is a  member  of  Albion’s  Valuation  Committee  and  its  Risk
Management Committee. He has a BA (Hons) in Accountancy & Finance from Nottingham Business School.

Ed Lascelles BA (Hons), heads up the technology investment team at Albion Capital, focusing on B2B software and disruptive tech
services. He joined Albion in 2004, having started his career advising public companies during the ‘dotcom’ boom, and became a
partner in 2009. He graduated from University College London with a first class honours degree in Philosophy.

Paul Lehair MSc, MA, joined Albion Capital with 10 years of experience in tech start-ups and investment banking. He came from
Citymapper where he was finance director for 5 years having joined when the company had less than ten employees. He also worked
in business operations at Viagogo and in M&A TMT at Citigroup. He is an investment manager at Albion specialising in technology
investing. He has a dual Masters degree in European Political Economy from the London School of Economics and Political Science and
Sciences Po Paris.

Catriona McDonald BA (Hons), joined Albion Capital in 2018 from Goldman Sachs where she worked on IPOs, M&A and leveraged
buyouts in New York and London. Her time in banking gave her experience of implementing proven systems and running detailed
analysis. She is now an investment manager at Albion specialising in technology investing. She graduated from Harvard University,
majoring in Economics.

Jane Reddin BA (Hons), is a partner at Albion Capital. She helps the Albion VCTs invest in strong founders, by assessing leadership
potential, and accelerating the scaling of Albion’s portfolio companies. In her 25 year career, she has transacted over 500 senior hires,
built international, new-market and fund teams and helped over 70 start-ups build high performing teams. Prior to joining Albion, she
spent  six  years  as  Talent  Adviser  at  Balderton  Capital  and  then  co-founded  The  Talent  Stack,  a  talent  management  consulting
company for startups. She joined Albion in 2021 and became partner in 2022. She developed the talent platform at Albion which
enables the sharing of talent and leadership development expertise with Albion’s early-stage community. She graduated from Durham
University with a BA in French and German.

Dr. Christoph Ruedig MBA, practised radiology and strategy consulting before becoming an investor in healthcare. He joined Albion
Capital in 2011 and became a partner in 2014. At Albion he focuses on digital health, with investments ranging from clinical trial
software  to  chronic  disease  management.  Prior  to  joining  Albion,  he  worked  at  General  Electric  UK,  where  he  was  responsible  for
mergers and acquisitions in healthcare, following a role in venture capital with 3i plc. He holds a degree in medicine from Ludwig-
Maximilians University, Munich and an MBA from INSEAD.

Nadine Torbey MSc, BEng, joined Albion Capital in 2018 from Berytech Fund Management, one of the first VC funds in the Middle
East, her investing experience includes: AI/Data Platforms and Infrastructure, CX, Digital Networks and Hardware. She is an investment
manager at Albion specialising in technology investing. She graduated from the American University of Beirut with a BSc in Electrical
and Computer Engineering, and followed this with an MSc in Innovation Management and Entrepreneurship from Brown University.

Robert Whitby-Smith BA (Hons), FCA, is a partner at Albion Capital specialising in software investing. Robert joined Albion in 2005
and became a partner in 2009. Previously Robert worked in corporate finance for Credit Suisse, KPMG and ING Barings, after qualifying
as a chartered accountant.

Jay Wilson MBA, MMath, comes from an advisory background and is focused on partnering with management teams. He joined
Albion Capital in 2019 from Bain & Company, where he had been a consultant since 2016 and is an investment director at Albion
specialising in technology investing. Prior to this he graduated from London Business School with an MBA having spent eight years as
a broker at ICAP Securities.

Marco  Yu  PhD,  MRICS,  specialises  in  energy  related  investment  and  has  in-depth  knowledge  and  understanding  of  energy
generation, distribution, balancing, storage as well as servicing the sector. He is Head of Renewables at Albion Capital, has a first class
degree in economics from Cambridge, a PhD in construction economics from UCL and has led over 20 investments to date. Prior to
joining Albion in 2007 he qualified as a Chartered Surveyor with Bouygues (UK), and advised on large capital projects with EC Harris.

24

Albion Venture Capital Trust PLC

263764 Albion Capital pp25-pp32.qxp  29/06/2022  15:46  Page 25

Portfolio of investments

                                                                                                                                                                        As at 31 March 2022                                   As at 31 March 2021

                                                                                                                               % voting                                                                                                                                                                Change 
                                                                                                                          rights held                       Cumulative                                                        Cumulative                                    in value 
                                                                                                                       by all Albion                            movement                                                        movement                                    for the 
                                                                                                 %  voting          managed              Cost*         in value              Value               Cost*           in value                Value            year** 
Fixed asset investments                                               rights       companies            £’000             £’000              £’000             £’000              £’000               £’000            £’000 

Chonais River Hydro Limited                                       9.2                50.0          3,074          1,304           4,378         3,074          1,197           4,271             107 

Cantab Research Limited (T/A Speechmatics)                2.5                11.4          1,798          1,026           2,824         1,144                   –           1,144          1,026 

Elliptic Enterprises Limited                                           1.4                   5.9          1,913             713           2,626         1,244                   –           1,244             713 

Radnor House School (TopCo) Limited                      6.9                48.3          1,259          1,229           2,488         1,259              914           2,173             315 

The Evewell Group Limited                                          5.2                33.0          1,272          1,154           2,426             863              803           1,666             350 

Seldon Technologies Limited                                       4.6                14.0          2,212                  –           2,212             902                   –              902                  – 

Gharagain River Hydro Limited                                11.5                50.0          1,363             521           1,884         1,363              431           1,794               90 

TransFICC Limited                                                         2.9                17.8          1,025             271           1,296             286                   –              286             271 

NuvoAir Holdings Inc                                                    2.3                11.2             943             344           1,287                  –                   –                    –             344 

Beddlestead Limited                                                     9.1                49.0          1,142             133           1,275         1,142            (336)             806             469 

Threadneedle Software Holdings  
Limited (T/A Solidatus)                                                 2.1                11.5          1,262                  –           1,262         1,262                   –           1,262                  – 

The Street by Street Solar Programme  
Limited                                                                             6.5                50.0             675             548           1,223             675              503           1,178               45 

Gravitee TopCo Limited (T/A Gravitee.io)                 3.7                18.4             813             223           1,036                  –                   –                    –             223 

Healios Limited                                                               2.4                17.5             678             339           1,017             678              339           1,017                  – 

uMotif Limited                                                                4.0                21.0          1,078              (76)          1,002             486                35              521            (111) 

Alto Prodotto Wind Limited                                         7.4                50.0             509             373              882             551              359              910               28 

MHS 1 Limited                                                             14.8                48.8          1,026            (169)             857         1,026            (110)             916              (59) 

Arecor Therapeutics PLC                                               0.7                   5.5             249             507              756             249              107              356             400 

The Voucher Market Limited (T/A WeGift)                1.8                10.0             735                  –              735             735                   –              735                  – 

Regenerco Renewable Energy Limited                      4.5                50.0             451             279              730             451              275              726                  4 

Kew Green VCT (Stansted) Limited                         45.2                50.0          1,234            (637)             597         1,234         (1,211)               23             574 

Brytlyt Limited                                                                3.4                14.8             577                  –              577                  –                   –                    –                  – 

PerchPeek Limited                                                          1.7                11.6             503                  –              503                  –                   –                    –                  – 

Imandra Inc.                                                                   1.3                   8.1             175             272              447             121                   –              121             272 

Dragon Hydro Limited                                                  7.3                30.0             264             169              433             277              174              451                (4) 

Erin Solar Limited                                                        18.6                50.0             520            (100)             420             520               (72)             448              (28) 

Limitless Technology Limited                                      1.8                11.0             471            (115)             356             471                47              518            (162) 

uMedeor Limited (T/A uMed)                                     3.2                   9.5             334                  –              334             334                   –              334                  – 

Accelex Technology Limited                                        3.6                16.5             324                  –              324                  –                   –                    –                  – 

AVESI Limited                                                                 7.4                50.0             242                78              320             242                82              324                (4) 

Harvest AD Limited                                                           –                      –             307                 (2)             305             307                   5              312                (7) 

Concirrus Limited                                                           1.9                   9.7             975            (753)             222             975                   –              975            (753) 

Greenenerco Limited                                                     3.9                50.0             102                72              174             110                71              181                  5 

Premier Leisure (Suffolk) Limited                                9.9                47.4             175              (10)             165             175                 (2)             173                (8) 

Regulatory Genome Development Limited               1.0                   4.9             146                  –              146                  –                   –                    –                  – 

Symetrica Limited                                                          0.3                   5.0                83              (17)               66               83               (17)               66                  – 

Avora Limited                                                                  4.2                16.7             750            (733)               17             750            (467)             283            (266) 

Forward Clinical Limited (T/A Pando)                        1.2                   9.2             149            (147)                  2             149            (144)                  5                (3) 

Total fixed asset investments                                                                30,808         6,796       37,604      23,138          2,983         26,121        3,831 

*The cost includes the original cost from Albion Venture Capital Trust PLC and the carried over value on merger from Albion Prime VCT PLC as at 25 September 2012. 
**As adjusted for additions and disposals during the year. 
The comparative cost and valuations for 31 March 2021 do not agree to the Annual Report and Financial Statements for the year ended 
31 March 2021 as the above list does not include brought forward investments that were fully disposed of in the year.

Albion Venture Capital Trust PLC

25

 
263764 Albion Capital pp25-pp32.qxp  29/06/2022  15:46  Page 26

Portfolio of investments continued

                                                                                                                                                                 Opening                                  Total     Gain/(loss) 
                                                                                                                                                                  carrying       Disposal       realised   on opening 
Realisations in the year ended                                                                                           Cost*            value      proceeds    gain/(loss)             value 
31 March 2022                                                                                                                      £’000              £’000              £’000             £’000                 £’000 

Disposals: 

Credit Kudos Limited                                                                                                                             584                 584              3,025            2,441               2,441 

Phrasee Limited                                                                                                                                      538              1,400              1,736            1,198                   336 

Loan stock repayments and other:                                                                                                                                                            

Alto Prodotto Wind Limited                                                                                                                    43                   57                   57                  14                        – 

Dragon Hydro Limited                                                                                                                             13                   13                   13                     –                        – 

Greenenerco Limited                                                                                                                                  8                   11                   11                     3                        – 

Escrow adjustments**                                                                                                                                 –                      –                   57                  57                     57 

Xperiome Limited***                                                                                                                               345                 288                      –              (345)              (288) 

Total                                                                                                                                                  1,531             2,353             4,899            3,368               2,546 

*The cost includes the original cost from Albion Venture Capital Trust PLC and the carried over value on merger from Albion Prime VCT PLC as at 25 September 2012. 
**These comprise fair value movements on deferred consideration on previously disposed investments and expenses which are incidental to the purchase or disposal of an 
investment 
***In administration  

Total change in value of investments for the year                                                                                                                                                3,831 

Movement in loan stock accrued interest                                                                                                                                                                                           (47) 

Unrealised gains sub-total                                                                                                                                                                                          3,784 

Realised gains in current year                                                                                                                                                                                                           2,546 

Finance income from the unwinding of discount on deferred consideration                                                                                                                            223 

Total gains on investments as per Income statement                                                                                                                                          6,553 

26

Albion Venture Capital Trust PLC

 
 
263764 Albion Capital pp25-pp32.qxp  29/06/2022  15:46  Page 27

Portfolio companies 

Geographical locations

Portfolio of 38 companies
employing over 1,800 people
predominantly in the United
Kingdom.

8 renewable energy
companies generating
approximately 24GWh
per annum, capable of
powering 7,400 typical
households.

Software and other technology

Healthcare 
(including digital healthcare)

Renewable energy

Business services and other

Education

Numbers indicate top 10
investments by value

Albion Venture Capital Trust PLC

27

263764 Albion Capital pp25-pp32.qxp  29/06/2022  15:46  Page 28

Portfolio companies continued

The top ten portfolio companies by value are shown below.

1. Chonais River Hydro Limited 
Chonais Hydro is a 2MW hydropower scheme near 
Loch Carron in the Scottish Highlands. It is a run-of-
river scheme, taking water from a small river via an 
intake on the mountainside. The scheme is low visual 
impact  with  the  only  visible  components  being  a 
small  intake  and  a  powerhouse,  both  of  which  are 
built  using  local  material.  It  generates  enough 
electricity to power about 2,000 homes. It benefits 
from  inflation-protected  renewable  subsidies  for  a 
period of 20 years. The scheme was commissioned 
in 2014 and has been generating successfully since.

Filleted audited results:  year to 30 September 2021

£’000

Investment information

Net liabilities
Basis of valuation:

(163)
Third party valuation – discounted cash flow

Income recognised in the year
Total cost
Total valuation
Voting rights
Voting rights for all Albion managed companies

£’000 

276 
3,074 
4,378 
9.2% 
50.0%

2. Cantab  Research  Limited 

(T/A 

Speechmatics) 

Speechmatics provides advanced speech recognition 
software.  Their  technology  can  automatically 
transcribe any voice or audio assets from any live or 
recorded media and convert it into text in real time 
with  leading  accuracy  across  a  wide  range  of 
languages.  The  software  can  be  deployed  using 
small  footprint  language  models,  which  allow  the 
speech  to  text  processing  to  be  performed  at  high 
accuracy both on premise and on device, as well as in 
the  cloud.  Albion  funds  invested  alongside  existing 
investors (IQ Capital and leading Cambridge angels) 
to accelerate growth.

Website: www.speechmatics.com 

Audited results: year to 31 December 2020                                              £’000            Investment information                                                                    £’000 

Turnover                                                                                                                         6,409             Income recognised in the year                                                                            – 
LBIDTA                                                                                                                        (3,976)             Total cost                                                                                                          1,798 
Loss before tax                                                                                                          (4,177)             Valuation                                                                                                          2,824 
Net assets                                                                                                                      3,704             Voting rights                                                                                                     2.5% 
Basis of valuation                                                 Cost and price of recent investment             Voting rights for all Albion  
                                                                                   (reviewed for impairment or uplift)             managed companies                                                                                   11.4%

28
28

Albion Venture Capital Trust PLC

263764 Albion Capital pp25-pp32.qxp  29/06/2022  15:46  Page 29

Portfolio companies continued

3. Elliptic Enterprises Limited 
Elliptic  provides  Anti  Money  Laundering  services  to 
digital asset (DA) institutions, e.g. crypto exchanges 
and banks, enabling them to detect financial crime 
and  comply  with  emerging  regulations.  Elliptic  is 
considered  a  key  regulatory  partner  and  spends 
considerable time liaising and advising the FCA, SEC 
and other state and regional regulators globally.   

Website: www.elliptic.co

Audited results: year to 31 March 2021

£’000

Investment information

Turnover
LBIDTA
Loss before tax
Net assets
Basis of valuation

4,359
(6,849)
(6,898)
7,686
Cost and price of recent investment 
(reviewed for impairment or uplift) 

Income recognised in the year
Total cost
Total valuation
Voting rights
Voting rights for all Albion managed companies

£’000 

– 
1,913 
2,626 
1.4% 
5.9% 

4. Radnor House School (TopCo) 

a 

Limited 
Radnor  House 
coeducational 
operates 
independent  school  near  Sevenoaks,  Kent.  The 
school is growing strongly with over 500 children on 
the  roll  and  further  capacity  to  expand.  Significant 
further investment has been made into the school's 
facilities  to  enable  it  to  deliver  a  personalised 
education  experience  to  each  student.  The 
curriculum  and  co-curricular  activities  are  designed 
to  give  each  child  a  wide  range  of  academic  and 
in  a  supportive  and  nurturing 
other  skills 
environment. 

Website: www.radnorhouse.org  

Audited results: year to 31 August 2021
Turnover
EBITDA
Loss before tax
Net assets     
Basis of valuation

£’000
7,548
622
(850)
12,205
Third party valuation – earnings multiple

Investment information
Income recognised in the year
Total cost
Total valuation
Voting rights
Voting rights for all Albion managed companies

£’000 
203 
1,259 
2,488 
6.9% 
48.3%

Albion Venture Capital Trust PLC

29

263764 Albion Capital pp25-pp32.qxp  29/06/2022  15:46  Page 30

Portfolio companies continued

5. The Evewell Group Limited
The  Evewell  owns  and  operates  private  pay
women’s health centres of excellence with one on
Harley  Street  and  another  one,  which  opened  in
2022,  in  Hammersmith,  both  focusing  on  fertility
and  IVF  treatment  but  uniquely  also  covering  all
aspects of a woman’s gynaecological health.

Filleted audited results: year to 31 December 2020

£’000

Investment information

Net liabilities
Basis of valuation:

(3,354)
Earnings multiple

Income recognised in the year
Total cost
Valuation
Voting rights
Voting rights for all Albion managed companies 

Website: www.evewell.com

£’000

143
1,272
2,426
5.2%
33.0%

6. Seldon Technologies Limited
Seldon  is  a  software  company  that  enables
enterprises to deploy Machine Learning models in
production.  Their  open  core  platform  allows  data
scientists and ML engineers to serve, monitor and
explain their models - increasing efficiency by 93%
and  improving  ROI  of  AI  initiatives  in  enterprise.
Tech  is  horizontal  with  customers  in:  Healthcare,
Financial  Sector,  Automotive,  Tech  companies,
Insurance, etc. 

Filleted unaudited results: year to 31 March 2021

£’000

Investment information

Net assets
Basis of valuation:

7,911
Cost and price of recent investment 
(reviewed for impairment or uplift)

Income recognised in the year
Total cost
Valuation
Voting rights
Voting rights for all Albion managed companies 

Website: www.seldon.io

£’000

–
2,212
2,212
4.6%
14.0%

30

Albion Venture Capital Trust PLC

263764 Albion Capital pp25-pp32.qxp  29/06/2022  15:46  Page 31

Portfolio companies continued

7. Gharagain River Hydro Limited
Gharagain  River  Hydro  is  a  1MW  hydropower
scheme near Loch Carron in the Scottish Highlands,
about  3  miles  from  Chonais  Hydro.  It  is  a  run-of-
river  scheme  with  the  same  design  as  Chonais
Hydro.  It  generates  enough  electricity  to  power
about  1,000  homes.  It  benefits  from  inflation-
protected  renewable  subsidies  for  a  period  of  20
years. The scheme was commissioned in 2014 and
has been generating successfully since.

Filleted audited results: year to 30 September 2021

£’000

Investment information

Net assets
Basis of valuation:

175
Third party valuation – discounted cash flow

Income recognised in the year
Total cost
Total valuation
Voting rights 
Voting rights for all Albion managed companies

£’000

119
1,363
1,884
11.5%
50.0%

8. TransFICC Limited 
TransFICC connects to fixed income trading venues
(codes to each of their raw APIs), normalises their
APIs and delivers all connections to the sellside and
buyside via one API. TransFICC thereby takes care
of  the  tech,  connectivity  and  testing  issues
associated  with  venue  connectivity,  abstracting
financial
away  enormous 
institutions.  The  long-term  vision  is  for  TransFICC
to  become  the  core  connectivity  platform  for  e-
trading.

complexity 

for 

Filleted audited results: year to 31 December 2020

£’000

Investment information

Net assets
Basis of valuation:

6,662
Cost and price of recent investment 
(reviewed for impairment or uplift)

Income recognised in the year
Total cost
Total Valuation
Voting rights
Voting rights for all Albion managed companies 

£’000

–
1,025
1,296
2.9%
17.8%

Website: www.transficc.com

Albion Venture Capital Trust PLC

31

263764 Albion Capital pp25-pp32.qxp  29/06/2022  15:46  Page 32

Portfolio companies continued

9. NuvoAir Holdings Inc
NuvoAir  provides  a  tech-enabled  service  platform
for  chronic  care  management  of  respiratory
conditions  such  as  asthma,  COPD  and  cystic
fibrosis.  Their  platform  is  used  by  hospitals  and
healthcare  systems  in  the  UK,  Europe  and  US  as
well  as  by  global  pharmaceutical  companies  in
clinical trials focused on respiratory disease areas.
Their vision is to become the leading platform for
remote  management  of  respiratory  conditions
globally.

Website: www.nuvoair.com

Audited results: year to 31 December 2021

£’000

Investment information

Turnover
LBITDA
Loss before tax
Net assets
Basis of valuation:

3,792
(2,373)
(2,084)
9,387
Cost and price of recent investment
(reviewed for impairment or uplift)

Income recognised in the year
Total cost
Total Valuation
Voting rights
Voting rights for all Albion managed companies 

£’000

–
943
1,287
2.3%
11.2%

10. Beddlestead Limited
Beddlestead owns and operates Syrencot House, an
exclusive use wedding venue near Andover offering
spaces  for  the  service,  reception,  banqueting,
catering and accommodation with a mature target
of  150  weddings  per  year.  The  venue  opened  in
2018 and following an intermittent period of trading
during Covid 19 is fully open and trading at mature
levels.

Filleted unaudited results: year to 31 December 2020

£’000

Investment information

Net assets
Basis of valuation:

1,263
Net assets 

Income recognised in the year
Total cost
Valuation
Voting rights
Voting rights for all Albion managed companies 

£’000

64
1,142
1,275
9.1%
49.0%

Website: www.syrencot.co.uk 

32

Albion Venture Capital Trust PLC

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 33

Directors’ report

The  Directors  submit  their  Annual  Report  and  the  audited 
Financial  Statements  on  the  affairs  of  Albion  Venture  Capital 
Trust  PLC  (the  “Company”)  for  the  year  ended  31  March  2022. 
The Statement of corporate governance on pages 39 to 44 forms 
a part of the Directors’ report. 

BUSINESS REVIEW 
Principal activity and status 
The principal activity of the Company is that of a Venture Capital 
Trust.  It  has  been  approved  by  H.M.  Revenue  &  Customs 
(“HMRC”)  as  a  Venture  Capital  Trust  in  accordance  with  the 
Income  Tax  Act  2007  and,  in  the  opinion  of  the  Directors,  the 
Company has conducted its affairs so as to enable it to continue 
to  obtain  such  approval.  In  order  to  maintain  its  status  under 
Venture  Capital  Trust  legislation,  a  VCT  must  comply  on  a 
continuing  basis  with  the  provisions  of  Section  274  of  the 
Income Tax Act 2007 and further details of this can be found on 
page 34 of this Directors’ report.  

The Company is not a close company for taxation purposes and 
its  shares  are  premium  listed  on  the  official  list  of  the  London 
Stock Exchange. 

Under current tax legislation, shares in the Company provide tax-
free  capital  growth  and  income  distribution,  in  addition  to  the 
income  and  capital  gains  tax  relief  some  investors  would  have 
obtained when they invested in the share offers. 

Capital structure 
Details  of  the  issued  share  capital,  together  with  details  of  the 
movements  in  the  Company’s  issued  share  capital  during  the 
year are shown in note 15. The Ordinary shares are designed for 
individuals  who  are  seeking,  over  the  long  term,  investment 
exposure to a diversified portfolio of unquoted investments. The 
investments are spread over a number of sectors, to produce a 
regular source of income, combined with the prospect of longer 
term capital growth.  

All  Ordinary  shares  (except  for  treasury  shares,  which  have  no 
right to dividend or voting rights) rank pari passu for voting rights 
and  each  Ordinary  share  is  entitled  to  one  vote.  There  are  no 
restrictions on the transfer of shares or on voting rights. 

Shareholders are entitled to receive dividends and the return of 
capital  on  winding  up  or  other  return  of  capital  based  on  the 
surpluses attributable to the shares. 

Issue and buy-back of Ordinary shares 
During  the  year  the  Company  issued  a  total  of  24,297,674 
Ordinary  shares  (2021:  1,759,986  Ordinary  shares),  of  which 
17,365,249  Ordinary  shares  (2021:  935,989  Ordinary  shares) 
were issued under the Albion VCTs Top Up Offers; and 6,932,425 
Ordinary  shares  (2021:  823,997  Ordinary  shares)  were  issued 
under the Dividend Reinvestment Scheme. 

Your Board, in conjunction with the boards of the other five VCTs 
managed  by  Albion  Capital  Group  LLP,  launched  a  prospectus 
top  up  offer  of  new  Ordinary  shares  on  6  January  2022.  The 
Board  announced  on  16  February  2022  that,  following  strong 
demand,  the  Company  had  reached  its  £10  million  limit  under 
the  Offer  and  was  fully  subscribed  and  closed  to  further 
applications. 

The Company operates a policy of buying back shares either for 
cancellation  or  for  holding  in  treasury.  Details  regarding  the 
current  buy-back  policy  can  be  found  on  page  7  of  the 
Chairman’s statement and details of share buybacks during the 
year can be found in note 15. 

Substantial interests and shareholder profile 
As  at  31  March  2022  and  at  the  date  of  this  Report,  the 
Company  was  not  aware  of  any  shareholder  who  had  a 
beneficial  interest  exceeding  3  per  cent.  of  voting  rights.  There 
have been no disclosures in accordance with Disclosure Guidance 
and Transparency Rule 5 made to the Company during the year 
ended 31 March 2022, and to the date of this Report.  

Future developments of the business 
Details on the future developments of the business can be found 
on page 8 of the Chairman’s statement and on page 10 of the 
Strategic report.  

Results and dividends 
Detailed  information  on  the  results  and  dividends  for  the  year 
ended  31  March  2022  can  be  found  in  the  Strategic  report  on 
page 10. 

Going concern  
In accordance with the Guidance on Risk Management, Internal 
Control and Related Financial and Business Reporting issued by 
the  Financial  Reporting  Council  (“FRC”)  in  2014,  and  the 
subsequent  updated  Going  concern,  risk  and  viability  guidance 
issued  by  the  FRC  due  to  Covid-19  in  2020,  the  Board  has 
assessed  the  Company’s  operation  as  a  going  concern.  The 
Company has sufficient cash and liquid resources, its portfolio of 
investments is well diversified in terms of sector, and the major 
cash outflows of the Company (namely investments, buy-backs 
and  dividends)  are  within  the  Company’s  control.  Cash  flow 
forecasts  are  discussed  quarterly  at  Board  level  with  regards  to 
going concern. The cash flow forecasts have been updated and 
stress  tested.  Accordingly,  after  making  diligent  enquiries,  the 
Directors have a reasonable expectation that the Company has 
adequate  resources  to  continue  in  operational  existence  over  a 
period of at least twelve months from the date of approval of the 
Financial Statements. For this reason, the Directors have adopted 
the going concern basis in preparing the accounts. The Directors 
do not consider there to be any material uncertainty over going 
concern. 

Albion Venture Capital Trust PLC 

33

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 34

Directors’ report continued

The  Board’s  assessment  of  liquidity  risk  and  details  of  the 
Company’s  policies  for  managing  its  capital  and  financial  risks 
are  shown  in  note  17.  The  Company’s  business  activities, 
together  with  details  of  its  performance  are  shown  in  the 
Strategic report and this Directors’ report. 

Post balance sheet events 
Details  of  events  that  have  occurred  since  31  March  2022  are 
shown in note 19. 

Principal risks and uncertainties 
A summary of the principal risks faced by the Company is set out 
on pages 16 to 18 of the Strategic report. 

VCT regulation 
The investment policy is designed to ensure that the Company 
continues to qualify and is approved as a VCT by HMRC. In order 
to  maintain  its  status  under  Venture  Capital  Trust  legislation,  a 
VCT  must  comply  on  a  continuing  basis  with  the  provisions  of 
Section 274 of the Income Tax Act 2007 as follows: 

1.        The Company’s income must be derived wholly or mainly 

from shares and securities; 

2.        At least 80 per cent. of the HMRC value of its investments 
must  have  been  represented  throughout  the  year  by 
shares  or  securities  that  are  classified  as  ‘qualifying 
holdings’; 

3.        At least 70 per cent. by HMRC value of its total qualifying 
holdings must have been represented throughout the year 
by holdings of ‘eligible shares’. Investments made before 
6  April  2018  from  funds  raised  before  6  April  2011  are 
excluded from this requirement; 

4.        At least 30 per cent. of funds raised in accounting periods 
beginning  on  or  after  6  April  2018  must  be  invested  in 
qualifying  holdings  by  the  anniversary  of  the  end  of  the 
accounting period in which the funds were raised; 

5.        At  the  time  of  investment,  or  addition  to  an  investment, 
the Company’s holdings in any one company (other than 
another  VCT)  must  not  have  exceeded  15  per  cent.  by 
HMRC value of its investments; 

6.        The Company must not have retained greater than 15 per 
cent.  of  its  income  earned  in  the  year  from  shares  and 
securities; 

7.        The  Company’s  shares,  throughout  the  year,  must  have 

been listed on a regulated market; 

8.        An  investment  in  any  company  must  not  cause  that 
company to receive more than £5 million in State aid risk 

34

Albion Venture Capital Trust PLC 

finance in the 12 months up to the date of the investment, 
nor  more  than  £12  million  in  total  (the  limits  are  £10 
million  and  £20  million  respectively  for  a  ‘knowledge 
intensive’ company); 

9.        The Company must not invest in a company whose trade 
is more than seven years old (ten years for a ‘knowledge 
intensive’  company)  unless  the  company  previously 
received State aid risk finance in its first seven years, or the 
company is entering a new market and a turnover test is 
satisfied;  

10.      The Company’s investment in another company must not 
be used to acquire another business, or shares in another 
company; and 

11.      The  Company  may  only  make  qualifying  investments  or 
certain  non-qualifying  investments  permitted  by  section 
274 of the Income Tax Act 2007. 

These tests drive a spread of investment risk through preventing 
holdings  of  more  than  15  per  cent.  by  HMRC  value  in  any 
portfolio  company.  The  tests  have  been  carried  out  and 
independently reviewed for the year ended 31 March 2022. The 
Company has complied with all tests and continues to do so.  

‘Qualifying  holdings’  include  shares  or  securities  (including 
unsecured  loans  with  a  five  year  or  greater  maturity  period)  in 
companies which have a permanent establishment in the UK and 
operate  a  ‘qualifying  trade’  wholly  or  mainly  in  the  United 
Kingdom.  The  investment  must  bear  a  sufficient  level  of  risk  to 
meet a risk-to-capital condition. Eligible shares must comprise at 
least 10 per cent. by HMRC value of the total of the shares and 
securities that the Company holds in any one portfolio company. 
‘Qualifying  trade’  excludes,  amongst  other  sectors,  dealing  in 
property  or  shares  and  securities,  insurance,  banking  and 
agriculture.  Details  of  the  sectors  in  which  the  Company  is 
invested can be found in the pie chart on page 9. 

  A  ‘knowledge  intensive’  company  is  one  which  is  carrying  out 
significant  amounts  of  R&D  from  which  the  greater  part  of  its 
business will be derived, or where those R&D activities are being 
carried out by staff with certain higher educational attainments. 

Portfolio  company  gross  assets  must  not  exceed  £15  million 
immediately  prior  to  the 
investment  and  £16  million 
immediately thereafter. 

On  31  March  2022,  the  HMRC  value  of  qualifying  investments 
(which includes a 12 month disregard for disposals) was 91.84% 
(2021: 91.03%). The Board continues to monitor this and all the 
VCT qualification requirements very carefully in order to ensure 
that  all  requirements  are  met  and  that  qualifying  investments 
comfortably  exceed  the  current  minimum  threshold,  which  is 

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 35

Directors’ report continued

80% required for the Company to continue to benefit from VCT 
tax  status.  The  Board  and  Manager  are  confident  that  the 
qualifying requirements can be met during the course of the year 
ahead. 

Environment 
The  management  and  administration  of  the  Company  is 
undertaken by the Manager. Albion Capital Group LLP recognises 
the importance of its environmental responsibilities, monitors its 
impact on the environment, and designs and implements policies 
to  reduce  any  damage  that  might  be  caused  by  its  activities. 
Initiatives  designed  to  minimise  the  Company’s  impact  on  the 
environment include recycling, favouring digital over printing and 
reducing energy consumption. Further details can be found in the 
Environmental, Social, and Governance (“ESG”) report on pages 
19 to 21. 

Global greenhouse gas emissions 
The  Company  qualifies  as  a  low  energy  user  with  regards  to 
greenhouse  gas  emissions,  producing  less  than  40,000kWh  of 
energy, and therefore is not required to report emissions from the 
operations  of  the  Company,  nor  does  it  have  responsibility  for 
any other emissions producing sources under the Companies Act 
2006 (Strategic report and Directors’ reports) Regulations 2013, 
including  those  within  our  underlying  investment  portfolio. 
Therefore, the Company is outside of the scope of Streamlined 
Energy Carbon Reporting. 

Anti-bribery  
The Company has a zero tolerance approach to bribery, and will 
not tolerate bribery under any circumstances in any transaction 
the Company is involved in.  

Albion  Capital  Group  LLP  conducts  due  diligence  on  the  anti-
bribery policies and procedures of all portfolio companies.  

Anti-facilitation of tax evasion  
The Company has a zero tolerance approach with regards to the 
facilitation  of  criminal  tax  evasion  and  has  a  robust  risk 
assessment procedure in place to ensure compliance. The Board 
reviews this policy and the prevention procedures in place for all 
associates on a regular basis. 

Diversity 
The  Board  currently  consists  of  three  male  Directors  and  one 
female  Director.  The  Board’s  policy  on  the  recruitment  of  new 
directors  is  to  attract  a  range  of  backgrounds,  skills  and 
experience  and  to  ensure  that  appointments  are  made  on  the 
grounds of merit against clear and objective criteria and to bear 
in mind gender and other diversity within the Board. 

More  details  on  the  Directors  can  be  found  in  the  Board  of 
Directors section on page 22. 

Packaged Retail and Insurance-based Investment Products 
("PRIIPs”)  
Investors  should  be  aware  that  the  PRIIPs  Regulation  requires 
the  Manager,  as  PRIIP  manufacturer,  to  prepare  a  Key 
Information Document ("KID") in respect of the Company. This 
KID must be made available by the Manager to retail investors 
prior to them making any investment decision and is available on 
the  Company's  webpage  on  the  Manager’s  website.  The 
Company is not responsible for the information contained in the 
KID and investors should note that the procedures for calculating 
the  risks,  costs  and  potential  returns  are  prescribed  by  the  law. 
The figures in the KID may not reflect the expected returns for 
the  Company  and  anticipated  performance  returns  cannot  be 
guaranteed. 

Alternative Investment Fund Managers Directive (“AIFMD”) 
Under  the  Alternative  Investment  Fund  Manager  Regulations 
2013 (as amended) the Company is a UK AIF and the Manager 
is a full scope UK AIFM. Ocorian Depositary (UK) Limited provides 
depositary services under the AIFMD. 

Material changes to information required to be made available 
to investors of the Company 
The  AIFMD  outlines  the  required  information  which  has  to  be 
made  available  to  investors  prior  to  investing  in  an  AIF  and 
directs that material changes to this information be disclosed in 
the Annual Report of the AIF. There were no material changes in 
the year. 

Assets of the Company subject to special arrangements arising 
from their illiquid nature 
There are no assets of the Company which are subject to special 
arrangements arising from their illiquid nature. 

Remuneration (unaudited) 
The  Manager  has  a  remuneration  policy  which  meets  the 
requirements of the AIFMD Remuneration Code and associated 
Financial Conduct Authority guidance. The remuneration policy 
together with the remuneration disclosures for the AIFM’s most 
recent reporting period are available on the Company’s webpage 
on the Manager’s website.  

Employees 
The Company is managed by Albion Capital Group LLP and has 
no  employees.  The  Board  consists  solely  of  non-executive 
Directors, who are considered key management personnel. 

Directors 
The  Directors  who  held  office  throughout  the  year,  and  their 
interests in the shares of the Company (together with those of 
their immediate family) are shown in the Directors’ remuneration 
report on page 46. 

Albion Venture Capital Trust PLC 

35

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 36

Directors’ report continued 

Directors’ indemnity 
Each  Director  has  entered  into  a  Deed  of  Indemnity  with  the 
Company  which  indemnifies  each  Director,  subject  to  the 
provisions of the Companies Act 2006 and the limitations set out 
in each deed, against any liability arising out of any claim made 
against themselves in relation to the performance of their duties 
as a Director of the Company. A copy of each Deed of Indemnity 
entered into by the Company with each Director is available at 
the registered office of the Company. 

Re-election of Directors 
Directors’ re-election is subject to the Articles of Association and 
the UK Corporate Governance Code. The AIC Code recommends 
that  all  Directors  submit  themselves  for  re-election  annually, 
therefore in accordance with the AIC Code, Richard Glover, Ann 
Berresford  and  Richard  Wilson  will  offer  themselves  for  re-
election. John Kerr will retire as a Director on 6 September 2022 
and is not being put forward for re-election accordingly. 

Advising ordinary retail investors 
The Company currently conducts its affairs so that its shares can 
be  recommended  by  financial  intermediaries  to  ordinary  retail 
investors  in  accordance  with  the  FCA’s  rules  in  relation  to  non-
mainstream investment products and intends to continue to do 
so for the foreseeable future. The FCA’s restrictions which apply 
to  non-mainstream  investment  products  do  not  apply  to  the 
Company’s  shares  because  they  are  shares  in  a  VCT  which,  for 
the purposes of the rules relating to non-mainstream investment 
products,  are  excluded  securities  and  may  be  promoted  to 
ordinary retail investors without restriction. 

Investment and co-investment 
The  Company  co-invests  with  other  Albion  Capital  Group  LLP 
managed  VCTs.  Allocation  of  investments  is  on  the  basis  of  an 
allocation  agreement  which  is  based,  inter  alia,  on  the  ratio  of 
cash available for investment and the HMRC VCT qualifying tests. 

Auditor 
The  Audit  Committee  annually  reviews  and  evaluates  the 
standard and quality of service provided by the Auditor, as well as 
value for money in the provision of these services. A resolution to 
re-appoint BDO LLP will be put to the Annual General Meeting. 

Cancellation of share premium and capital redemption 
reserve  
The Company obtained authority to cancel the amount standing 
to  the  credit  of  its  share  premium  and  capital  redemption 
reserves at the Annual General Meeting on 7 September 2021. 
The  purpose  of  the  proposal  was  to  increase  the  distributable 
reserves available to the Company for the payment of dividends, 
the buy-back of shares, and for other corporate purposes.  

The proposal received the consent of the Court on 10 December 
2021,  and  the  changes  have  been  registered  at  Companies 
House. Over time, this will create additional distributable reserves 
of £43.1 million. 

Annual General Meeting 
The Company’s Annual General Meeting (“AGM”) will be held at 
noon on 6 September 2022 via the Lumi platform. Information 
on  how  to  participate  in  the  live  webcast  can  be  found  on  the 
Manager’s website at www.albion.capital/vct-hub/agms-events. 

The  AGM  will  include  a  presentation  from  the  Manager,  the 
answering  of  questions  received  from  shareholders  and  the 
formal  business  of  the  AGM,  which  includes  voting  on  the 
resolutions proposed by the Board by way of a poll. Registration 
details for the webcast will be emailed to shareholders and will be 
available  at  www.albion.capital/vct-hub/agms-events  prior  to 
the AGM. 

The  Board  welcomes  questions  from  shareholders  at  the  AGM 
and  shareholders  will  be  able  to  ask  questions  using  the  Lumi 
platform  during  the  AGM.  Alternatively,  shareholders  can  email 
their questions to AAVCchair@albion.capital prior to the AGM.  

Shareholders will be able to vote during the AGM using the Lumi 
platform.  Shareholders  are  encouraged  to  complete  and  return 
proxy cards in advance of the AGM but those participating in the 
AGM will be able to cast their votes through the Lumi platform 
once the Chairman declares the poll open. 

The  results  of  the  poll  held  at  the  AGM  will  be  announced 
through a Regulatory Information Service and will be published 
on  the  Company’s  webpage  on  the  Manager’s  website  at 
www.albion.capital/funds/AAVC  as 
reasonably 
practicable following the AGM. 

soon  as 

Shareholders’  views  are  important,  and  the  Board  encourages 
shareholders to vote on the resolutions. You can cast your vote by 
using  the  proxy  form  enclosed  with  this  Annual  Report  or 
electronically at www.investorcentre.co.uk/eproxy. The Board has 
carefully considered the business to be approved at the AGM and 
recommends shareholders to vote in favour of all the resolutions 
being proposed. 

Full details of the business to be conducted at the AGM are given 
in the Notice of the Meeting on pages 72 to 75. 

The  ordinary  business  resolutions  1  to  7  includes  receiving  and 
adopting  the  Company’s  accounts,  to  approve  the  Directors’ 
remuneration  policy  and  report,  to  re-elect  Richard  Glover,  Ann 
Berresford and Richard Wilson as Directors, and to appoint BDO 
as auditor for the next year end and to fix their remuneration. 

36

Albion Venture Capital Trust PLC 

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 37

Directors’ report continued

£2,013,000.  No  Ordinary  shares  were  purchased  for  treasury 
during the year. 

Recommendation 
The Board believes that the passing of the resolutions above is in 
the  best  interests  of  the  Company  and  its  shareholders  as  a 
whole, and unanimously recommends that you vote in favour of 
these resolutions, as the Directors intend to do in respect of their 
own shareholdings. 

Disclosure of information to the Auditor 
In the case of the persons who are Directors of the Company at 
the date of approval of this report: 

•   so far as each of the Directors are aware, there is no relevant 
audit  information  of  which  the  Company’s  Auditor  is 
unaware; and 

•   each of the Directors has taken all the steps that they ought 
to have taken as a Director to make themselves aware of any 
information  and  to  establish  that  the 
relevant  audit 
Company’s Auditor is aware of that information. 

This disclosure is given and should be interpreted in accordance 
with the provisions of s418 of the Companies Act 2006. 

By Order of the Board 

Albion Capital Group LLP 
Company Secretary 
1 Benjamin Street 
London, EC1M 5QL 
29 June 2022

Resolutions relating to the following items of special business will 
be  proposed  at  the  forthcoming  Annual  General  Meeting  for 
which shareholder approval is required in order to comply either 
with  the  Companies  Act  or  the  Listing  Rules  of  the  Financial 
Conduct Authority. 

Resolution numbers 8 to 10 replace the authorities given to the 
Directors at the Annual General Meeting in 2021. The authorities 
sought at the forthcoming Annual General Meeting will expire 15 
months  from  the  date  that  the  resolution  is  passed  or  at  the 
conclusion of the next Annual General Meeting of the Company, 
whichever is earlier. 

Authority to allot shares 
Ordinary resolution number 8 will request the authority to allot 
up to an aggregate nominal amount of £277,049 representing 
approximately 20 per cent. of the issued Ordinary share capital 
of the Company as at the date of this Report. 

During  the  year,  Ordinary  shares  were  allotted  as  described  in 
detail in note 15. 

The  Directors’  current  intention  is  to  allot  shares  under  the 
Dividend  Reinvestment  Scheme  and  any  Albion  VCTs  Top  Up 
Offers. The Company currently holds 17,153,431 Ordinary shares 
in treasury which represents 12.5 per cent. of the total Ordinary 
share capital in issue as at 31 March 2022. 

Disapplication of pre-emption rights 
Special  resolution  number  9  will  request  the  authority  for  the 
Directors  to  allot  equity  securities  for  cash  without  first  being 
required  to  offer  such  securities  to  existing  members.  This  will 
include  the  sale  on  a  non  pre-emptive  basis  of  any  shares  the 
Company  holds  in  treasury  for  cash.  The  authority  relates  to  a 
maximum  aggregate  of  £277,049  of  the  nominal  value  of  the 
share  capital  representing  approximately  20  per  cent.  of  the 
issued Ordinary share capital of the Company as at the date of 
this report.  

Purchase of own shares 
Special  resolution  number  10  will  request  the  authority  to 
purchase a maximum of 20,764,805 shares representing 14.99 
per cent. of the Company's issued Ordinary share capital at, or 
between,  the  minimum  and  maximum  prices  specified  in 
resolution 10.  

The Board believes that it is helpful for the Company to continue 
to  have  the  flexibility  to  buy  its  own  shares  and  this  resolution 
seeks authority from shareholders to do so.  

During the financial year under review, the Company purchased 
3,919,566 Ordinary shares for cancellation representing 2.9 per 
cent. of called up share capital, at an aggregate consideration of 

Albion Venture Capital Trust PLC 

37

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 38

Statement of Directors’ responsibilities 

Website publication 
The Directors are responsible for ensuring the Annual Report and 
Financial Statements are made available on a website. Financial 
Statements  are  published  on  the  Company’s  webpage  on  the 
Manager’s  website 
in 
accordance with legislation in the United Kingdom governing the 
preparation  and  dissemination  of  Financial  Statements,  which 
may vary from legislation in other jurisdictions. The Company’s 
webpage is maintained on the Board’s behalf by the Manager. 

(www.albion.capital/funds/AAVC) 

Directors’ responsibilities pursuant to Disclosure Guidance 
and Transparency Rule 4 of the UK Listing Authority 
The Directors confirm to the best of their knowledge: 

•   The Financial Statements have been prepared in accordance 
with  UK  GAAP  and  give  a  true  and  fair  view  of  the  assets, 
liabilities, financial position and profit of the Company. 

•   The Annual Report includes a fair review of the development 
and performance of the business and the financial position of 
the Company, together with a description of the principal risks 
and uncertainties that it faces. 

For and on behalf of the Board 

Richard Glover 
Chairman 
29 June 2022

The  Directors  are  responsible  for  preparing  the  Annual  Report 
and Financial Statements in accordance with applicable law and 
regulations.  

Company  law  requires  the  Directors  to  prepare  Financial 
Statements for each financial year. Under that law the Directors 
have elected to prepare the Company’s Financial Statements in 
accordance  with  United  Kingdom  Generally  Accepted 
Accounting  Practice  (“UK  GAAP”)  (United  Kingdom  Accounting 
Standards and applicable law). Under company law the Directors 
must  not  approve  the  Financial  Statements  unless  they  are 
satisfied that they give a true and fair view of the state of affairs 
of the Company and of the profit or loss for the Company for that 
period.  

In  preparing  these  Financial  Statements,  the  Directors  are 
required to: 

•   select  suitable  accounting  policies  and  then  apply  them 

consistently; 

•   make  judgements  and  accounting  estimates  that  are 

reasonable and prudent; 

•   state whether they have been prepared in accordance with UK 
GAAP  subject  to  any  material  departures  disclosed  and 
explained in the Financial Statements; and  

•   prepare a Directors’ report, a Strategic report and Directors’ 
remuneration report which comply with the requirements of 
the Companies Act 2006. 

The  Directors  are  responsible  for  keeping  adequate  accounting 
records  that  are  sufficient  to  show  and  explain  the  Company’s 
transactions and disclose with reasonable accuracy at any time 
the  financial  position  of  the  Company  and  enable  them  to 
ensure  that  the  Financial  Statements  comply  with  the 
Companies Act 2006. They are also responsible for safeguarding 
the assets of the Company and hence for taking reasonable steps 
for the prevention and detection of fraud and other irregularities.  

The Directors are responsible for ensuring that the Annual Report 
and  Financial  Statements,  taken  as  a  whole,  are  fair,  balanced, 
and  understandable  and  provide  the  information  necessary  for 
shareholders  to  assess  the  Company’s  position,  performance, 
business model and strategy.  

38

Albion Venture Capital Trust PLC 

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 39

Statement of corporate governance

Background  
The Financial Conduct Authority requires all companies listed on 
a  regulated  market  to  disclose  how  they  have  applied  the 
principles and complied with the provisions of the UK Corporate 
Governance Code (the “Code”) issued by the Financial Reporting 
Council (“FRC”) in 2018.  

The Board has considered the Principles and Provisions of the AIC 
Code  of  Corporate  Governance  (“AIC  Code”).  The  AIC  Code 
addresses the Principles and Provisions set out in the Code, as well 
as setting out additional Provisions on issues that are of specific 
relevance  to  the  Company  and  other  investment  companies. 
Closed-ended  investment  companies  have  particular  factors 
which  have  an  impact  on  their  governance  arrangements, 
principally  from  four  features:  outsourcing  their  day  to  day 
activities  to  external  service  providers  and  being  governed  by 
boards  of  non-executive  directors;  the  importance  of  the 
Manager  in  the  outsourcing  compared  to  a  typical  supplier; 
having no executive directors or employees and consequently no 
executive  remuneration  packages;  and  no  customers  in  the 
traditional sense, only shareholders.  

The  Board  considers  that  reporting  against  the  Principles  and 
Provisions of the AIC Code, which has been endorsed by the FRC, 
provides  more  relevant  information  to  shareholders.  The 
Company has complied with the Principles and Provisions of the 
AIC Code.  

The AIC Code is available on the AIC website (www.theaic.co.uk). 
It  includes  an  explanation  of  how  the  AIC  Code  adapts  the 
Principles  and  Provisions  set  out  in  the  Code  to  make  them 
relevant for investment companies. 

Board of Directors 
The  Board  consists  solely  of 
independent  non-executive 
Directors. Richard Glover is the Chairman, Ann Berresford is the 
Senior  Independent  Director  and  John  Kerr  is  Chairman  of  the 
Audit Committee. All Directors are non-executive and day-to-day 
management responsibilities are sub-contracted to the Manager. 
The  Board  will  continue  to  act  independently  of  the  Manager 
and the Directors consider that the size of the Board is adequate 
to meet the Company’s future needs. 

The Board does not have a policy of limiting the tenure of any 
Director as the Board does not consider that a Director’s length 
of  service  reduces  their  ability  to  act  independently  of  the 
Manager. 

The AIC Code requires that all Directors submit themselves for re-
election  annually,  therefore  in  accordance  with  the  AIC  Code, 
Richard  Glover,  Ann  Berresford  and  Richard  Wilson  will  offer 
themselves  for  re-election  at  the  forthcoming  Annual  General 
Meeting. John Kerr will retire as a Director on 6 September 2022. 

The  Directors  have  a  range  of  business  and  financial  skills, 
including serving on the boards of other investment companies, 
which  are  relevant  to  the  Company;  these  are  described  in  the 
Board of Directors section of this Report on page 22. All of the 
Directors have demonstrated that they have sufficient time, skill 
and experience to acquit their Board responsibilities and to work 
together effectively. Directors are provided with key information 
on the Company’s activities, including regulatory and statutory 
requirements, and internal controls, by the Manager. The Board 
has access to secretarial advice and compliance services by the 
Manager, who is responsible for ensuring that Board procedures 
are  followed  and  applicable  procedures  complied  with.  All 
Directors  are  able  to  take  independent  professional  advice  in 
furtherance  of  their  duties  if  necessary.  The  Company  has  in 
place Directors’ & Officers’ Liability Insurance. 

The  Directors  have  considered  diversity  in  relation  to  the 
composition  of  the  Board  and  have  concluded  that  its 
membership is diverse in relation to experience and balance of 
skills. Further details on the recruitment of new directors can be 
found in the Nomination Committee section on page 42. 

The Board met four times during the year as part of its regular 
programme of Board meetings, with all Directors attending each 
meeting. A sub-committee of the Board comprising at least two 
Directors  met  during  the  year  to  allot  shares  issued  under  the 
Dividend  Reinvestment  Scheme  and  the  Albion  VCTs  Top  Up 
Offers.  A  sub-committee  of  the  Board  also  met  to  approve  the 
terms  and  contents  of  the  Offer  Documents  under  the  Albion 
VCTs’ Prospectus Top Up Offers 2021/22. There is regular contact 
between  individual  members  of  the  Board.  Representatives  of 
the  Manager  attend  Board  meetings  and  participate  in  Board 
discussions,  other  than  on  matters  where  there  might  be  a 
perceived  conflict  of  interest  between  the  Manager  and  the 
Company. 

The  Chairman  ensures  that  all  Directors  receive,  in  a  timely 
manner,  all  relevant  management,  regulatory  and  financial 
information.  The  Board  receives  and  considers  reports  regularly 
from the Manager and other key advisers, and ad hoc reports and 
information are supplied to the Board as required. The Board has 
a formal schedule of matters reserved for it and the agreement 
between the Company and its Manager sets out the matters over 
which the Manager has authority and limits beyond which Board 
approval must be sought. 

The  Manager  has  authority  over  the  management  of  the 
investment  portfolio,  the  organisation  of  custodial  services, 
accounting,  secretarial  and  administrative  services.  The  main 
issues reserved for the Board include: 

•   the  appointment,  evaluation,  remuneration  and  removal  of 

the Manager; 

Albion Venture Capital Trust PLC 

39

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 40

Statement of corporate governance 

continued 

•   the  consideration  and  approval  of  future  developments  or 
changes  to  the  investment  policy,  including  risk  and  asset 
allocation; 

•   consideration of corporate strategy and corporate events that 

arise; 

The evaluation process has consistently identified that the Board 
works well together and has the right balance of skills, experience, 
independence  and  knowledge  of  the  Company  amongst  the 
Directors.  Diversity  within  the  Board  is  achieved  through  the 
appointment of directors with different backgrounds and skills.  

•   application  of  the  principles  of  the  AIC  Code,  corporate 

governance and internal control; 

•   review  of  sub-committee  recommendations,  including  the 
recommendation  to  shareholders  for  the  appointment  and 
remuneration of the Auditor; 

•   approving  the  Annual  Report  and  Financial  Statements,  the 
Half-yearly  Financial  Report,  the  Interim  Management 
Statements (which the Company will continue to publish), net 
asset  value  updates  (where  required),  and  the  associated 
announcements; 

•   approval of the dividend policy and payments of appropriate 

dividends to shareholders; 

•   the performance of the Company, including monitoring of the 

discount of share price to the net asset value;  

•   share buy-back and treasury share policies; 

•   participation in dividend re-investment schemes and Top Up 

Offers; and 

•   monitoring  shareholder  profile  and  considering  shareholder 

communications. 

Given the size, nature and complexity of the Company, the Board 
considers 
to  establish  a  Management 
Engagement Committee. 

it  unnecessary 

It is the responsibility of the Board to present an Annual Report 
and  Financial  Statements  that  are  fair,  balanced  and 
understandable,  which  provides  the  information  necessary  for 
shareholders  to  assess  the  position,  performance,  strategy  and 
business model of the Company. 

Committees’ and Directors’ performance evaluation 
Performance  of  the  Board  and  the  Directors  is  assessed  on  the 
following: 

•   attendance at Board and Committee meetings; 

•   the contribution made by individual Directors at, and outside 

of, Board and Committee meetings; and 

•   completion  of  a  detailed  internal  assessment  process  and 
annual performance evaluation conducted by the Chairman. 
The  Senior  Independent  Director  reviews  the  Chairman’s 
annual performance evaluation. 

40

Albion Venture Capital Trust PLC 

Directors  are  offered  training,  both  at  the  time  of  joining  the 
Board  and  on  other  occasions  where  required.  The  Directors 
attend  external  courses  and  industry  events  which  provides 
further  experience  to  help  them  fulfil  their  responsibilities.  The 
Board  also  undertakes  a  proper  and  thorough  evaluation  of  its 
committees on an annual basis. 

In  light  of  the  performance  of  the  individual  Directors  and  the 
structured  performance  evaluation,  Richard  Glover,  Ann 
Berresford  and  Richard  Wilson,  are  considered  to  be  effective 
Directors who demonstrate strong commitment to the role. The 
Board believes it to be in the best interest of the Company to re-
appoint  these  Directors  at  the  forthcoming  Annual  General 
Meeting and has nominated them for re-election accordingly. As 
John Kerr is retiring from the Board on 6 September 2022, he is 
not  being  put  forward  for  re-election.  For  more  details  on  the 
specific background, skills and experience of each Director, please 
see the Board of Directors section on page 22. 

Remuneration Committee 
Ann Berresford is Chairman of the Remuneration Committee and 
all  of  the  Directors  are  members  of  this  Committee.  From 
6 September 2022, Richard Wilson will take over as Chairman of 
the  Remuneration  Committee.  Given  the  size  of  the  Board  and 
the complexity of the business, all Directors are members of this 
committee as their background, skills and experience are relevant 
for the Committee's responsibilities. The Committee meets once 
a year and held one formal meeting during the year which was 
attended by all the members of the Committee. 

The terms of reference for the Remuneration Committee can be 
found on the Company’s webpage on the Manager’s website at 
www.albion.capital/funds/AAVC 
“Corporate 
Governance” section. 

under 

the 

Audit Committee 
John Kerr is Chairman of the Audit Committee and all Directors 
are  members  of  this  Committee.  In  accordance  with  the  AIC 
Code, members of the Audit Committee have recent and relevant 
financial experience, as well as experience relevant to the sector. 
John Kerr will retire as a Director at the Annual General Meeting 
on 6 September 2022 and Ann Berresford will take over as Audit 
Committee  Chairman.  Given  the  size  of  the  Board  and  the 
complexity of the business, Richard Glover is both Chairman of 
the  Board  and  a  member  of  the  Audit  Committee  as  his 
background,  skills  and  experience  are  relevant  for  the 
Committee’s  responsibilities.  The  Committee  met  twice  during 

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 41

Statement of corporate governance 

continued 

the year ended 31 March 2022, which were fully attended by all 
the members of the Committee. 

The  Independent  Auditor,  BDO  LLP,  attended  the  Audit 
Committee  meeting  at  which  the  Annual  Report  and  Financial 
Statements for the year ended 31 March 2022 were discussed. 
BDO LLP also met with the Audit Committee prior to the meeting 
without the presence of the Manager. 

Written  terms  of  reference  have  been  constituted  for  the  Audit 
Committee and can be found on the Company’s webpage on the 
Manager’s website at www.albion.capital/funds/AAVC under the 
“Corporate Governance” section. 

During  the  year  under  review,  the  Committee  discharged  its 
responsibilities including: 

•   formally  reviewing  the  Annual  Report  and  Financial 
Statements  and  the  Half-yearly  Financial  Report,  with 
particular focus on the main areas requiring judgement and 
on critical accounting policies; 

•   reviewing  the  effectiveness  of  the  internal  controls  system 
and examination of the Internal Controls Report produced by 
the Manager; 

•   meeting  with  the  external  Auditor  and  reviewing  their 

findings;  

•   reviewing  the  performance  of  the  Manager  and  making 
recommendations  regarding  their  re-appointment  to  the 
Board; 

•   highlighting  the  key  risks  and  specific  issues  relating  to  the 
including  the  reasonableness  of 
Financial  Statements 
valuations,  compliance  with  accounting  standards  and  UK 
law, corporate governance and listing and disclosure rules as 
well  as  going  concern  and  viability  statements.  These  issues 
were  addressed  through  detailed  review,  discussion  and 
challenge  by  the  Board  of  these  matters,  as  well  as  by 
reference to underlying technical information to back up the 
discussions. Taking into account risk factors that impact on the 
Company both as reflected in the annual accounts and in a 
detailed risk matrix, both of which are reviewed periodically in 
detail, including in the context of emerging risks;  

•   advising  the  Board  on  whether  the  Annual  Report  and 
Financial Statements, taken as a whole, is fair, balanced and 
understandable  and  provides  the  information  necessary  for 
shareholders to assess the Company’s position, performance, 
business model and strategy; and 

•   reporting  to  the  Board  on  how  it  has  discharged  its 

responsibilities. 

The  Board,  and  particularly  the  Audit  Committee,  monitors 
closely  developments  in  the  provision  of  audit  services  and  is 

aware that the costs of rendering audit services from most audit 
firms  are  increasing  significantly,  with  more  pressure  on  those 
firms  who  provide  services  to  listed  companies  and  for  those 
companies  operating  in  a  regulated  environment.  The  Board  is 
satisfied  from  discussions  with  the  current  audit  firm  and  from 
scrutiny of what is happening elsewhere, that BDO continues to 
provide the Company with an independent and expert review of 
its  financial  reporting  from  an  audit  firm  with  significant 
experience  in  the  sector  and  on  a  competitive  fee  base  for  the 
work required in reporting on an extensive portfolio of unquoted 
investments. 

The  Committee  also  examines  going  concern  and  viability 
statements, using financial projections provided by the Manager 
on  the  Company  and  by  examining  the  liquidity  in  the 
Company’s portfolio, including cash and realisable investments, 
the committed costs of the Company and where liquidity might 
be found if required. The Audit Committee also receives regular 
reports on compliance with VCT status, which is subject to various 
investment 
internal  controls  and  external  review  when 
commitments are made. 

Financial Statements 
The Audit Committee has initial responsibility for reviewing the 
Financial Statements and reporting on any significant issues that 
arise  in  relation  to  the  audit  of  the  Financial  Statements  as 
outlined below. The Audit Committee considered whether these 
issues  were  properly  considered  at  the  planning  stage  of  the 
audit  and  the  issues  were  discussed  with  the  external  Auditor 
prior to the completion of the audit of the Financial Statements. 
No major conflicts arose between the Audit Committee and the 
external Auditor in respect of their work during the period.  

The  key  accounting  and  reporting  issues  considered  by  the 
Committee were: 

The valuation of the Company’s investments 
Valuations  of  investments  are  prepared  by  the  Manager.  The 
Audit Committee reviewed the estimates and judgements made 
in relation to these investments and were satisfied that they were 
appropriate. The Audit Committee also discussed the controls in 
place  over  the  valuation  of  investments.  The  Committee 
recommended investment valuations to the Board for approval.  

Revenue recognition 
The  revenue  generated  from  loan  stock  interest  and  dividend 
income has been considered by the Audit Committee as part of 
its review of the Annual Report as well as a quarterly review of the 
management  accounts  prepared  by  the  Manager.  The  Audit 
Committee  has  considered  the  controls  in  place  over  revenue 
recognition  to  ensure  that  amounts  received  are  in  line  with 
expectation and budget.  

Albion Venture Capital Trust PLC 

41

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 42

Statement of corporate governance 

continued 

Following  detailed  reviews  of  the  Annual  Report  and  Financial 
Statements and consideration of the key areas of risk identified, 
the  Board  as  a  whole  have  concluded  that  the  Financial 
Statements are fair, balanced and understandable and that they 
provide the information necessary for shareholders to assess the 
Company’s position, performance, business model and strategy. 

pertinent  questions  are  asked  to  help  the  Audit  Committee 
determine if the Auditor’s skills and approach to the annual audit 
and issues that arise during the course of the audit match all the 
relevant  and  appropriate  criteria  for  the  audit  to  have  been  an 
effective  and  objective  review  of  the  Company’s  year-end 
reporting. 

Relationship with the External Auditor 
The  Audit  Committee  reviews  the  performance  and  continued 
suitability of the Company’s external Auditor on an annual basis. 
They  assess  the  external  Auditor’s  independence,  qualification, 
extent of relevant experience, effectiveness of audit procedures 
as well as the robustness of their quality assurance procedures. In 
advance  of  each  audit,  the  Committee  obtains  confirmation 
from the external Auditor that they are independent and of the 
level  of  non-audit  fees  earned  by  them  and  their  affiliates.  No 
non-audit services were provided during the financial year ended 
31 March 2022. 

As part of its work, the Audit Committee has undertaken a formal 
evaluation of the external Auditor against the following criteria; 

–   Qualification 

–   Expertise 

–   Resources 

–   Effectiveness 

–   Independence 

–   Leadership 

In order to form a view of the effectiveness of the external audit 
process, the Committee took into account information from the 
Manager regarding the audit process, the formal documentation 
issued  to  the  Audit  Committee  and  the  Board  by  the  external 
Auditor regarding the external audit for the year ended 31 March 
2022, and assessments made by individual Directors. 

In 2017 the Audit Committee undertook a tendering exercise for 
the provision of audit services. As a result of this process, BDO LLP 
was retained as Auditor. BDO first acted as Auditor for the year 
ended 31 March 2008 and this will be year 15 of their tenure. In 
order  to  safeguard  the  quality  of  the  audit  team,  the  audit 
engagement partner is rotated every five years. This year is the 
second  year  that  Peter  Smith  has  acted  as  audit  engagement 
partner  and  rotation  will  take  place  before  the  year  ended  31 
March  2026.  The  Audit  Committee  annually  reviews  and 
evaluates  the  standard  and  quality  of  service  provided  by  the 
Auditor,  as  well  as  value  for  money  in  the  provision  of  these 
services.  

The  Audit  Committee  also  has  an  annual  meeting  with  the 
external  Auditor,  without  the  Manager  present,  at  which 

42

Albion Venture Capital Trust PLC 

Based  on  the  assurance  obtained,  the  Audit  Committee 
recommended to the Board a resolution to re-appoint BDO LLP 
as Auditor at the forthcoming Annual General Meeting. 

Nomination Committee 
The Nomination Committee consists of all Directors, with Richard 
Glover  as  Chairman.  All  Directors  sit  on  the  Nomination 
Committee as their balance of skills and knowledge are relevant 
to the Committee’s responsibilities. The terms of reference of the 
Nomination  Committee  are  to  evaluate  the  balance  of  skills, 
experience and time commitment of the current Board members 
and  make  recommendations  to  the  Board  as  and  when  a 
particular appointment arises. 

The  Board’s  policy  on  the  recruitment  of  new  directors  is  to 
attract  a  range  of  backgrounds,  skills  and  experience  and  to 
ensure  that  appointments  are  made  on  the  grounds  of  merit 
against clear and objective criteria and bear in mind gender and 
other diversity within the Board. The Board is also mindful of the 
importance  of  creating  good  working  relationships  within  the 
Board  and  with  external  agents.  The  Nomination  Committee 
reviews succession planning regularly which includes considering 
tenure of existing Board members and any potential skills gaps 
that  might  need  to  be  addressed  when  Board  membership 
changes. 

After  the  year  end,  the  Nomination  Committee  met  to  discuss 
the appointment of a new Director. The Nomination Committee 
identify 
carried  out  a  formal  and  extensive  process  to 
appropriately  qualified  people,  and  following  a  detailed 
interviewing  and 
the  Nomination 
referencing  process, 
Committee recommended the appointment of Neeta Patel CBE 
as a new Director from 1 July 2022. 

The Nomination Committee held one formal meeting during the 
year,  which  was  fully  attended  by  all  the  members  of  the 
Committee. 

The  terms  of  reference  for  the  Nomination  Committee  can  be 
found on the Company’s webpage on the Manager’s website at 
www.albion.capital/funds/AAVC 
Corporate 
Governance section. 

under 

the 

Internal control 
In accordance with the AIC Code, the Board has an established 
process for identifying, evaluating and managing the significant 

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 43

Statement of corporate governance 

continued 

risks  faced  by  the  Company.  This  process  has  been  in  place 
throughout  the  year  and  continues  to  be  subject  to  regular 
review by the Board in accordance with the FRC guidance “Risk 
Management,  Internal  Control  and  Related  Financial  and 
Business Reporting”. The Board is responsible for the Company’s 
system  of  internal  control  and  for  reviewing  its  effectiveness. 
However,  such  a  system  is  designed  to  manage,  rather  than 
eliminate the risks of failure to achieve the Company’s business 
objectives  and  can  only  provide  reasonable  and  not  absolute 
assurance against material misstatement or loss. 

it has access to Azets, which, as internal auditor for Albion Capital 
Group  LLP  from  2021,  undertakes  periodic  examination  of  the 
business  processes  and  controls  environment  at  Albion  Capital 
Group LLP, and ensures that any recommendations to implement 
improvements  in  controls  are  carried  out.  During  the  year,  the 
Audit Committee and the Board reviewed internal audit reports 
prepared  by  the  Manager’s  previous  internal  auditor,  PKF 
Littlejohn LLP. The Board will continue to monitor its system of 
internal control in order to provide assurance that it operates as 
intended. 

The  Board,  assisted  by  the  Audit  Committee,  monitors  all 
controls, 
including  financial,  operational  and  compliance 
controls,  and  risk  management.  The  Audit  Committee  receives 
each  year  from  the  Manager  a  formal  report,  which  details  the 
steps taken to monitor the areas of risk, including those that are 
not directly the responsibility of the Manager, and which reports 
the details of any known internal control failures. Steps continue 
to  be  taken  to  embed  the  system  of  internal  control  and  risk 
management  into  the  operations  and  culture  of  the  Company 
and  its  key  suppliers,  and  to  deal  with  areas  of  improvement 
which  come  to  the  Manager’s  and  the  Audit  Committee’s 
attention. 

The  Board,  through  the  Audit  Committee,  has  performed  a 
specific  assessment  for  the  purpose  of  this  Annual  Report.  This 
assessment  considers  all  significant  aspects  of  internal  control 
arising during the year. The Audit Committee assists the Board in 
discharging its review responsibilities. 

The main features of the internal control system with respect to 
financial reporting, implemented throughout the year are: 

•   segregation of duties between the preparation of valuations 

and recording into accounting records; 

•   independent  third  party  valuations  of  the  majority  of  the 
asset-based  investments  within  the  portfolio  are  undertaken 
annually; 

•   reviews  of  valuations  are  carried  out  by  the  Valuations 
Committee and reviews of financial reports are carried out by 
the operations partner of Albion Capital Group LLP; 

•   bank reconciliations are carried out monthly by the Manager; 

•   all published financial reports are reviewed by the Manager’s 

compliance department; 

•   the Board reviews financial information; and 

•   a  separate  Audit  Committee  of  the  Company  reviews 
financial information (including valuations) to be published. 

As  the  Board  has  delegated  the  investment  management  and 
administration to Albion Capital Group LLP, the Board feels that 
it is not necessary to have its own internal audit function. Instead, 

In  addition  to  this,  Ocorian  Depositary  (UK)  Limited,  the 
Company’s external Depositary, provides cash monitoring, asset 
verification, and oversight services to the Company and reports 
to  the  Board  on  a  quarterly  basis.  The  Board  and  the  Audit 
Committee will continue to monitor its system of internal control 
in order to provide assurance that it operates as intended.  

Conflicts of interest 
Directors  review  the  disclosure  of  conflicts  of  interest  annually, 
with any changes reviewed and noted at the beginning of each 
Board meeting. A Director who has conflicts of interest has two 
independent Directors authorise those conflicts, and is excluded 
from  discussions  or  decisions  regarding  those  conflicts. 
Procedures  to  disclose  and  authorise  conflicts  of  interest  have 
been adhered to throughout the year. 

Capital structure and Articles of Association 
Details  regarding  the  Company’s  capital  structure,  substantial 
interests  and  Directors’  powers  to  buy  and  issue  shares  are 
detailed in full on page 33 of the Directors’ report. The Company 
is not party to any significant agreements that may take effect, 
alter  or  terminate  upon  a  change  of  control  of  the  Company 
following a takeover bid. 

Any amendments to the Company’s Articles of Association are 
by  way  of  a  special  resolution  subject  to  ratification  by 
shareholders. 

Relationships with shareholders 
The  Company’s  Annual  General  Meeting  is  on  6  September 
2022.  The  Annual  General  Meeting  typically 
includes  a 
presentation  from  the  Manager  on  the  portfolio  and  on  the 
Company, as well as answering questions that shareholders may 
have. The AGM will be held virtually. 

Shareholders are also invited to attend the annual Shareholders’ 
Seminar.  Representatives  of  the  Board  usually  attend  the 
seminar. The Board considers this an important interactive event 
and invites shareholders to attend this year’s event scheduled for 
23 November 2022 at the Royal College of Surgeons. To reserve 
a place, email info@albion.capital. 

Albion Venture Capital Trust PLC 

43

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 44

Statement of corporate governance 

continued 

Shareholders  and  financial  advisers  are  able  to  obtain 
information  on  holdings  and  performance  using  the  contact 
details provided on page 2.  

The  Company’s  share  buy-back  programme  operates  in  the 
market through brokers. In order to sell shares, as they are quoted 
on  the  London  Stock  Exchange,  investors  should  approach  a 
broker  to  undertake  the  sale.  Banks  may  be  able  to  assist 
shareholders  with  a  referral  to  a  broker  within  their  banking 
group. More information on share buy-backs can be found in the 
Chairman's statement on page 7. 

Statement of compliance 
The  Directors  consider  that  the  Company  has  complied 
throughout the year ended 31 March 2022 with all the relevant 
provisions set out in the AIC Code issued in 2019. By reporting 
against the AIC Code, the Board are meeting their obligations in 
relation  to  the  2018  UK  Corporate  Governance  Code  (and 
associated disclosure requirements under paragraph 9.8.6 of the 
Listing  Rules).  The  Directors  also  consider  that  they  are 
complying  with  their  statutory  responsibilities  and  other 
regulatory provisions which have a bearing on the Company. 

For and on behalf of the Board 

Richard Glover 
Chairman 
29 June 2022

44

Albion Venture Capital Trust PLC 

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 45

Directors’ remuneration report

by the Company’s Articles of Association, changes to which are 
made by ordinary resolution.  

The AIC Code requires that all Directors submit themselves for re-
election  annually,  therefore  in  accordance  with  the  AIC  Code, 
Richard  Glover,  Ann  Berresford  and  Richard  Wilson  will  offer 
themselves  for  re-election  at  the  forthcoming  Annual  General 
Meeting. John Kerr will retire as a Director on 6 September 2022 
and is not being put forward for re-election accordingly. 

None of the Directors have a service contract with the Company, 
and as such there is no policy on termination payments. There is 
no notice period and no payments for loss of office were made 
during  the  period.  On  being  appointed  to  the  Board,  Directors 
receive a letter from the Company setting out the terms of their 
appointment  and  their  specific  duties  and  responsibilities.  The 
Company  is  managed  by  Albion  Capital  Group  LLP  and  has  no 
employees. The Board consists solely of non-executive Directors, 
who are considered key management personnel.  

Shareholders’  views  in  respect  of  Directors’  remuneration  are 
regarded  highly  and  the  Board  encourages  Shareholders’  to 
communicate  their  thoughts  to  the  Board,  which  it  takes  into 
account  where  appropriate  when  formulating  its  policy.  At  the 
last  Annual  General  Meeting,  98.9%  of  shareholders  voted  for 
the  resolution  approving  the  Directors’  remuneration  report, 
1.1%  of  shareholders  voted  against  the  resolution  and  of  the 
total  votes  cast,  197,157  were  withheld  (being  0.2%  of  total 
voting rights), which shows significant shareholder support. 

Annual report on remuneration 
The  remuneration  of  individual  Directors’  is  determined  by  the 
Remuneration Committee within the framework set by the Board. 
The Committee meets at least once a year and met once during 
the  year  under  review  with  full  attendance  from  all  of  its 
members.  

It is responsible for reviewing the remuneration of the Directors 
and the Company’s remuneration policy to ensure that it reflects 
the  duties,  responsibilities  and  value  of  time  spent  by  the 
Directors  on  the  business  of  the  Company  and  makes 
recommendations to the Board accordingly.  

Introduction 
This  report  is  submitted  in  accordance  with  Section  420  of  the 
Companies Act 2006 and describes how the Board has applied 
the principles relating to the Directors’ remuneration.  

An  ordinary  resolution  will  be  proposed  at  the  Annual  General 
Meeting of the Company to be held on 6 September 2022 for the 
approval of the Directors’ remuneration report as set out below. 

The current Remuneration Policy was approved by shareholders 
(95.0%  of  shareholders  voted  for  the  resolution,  5.0%  voted 
against the resolution, and of the total votes cast, 208,709 votes 
were withheld (being 0.2% of total voting rights)) at the Annual 
General  Meeting  held  on  19  August  2020  and  will  remain  in 
place for a three year period. It will next be put to shareholders at 
the 2023 AGM. 

The  Company’s  independent  Auditor,  BDO  LLP,  is  required  to 
give its opinion on certain information included in this report, as 
indicated  below.  The  Auditor’s  opinion  is  included  in  the 
Independent Auditor’s Report. 

Annual statement from the Chairman of the Remuneration 
Committee 
The Remuneration Committee comprises all of the Directors with 
Ann  Berresford  as  Chairman.  From  6  September  2022,  Richard 
Wilson  will  take  over  as  Chairman  of  the  Remuneration 
Committee.   

The Remuneration Committee met after the year end to review 
Directors’  responsibilities  and  fees  against  the  market  and 
concluded that the current level of remuneration, which were last 
increased for the Chairman in 2019, and for all other Directors in 
2015, should be increased to remain competitive and reflective 
of the workload and responsibilities required from the Directors. 
The  Committee  agreed  to  raise  the  fee  for  the  Chairman  to 
£27,500 from £27,000, the Chairman of the Audit Committee to 
£25,500 from £24,000 and all other Directors to £23,500 from 
£22,000. The change in remuneration will take place from 1 April 
2022 and is in line with the remuneration policy detailed below. 

Directors’ remuneration policy 
The  Company’s  policy  is  that  fees  payable  to  non-executive 
Directors should reflect their expertise, responsibilities and time 
spent  on  Company  matters.  In  determining  the  level  of  non-
executive  remuneration,  market  equivalents  are  considered  in 
comparison  to  the  overall  activities  and  size  of  the  Company. 
There  is  no  performance  related  pay  criteria  applicable  to  non-
executive Directors.  

The  current  maximum 
level  of  non-executive  Directors’ 
remuneration is £150,000 per annum in aggregate which is fixed 

Albion Venture Capital Trust PLC 

45

263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 46

Directors’ remuneration report continued 

Directors’ remuneration 
The following items have been audited. 

The following table shows an analysis of the total fixed remuneration of individual Directors, exclusive of National Insurance: 

                                                                        Year ended
                                                                           31 March
                                                                                   2020
                                                                                 £’000

Year ended              Year ended
31 March                 31 March
2021                          2022
£’000                        £’000

Percentage                     Percentage 
change 2020                  change 2021 
to 2021                            to 2022 
%                                     % 

Richard Glover                                                              26

27                               27

3.8                                       – 

John Kerr                                                                       24

24                               24

–                                       – 

Ann Berresford                                                             22

22                               22

–                                       – 

Richard Wilson (appointed 1 May 2020)                 –

20                               22

n/a                                 10.0 

Jeff Warren (passed away 6 January 2020)         18

–                                  –

n/a                                       – 

Ebbe Dinesen (retired 1 August 2019)                     7

–                                  –

n/a                                       – 

                                                                                        97

93                               95

4.2                                    2.2 

There has been no increase in the base remuneration of each of the Directors’ positions during the year. The changes from the prior 
year are due to remuneration being pro-rated for Richard Wilson as he joined the Board part way through the prior year. 

The  Company  does  not  confer  any  share  options,  long  term  incentives  or  retirement  benefits  to  any  Director,  nor  does  it  make  a 
contribution  to  any  pension  scheme  on  behalf  of  the  Directors.  There  are  therefore  no  variable  elements  to  the  Directors’ 
remuneration. 

Each Director of the Company was remunerated personally through the Manager’s payroll which has been recharged to the Company. 

The Directors’ remuneration for the year ending 31 March 2023 is expected to be approximately £100,000.  

In addition to Directors’ remuneration, the Company pays an annual premium in respect of Directors’ & Officers’ Liability Insurance 
of £23,965 (2021: £19,023). The increase has been due to changes in the market for the provision of insurance, and is in line with the 
increases seen across the wider Directors’ & Officers’ Liability Insurance market. 

Directors’ interests 
The  Directors  who  held  office  throughout  the  year  and  their  interests  in  the  shares  of  the  Company  (together  with  those  of  their 
immediate family) are as follows: 

Richard Glover

John Kerr

Ann Berresford 

Richard Wilson 

31 March 2022             31 March 2021  
(Number                       (Number  
 of shares)                       of shares) 

88,681                            50,441 

34,656                            29,876 

15,765                            10,389 

25,000                            25,000 

164,102                          115,706 

There have been no changes in the holdings of the Directors between 31 March 2022 and the date of this Report. 

The following items have not been audited. 

Albion Capital Group LLP, its partners and staff hold a total of 1,324,035 shares in the Company as at 31 March 2022. 

46

Albion Venture Capital Trust PLC 

           
           
           
           
263764 Albion Capital pp33-pp47.qxp  29/06/2022  15:47  Page 47

Directors’ remuneration report continued 

Performance graph 
The graph that follows shows the Company’s Ordinary share price total return against the FTSE All-Share Index total return, in both 
instances with dividends reinvested, since 1 April 2012. The Directors consider the FTSE All-Share Index to be the most appropriate 
benchmark for the Company as it contains a large range of sectors within the UK economy similar to a generalist VCT. Investors should, 
however, be reminded that shares in VCTs generally trade at a discount to the actual net asset value of the Company. 

There are no options, issued or exercisable, in the Company which would distort the graphical representation that follows. 

Ordinary share price total return relative to the
FTSE All-Share Index total return 
(in both cases with dividends reinvested)

250

200

150

100

50

)
e
r
a
h
s

r
e
p
e
c
n
e
p
(
n
r
u
t
e
R

0

Mar
2012

Mar
2013

Mar
2014

Mar
2015

Mar
2016

Mar
2017

Mar
2018

Mar
2019

Mar
2020

Mar
2021

Mar
2022

Ordinary share price total return      

FTSE All-Share Index total return

Methodology: The Ordinary share price total return to the shareholder, including original amount invested (rebased to 100), assuming 
that dividends were reinvested at the share price of the Company at the time the shares were quoted ex-dividend. Transaction costs 
are not taken into account. 

Directors’ pay compared to distribution to shareholders for the year 

Total dividend distribution to shareholders* 

Share buybacks

Total Directors fees

31 March
2022
£’000

25,382

2,013

95

31 March                                           
2021                      Percentage 
£’000                             change 

4,263                              495% 

2,043                            (1.5)% 

93                            (2.2)% 

*The current year includes special dividends of 22.00 pence per share, totalling £22,050,000. 

For and on behalf of the Board 

Richard Glover  
Director 
29 June 2022

Albion Venture Capital Trust PLC 

47

           
           
           
 
 
 
263764 Albion Capital pp48-pp53.qxp  29/06/2022  15:48  Page 48

Independent Auditor’s report to the Members of 
Albion Venture Capital Trust PLC

Opinion on the financial statements 
In our opinion the financial statements: 

•   give a true and fair view of the state of the Company’s affairs 
as at 31 March 2022 and of its profit for the year then ended; 

•   have  been  properly  prepared  in  accordance  with  United 

Kingdom Generally Accepted Accounting Practice; 

•   have been prepared in accordance with the requirements of 

the Companies Act 2006. 

We  have  audited  the  financial  statements  of  Albion  Venture 
Capital Trust PLC (the ‘Company’) for the year ended 31 March 
2022 which comprise the income statement, the balance sheet, 
the statement of changes in equity, the statement of cashflows 
and  notes  to  the  financial  statements,  including  a  summary  of 
significant accounting policies. The financial reporting framework 
that has been applied in their preparation is applicable law and 
United  Kingdom  Accounting  Standards,  including  Financial 
Reporting  Standard  102  The  Financial  Reporting  Standard 
applicable  in  the  UK  and  Republic  of  Ireland  (United  Kingdom 
Generally Accepted Accounting Practice). 

Basis for opinion 
We  conducted  our  audit  in  accordance  with  International 
Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our 
responsibilities under those standards are further described in the 
Auditor’s responsibilities for the audit of the financial statements 
section of our report. We believe that the audit evidence we have 
obtained is sufficient and appropriate to provide a basis for our 
opinion. Our audit opinion is consistent with the additional report 
to the audit committee.  

Independence 
Following the recommendation of the audit committee, we were 
appointed by the Board of Directors on 31 March 2008 to audit 
the financial statements for the year ending 31 March 2008 and 
subsequent  financial  periods.  The  period  of  total  uninterrupted 
engagement  including  retenders  and  reappointments  is  15 
years,  covering  the  years  ending  31  March  2008  to  31  March 
2022.  We  remain  independent  of  the  Company  in  accordance 
with the ethical requirements that are relevant to our audit of the 
financial  statements  in  the  UK,  including  the  FRC’s  Ethical 
Standard as applied to listed public interest entities, and we have 
fulfilled our other ethical responsibilities in accordance with these 
requirements. The non-audit services prohibited by that standard 
were not provided to the Company.  

Conclusions relating to going concern 
In auditing the financial statements, we have concluded that the 
Directors’  use  of  the  going  concern  basis  of  accounting  in  the 
preparation  of  the  financial  statements  is  appropriate.  Our 
evaluation of the Directors’ assessment of the Company’s ability to 
continue to adopt the going concern basis of accounting included: 

•   Obtaining the VCT compliance reports during the year and as 
at year end and reviewing their calculations to check that the 
Company was meeting its requirements to retain VCT status; 

•   Consideration of the Company’s expected future compliance 
with VCT legislation, the absence of bank debt, contingencies 
and commitments and any market or reputational risks;  

48

Albion Venture Capital Trust PLC

•   Reviewing  the  forecasted  cash  flows  that  support  the 
Directors’  assessment  of  going  concern,  challenging 
assumptions  and  judgements  made  in  the  forecasts,  and 
assessing  them  for  reasonableness.  In  particular,  we 
considered  the  available  cash  resources  relative  to  the 
forecast  expenditure  which  was  assessed  against  the  prior 
year for reasonableness;  

•   Considering  the  impact  of  market  volatility  and  uncertainty, 
including  as  a  result  of  the  impact  of  Russian  aggression  in 
Ukraine; 

•   Calculating financial ratios to ascertain the financial health of 

the Company. 

Based  on  the  work  we  have  performed,  we  have  not  identified 
any material uncertainties relating to events or conditions that, 
individually  or  collectively,  may  cast  significant  doubt  on  the   
Company’s ability to continue as a going concern for a period of 
at least twelve months from when the financial statements are 
authorised for issue.  

In relation to the Company’s reporting on how it has applied the 
UK  Corporate  Governance  Code,  we  have  nothing  material  to 
add or draw attention to in relation to the Directors’ statement in 
the financial statements about whether the Directors considered 
it appropriate to adopt the going concern basis of accounting. 

Our responsibilities and the responsibilities of the Directors with 
respect to going concern are described in the relevant sections of 
this report. 

Overview 
                                                                               2022                 2021 
Key audit       Valuation of Unquoted                  4                         4 
matters          Investments 
Materiality    Company financial statements as a whole 
                         £1.1m (2021:£1.18m) based on 2% (2021: 2%) 
of net assets adjusted to exclude for fundraising 
during the year 

An overview of the scope of our audit 
Our  audit  was  scoped  by  obtaining  an  understanding  of  the 
Company and its environment, including the Company’s system 
of 
internal  control,  and  assessing  the  risks  of  material 
misstatement in the financial statements.  We also addressed the 
risk  of  management  override  of  internal  controls,  including 
assessing  whether  there  was  evidence  of  bias  by  the  Directors 
that may have represented a risk of material misstatement. 

Key audit matters 
Key  audit  matters  are  those  matters  that,  in  our  professional 
judgement, were of most significance in our audit of the financial 
statements of the current period and include the most significant 
assessed  risks  of  material  misstatement  (whether  or  not  due  to 
fraud)  that  we  identified,  including  those  which  had  the  greatest 
effect on: the overall audit strategy, the allocation of resources in 
the audit, and directing the efforts of the engagement team. This 
matter was addressed in the context of our audit of the financial 
statements as a whole, and in forming our opinion thereon, and we 
do not provide a separate opinion on this matter.

263764 Albion Capital pp48-pp53.qxp  29/06/2022  15:48  Page 49

Independent Auditor’s report to the Members of 
Albion Venture Capital Trust PLC continued

Key Audit Matter

How the scope of our audit addressed the key audit matter 

Valuation of unquoted 
investments (Notes 2 and 11 to 
the financial statements) 

There  is  a  high  level  of  estimation 
uncertainty involved in determining 
the 
investment 
valuations;  consisting  of  both 
equity and loan stock instruments. 

unquoted 

The  Investment  Manager’s  fee  is 
based  on  the  value  of  the  net 
assets  of  the  fund,  as  shown  in 
note 5. 

As  the  Investment  Manager  is 
responsible for valuing investments 
for  the  financial  statements,  there 
is a potential risk of overstatement 
of investment valuations.  

For our sample of loans held at fair value we: 

•   Vouched security held to documentation 

•   Considered  the  assumption  that  fair  value  is  not  significantly  different  to  cost  by 
challenging the assumption that there is no significant movement in the market interest 
rate since acquisition and considering the “unit of account” concept.  

•   Reviewed the treatment of accrued redemption premium/other fixed returns in line with 

the SORP. 

For 98% of the investment portfolio, we performed the following: 

•   Considered  whether  the  valuation  methodology  is  the  most  appropriate  in  the 
circumstances  under  the  International  Private  Equity  and  Venture  Capital  Valuation 
(“IPEV”) Guidelines. Where there has been a change in valuation methodology from prior 
year, we assessed whether the change was appropriate. 

•   Considered  the  change  in  market  multiples  and  discount  applied  from  prior  year  and  if 

these were supported by the performance of the underlying investment. 

•   Ensured that the valuation was based on recent financial information and reviewed the 

arithmetic accuracy of the valuation. 

Further, 54% of the unquoted portfolio is based on valuations using net assets, cost (where 
the investment was recently acquired), the price of a recent investment, bid price or an offer 
to acquire the investee company.  

For  such  investments,  we  checked  the  cost,  net  assets  or  third  party  offer  to  supporting 
evidence,  reviewed  the  calibration  of  fair  value  and  considered  the  Investment  Manager’s 
determination  of  whether  there  were  any  reasons  why  the  valuation  and  the  valuation 
methodology was not appropriate at 31 March 2022. This is particularly pertinent in those 
circumstances  where  the  impact  of  COVID-19,  rising  inflation,  the  war  in  Ukraine  and  the 
resulting  impact  may  call  into  question  whether  the  price  of  recent  investment  remains 
reflective of fair value. 

The remaining 46% of the investment portfolio is valued with reference to more subjective 
techniques  with  35%  supported  by  a  valuation  performed  by  experts  (27%  DCF  and  8% 
Earnings Multiple). The remaining 11% of the portfolio is valued using multiples of revenue 
/earnings or Bid price, as described in note 11 of the financial statements.  

For such investments that were included in our detailed sample, we: 

•   Re-performed the calculation of the investment valuation 

•   Verified and benchmarked key inputs and estimates to independent information from our 

own research and against metrics from the most recent investments 

•   Challenged  the  assumptions  inherent  to  valuation  of  unquoted  investments  and 
assessment of impact of the estimation uncertainty concerning these assumptions and 
the disclosure of these uncertainties in the financial statements 

Albion Venture Capital Trust PLC

49

 
263764 Albion Capital pp48-pp53.qxp  29/06/2022  15:48  Page 50

Independent Auditor’s report to the Members of 
Albion Venture Capital Trust PLC continued

Key Audit Matter

How we addressed the Key Audit Matter in the Audit 

•   Where a valuation has been performed by a third party management’s expert, we have 
assessed  the  competence  and  capabilities  of  that  expert,  the  quality  of  their  work  and 
their qualifications, as well as challenging the basis of inputs and assumptions used by the 
expert. We have also considered any updates for subsequent information to the valuation 
made by the investment manager and obtained appropriate evidence for those changes 

•   Where appropriate, we performed sensitivity analysis on the valuation calculations where 

there is sufficient evidence to suggest reasonable alternative inputs might exist 

Key observations 
Based on the procedures performed we consider the investment valuations to be appropriate 
considering the level of estimation uncertainty. 

Our application of materiality 
We apply the concept of materiality both in planning and performing our audit, and in evaluating the effect of misstatements. We consider 
materiality to be the magnitude by which misstatements, including omissions, could influence the economic decisions of reasonable users 
that are taken on the basis of the financial statements. 

In order to reduce to an appropriately low level the probability that any misstatements exceed materiality, we use a lower materiality level, 
performance materiality, to determine the extent of testing needed. Importantly, misstatements below these levels will not necessarily be 
evaluated  as  immaterial  as  we  also  take  account  of  the  nature  of  identified  misstatements,  and  the  particular  circumstances  of  their 
occurrence, when evaluating their effect on the financial statements as a whole.  

Based on our professional judgement, we determined materiality for the financial statements as a whole and performance materiality as 
follows: 

                                                                                             Company financial statements 

                                                                                    2022                                                                      2021 

Materiality                                                             £1,100,000                                                           £1,180,000 

Basis for determining materiality                 2% of net assets adjusted to exclude            2% of gross investments
                                                                                   for fundraising during the year 

Rationale for the benchmark applied          In  setting  materiality,  we  have  had  regard  to  the  nature  and  disposition  of  the 
investment  portfolio.  Given  that  the  VCT’s  portfolio  is  comprised  of  unquoted 
investments  which  would  typically  have  a  wider  spread  of  reasonable  alternative 
possible valuations, we have applied a percentage of 2% of adjusted net asset value. 
This was changed from the prior year benchmark of gross investment value to align to 
a  standardised  benchmark  across  the  investment  company  sector.  The  benchmark 
used is lower than the net asset value to take into account cash that has been recently 
raised. 

Performance materiality                                   £825,000                                                              £890,000 

Basis for determining performance              75% of materiality 
materiality                                                             The level of performance materiality applied was set after having considered a number 
of factors including the expected total value of known and likely misstatements and the 
level of transactions in the year. 

50

Albion Venture Capital Trust PLC

 
263764 Albion Capital pp48-pp53.qxp  29/06/2022  15:48  Page 51

Independent Auditor’s report to the Members of 
Albion Venture Capital Trust PLC continued

Lower testing threshold 
We  determined  that  for  Revenue  return  before  tax,  a 
misstatement  of 
less  than  materiality  for  the  financial 
statements  as  a  whole,  could  influence  users  of  the  financial 
statements as it is a measure of the Company’s performance of 
income  generated  from  its  investments  after  expenses.  As  a 
result,  we  determined  a  lower  testing  threshold  for  those  items 
impacting revenue return of £80,000 (2021: £85,000) based on 
5% of expenditure (2021: 5%).  

Other Code provisions 
•   Directors' statement on fair, balanced and understandable;  

•   Board’s  confirmation  that  it  has  carried  out  a  robust 

assessment of the emerging and principal risks;  

•   The section of the annual report that describes the review of 
effectiveness  of  risk  management  and  internal  control 
systems; and 

Reporting threshold 
We  agreed  with  the  Audit  Committee  that  we  would  report  to 
them all individual audit differences in excess of £55,000 (2021: 
£23,000).  We  also  agreed  to  report  differences  below  this 
threshold  that,  in  our  view,  warranted  reporting  on  qualitative 
grounds. 

Other information 
The directors are responsible for the other information. The other 
information  comprises  the  information  included  in  the  annual 
report  and  financial  statements  other  than  the  financial 
statements and our auditor’s report thereon. Our opinion on the 
financial  statements  does  not  cover  the  other  information  and, 
except to the extent otherwise explicitly stated in our report, we 
do  not  express  any  form  of  assurance  conclusion  thereon.  Our 
responsibility  is  to  read  the  other  information  and,  in  doing  so, 
consider whether the other information is materially inconsistent 
with the financial statements or our knowledge obtained in the 
course  of  the  audit,  or  otherwise  appears  to  be  materially 
misstated.  If  we  identify  such  material  inconsistencies  or 
apparent material misstatements, we are required to determine 
whether this gives rise to a material misstatement in the financial 
statements  themselves.  If,  based  on  the  work  we  have 
performed, we conclude that there is a material misstatement of 
this other information, we are required to report that fact. 

We have nothing to report in this regard. 

Corporate governance statement 
The Listing Rules require us to review the Directors’ statement in 
relation to going concern, longer-term viability and that part of 
the Corporate Governance Statement relating to the Company’s 
compliance with the provisions of the UK Corporate Governance 
Code specified for our review.  

Based  on  the  work  undertaken  as  part  of  our  audit,  we  have 
concluded that each of the following elements of the Corporate 
Governance Statement is materially consistent with the financial 
statements or our knowledge obtained during the audit. 

Going concern and longer-term viability 
•   The Directors' statement with regards to the appropriateness 
of adopting the going concern basis of accounting and any 
material uncertainties identified; and 

•   The  Directors’  explanation  as  to  their  assessment  of  the 
Company’s prospects, the period this assessment covers and 
why the period is appropriate. 

•   The section describing the work of the audit committee.  

Other Companies Act 2006 reporting 
Based  on  the  responsibilities  described  below  and  our  work 
performed during the course of the audit, we are required by the 
Companies Act 2006 and ISAs (UK) to report on certain opinions 
and matters as described below.  

Strategic report and Directors’ report 
In our opinion, based on the work undertaken in the course of the 
audit: 

•   the  information  given  in  the  Strategic  report  and  the 
Directors’ report for the financial year for which the financial 
statements  are  prepared  is  consistent  with  the  financial 
statements; and 

•   the  Strategic  report  and  the  Directors’  report  have  been 
prepared in accordance with applicable legal requirements. 

In the light of the knowledge and understanding of the Company 
and its environment obtained in the course of the audit, we have 
not identified material misstatements in the Strategic report or 
the Directors’ report. 

Directors’ remuneration 
In our opinion, the part of the Directors’ remuneration report to 
be  audited  has  been  properly  prepared  in  accordance  with  the 
Companies Act 2006. 

Matters on which we are required to report by exception 
We have nothing to report in respect of the following matters in 
relation to which the Companies Act 2006 requires us to report 
to you if, in our opinion: 

•   adequate accounting records have not been kept, or returns 
adequate for our audit have not been received from branches 
not visited by us; or 

•   the  financial  statements  and  the  part  of  the  Directors’ 
remuneration report to be audited are not in agreement with 
the accounting records and returns; or 

•   certain disclosures of Directors’ remuneration specified by law 

are not made; or 

•   we have not received all the information and explanations we 

require for our audit. 

Albion Venture Capital Trust PLC

51

263764 Albion Capital pp48-pp53.qxp  29/06/2022  15:48  Page 52

Independent Auditor’s report to the Members of 
Albion Venture Capital Trust PLC continued

Responsibilities of Directors 
As  explained  more  fully 
in  the  Statement  of  Directors’ 
responsibilities the Directors are responsible for the preparation 
of the financial statements and for being satisfied that they give 
a true and fair view, and for such internal control as the Directors 
determine  is  necessary  to  enable  the  preparation  of  financial 
statements  that  are  free  from  material  misstatement,  whether 
due to fraud or error. 

In  preparing  the  financial  statements,  the  Directors  are 
responsible for assessing the Company’s ability to continue as a 
going concern, disclosing, as applicable, matters related to going 
concern and using the going concern basis of accounting unless 
the Directors either intend to liquidate the Company or to cease 
operations, or have no realistic alternative but to do so. 

Auditor’s responsibilities for the audit of the financial 
statements 
Our objectives are to obtain reasonable assurance about whether 
the  financial  statements  as  a  whole  are  free  from  material 
misstatement,  whether  due  to  fraud  or  error,  and  to  issue  an 
auditor’s report that includes our opinion. Reasonable assurance 
is a high level of assurance, but is not a guarantee that an audit 
conducted  in  accordance  with  ISAs  (UK)  will  always  detect  a 
material  misstatement  when  it  exists.  Misstatements  can  arise 
from fraud or error and are considered material if, individually or 
in the aggregate, they could reasonably be expected to influence 
the  economic  decisions  of  users  taken  on  the  basis  of  these 
financial statements. 

Extent to which the audit was capable of detecting 
irregularities, including fraud 
Irregularities,  including  fraud,  are  instances  of  non-compliance 
with laws and regulations. We design procedures in line with our 
responsibilities, outlined above, to detect material misstatements 
in  respect  of  irregularities,  including  fraud.  The  extent  to  which 
our procedures are capable of detecting irregularities, including 
fraud is detailed below: 

We  gained  an  understanding  of  the  legal  and  regulatory 
framework applicable to the Company and the industry in which 
it operates, and considered the risk of acts by the Company which 
were contrary to applicable laws and regulations, including fraud. 
These  included  but  were  not  limited  to  compliance  with 
Companies Act 2006, the FCA listing and DTR rules, the principles 
of  the  UK  Corporate  Governance  Code,  industry  practice 
represented  by  the  Statement  of  Recommended  Practice: 
Financial  Statements  of  Investment  Trust  Companies  and 
Venture  Capital  Trusts  (“the  SORP”)  and  updated  in  February 
2018  with  consequential  amendments  and  the  applicable 
financial  reporting  framework.  We  also  considered  the 
Company’s qualification as a VCT under UK tax legislation.  

Our procedures included: 

•   obtaining  an  understanding  of  the  control  environment  in 

monitoring compliance with laws and regulations; 

•   agreement  of  the  financial  statement  disclosures  to 

underlying supporting documentation; 

52

Albion Venture Capital Trust PLC

•   enquiries  of  management  and  those  charged  with 
governance relating to the existence of any non-compliance 
with laws and regulations including fraud occurring within the 
Company and its operations; and 

•   obtaining  the  VCT  compliance 

reports  prepared  by 
management’s expert during the year and as at year end and 
reviewing  their  calculations  to  check  that  the  Company  was 
meeting its requirements to retain VCT status; and 

•   Reviewing  minutes  of  board  meetings  and 

legal 
correspondence  and  invoices  throughout  the  period  for 
instances  of  non-compliance  with  laws  and  regulations  and 
fraud. 

We  assessed  the  susceptibility  of  the  financial  statement  to 
material misstatement including fraud and considered the fraud 
risk  areas  to  be  the  valuation  of  unquoted  investments  and 
management override of controls. 

Our tests included, but were not limited to: 

•   The  procedures  set  out  in  the  Key  Audit  Matters  section 

above; 

•   Obtaining independent evidence to support the ownership of 

investments; 

•   Recalculating investment management fees in total; 

•   Obtaining independent confirmation of bank balances; and 

•   Testing journals which met a defined risk criteria by agreeing 
to  supporting  documentation  and  evaluating  whether  there 
was  evidence  of  bias  by  the  Investment  Manager  and 
Directors that represented a risk of material misstatement due 
to fraud. 

We also communicated relevant identified laws and regulations 
and potential fraud risks to all engagement team members and 
remained  alert  to  any  indications  of  fraud  or  non-compliance 
with laws and regulations throughout the audit. 

Our  audit  procedures  were  designed  to  respond  to  risks  of 
material  misstatement  in  the  financial  statements,  recognising 
that  the  risk  of  not  detecting  a  material  misstatement  due  to 
fraud is higher than the risk of not detecting one resulting from 
error,  as  fraud  may  involve  deliberate  concealment  by,  for 
example, forgery, misrepresentations or through collusion. There 
are  inherent  limitations  in  the  audit  procedures  performed  and 
the further removed non-compliance with laws and regulations is 
from  the  events  and  transactions  reflected  in  the  financial 
statements, the less likely we are to become aware of it. 

A  further  description  of  our  responsibilities  is  available  on  the 
at: 
Financial 
www.frc.org.uk/auditorsresponsibilities.  This  description  forms 
part of our auditor’s report. 

Reporting 

Council’s 

website 

Use of our report 
This report is made solely to the Company’s members, as a body, 
in accordance with Chapter 3 of Part 16 of the Companies Act 

263764 Albion Capital pp48-pp53.qxp  29/06/2022  15:48  Page 53

Independent Auditor’s report to the Members of 
Albion Venture Capital Trust PLC continued

2006.  Our  audit  work  has  been  undertaken  so  that  we  might 
state to the Company’s members those matters we are required 
to state to them in an auditor’s report and for no other purpose. 
To  the  fullest  extent  permitted  by  law,  we  do  not  accept  or 
assume  responsibility  to  anyone  other  than  the  Company  and 
the Company’s members as a body, for our audit work, for this 
report, or for the opinions we have formed. 

Peter Smith (Senior Statutory Auditor) 
For and on behalf of BDO LLP, Statutory Auditor 
London 
United Kingdom 
29 June 2022 

BDO  LLP  is  a  limited  liability  partnership  registered  in  England 
and Wales (with registered number OC305127).

Albion Venture Capital Trust PLC

53

263764 Albion Capital pp54-pp57.qxp  29/06/2022  15:48  Page 54

Income statement

                                                                                                Revenue            Capital                Total          Revenue             Capital                 Total 
                                                                             Note              £’000              £’000              £’000               £’000               £’000               £’000 

Year ended 31 March 2022

Year ended 31 March 2021 

Gains on investments                                             3                        –             6,553             6,553                        –               6,508               6,508 

Investment income                                                 4               1,037                     –             1,037               2,467                        –               2,467 

Investment Manager’s fees*                                 5                 (122)           (1,097)           (1,219)                (337)            (1,010)            (1,347) 

Other expenses                                                         6                 (411)                    –               (411)                (363)                      –                 (363) 

Profit on ordinary activities before tax                              504             5,456             5,960               1,767               5,498               7,265 

Tax (charge)/credit on ordinary activities           8                   (97)                  98                     1                 (299)                 192                 (107) 

Profit and total comprehensive income  

attributable to shareholders                                                  407             5,554             5,961               1,468               5,690               7,158 

Basic and diluted return per  

share (pence)**                                                    10                 0.39                5.38                5.77                  1.46                  5.64                  7.10 

* For more information on the allocation between revenue and capital please see the accounting policies on page 59. 

** Adjusted for treasury shares 

The accompanying notes on pages 58 to 71 form an integral part of these Financial Statements. 

The total column of this Income statement represents the profit and loss account of the Company. The supplementary revenue and 
capital  columns  have  been  prepared  in  accordance  with  The  Association  of  Investment  Companies’  Statement  of  Recommended 
Practice.

54

Albion Venture Capital Trust PLC

 
263764 Albion Capital pp54-pp57.qxp  29/06/2022  15:48  Page 55

Balance sheet

                                                                                                                                                                                             31 March 2022         31 March 2021 

                                                                                                                                                             Note                          £’000                          £’000 

Fixed asset investments                                                                                                                   11                        37,604                        28,355 

Current assets 

Trade and other receivables                                                                                                                13                          1,926                           1,561 

Cash and cash equivalents                                                                                                                                              24,668                        43,562 

                                                                                                                                                                                              26,594                        45,123 

Total assets                                                                                                                                                                        64,198                        73,478 

Payables: amounts falling due within one year 

Trade and other payables                                                                                                                    14                            (261)                           (790) 

Total assets less current liabilities                                                                                                                             63,937                        72,688 

Equity attributable to equity holders 

Called-up share capital                                                                                                                         15                          1,369                           1,165 

Share premium                                                                                                                                                                   10,047                        40,668 

Capital redemption reserve                                                                                                                                                      22                                   7 

Unrealised capital reserve                                                                                                                                                   6,550                           3,588 

Realised capital reserve                                                                                                                                                       7,693                        21,829 

Other distributable reserve                                                                                                                                               38,256                           5,431 

Total equity shareholders’ funds                                                                                                                               63,937                        72,688 

Basic and diluted net asset value per share (pence)*                                                            16                          53.38                           73.13 

* Excluding treasury shares 

The accompanying notes on pages 58 to 71 form an integral part of these Financial Statements. 

These Financial Statements were approved by the Board of Directors and authorised for issue on 29 June 2022, and were signed on 
its behalf by: 

Richard Glover 
Chairman 

Company number: 03142609

Albion Venture Capital Trust PLC

55

 
 
 
 
 
263764 Albion Capital pp54-pp57.qxp  29/06/2022  15:48  Page 56

Statement of changes in equity

                                                                       Called-up                                        Capital       Unrealised           Realised                Other 
                                                                              share                Share     redemption              capital              capital   distributable 

                                                                           capital          premium              reserve              reserve            reserve*            reserve*                 Total 
                                                                             £’000                £’000                £’000                £’000                £’000                £’000                £’000 

At 1 April 2021                                                  1,165              40,668                        7                3,588              21,829                5,431              72,688 

Return and total comprehensive  

income for the year                                                          –                        –                        –                3,784                1,770                   407                5,961 

Transfer of previously unrealised gains  

on realisations of investments                                       –                        –                        –                  (822)                  822                        –                        – 

Purchase of shares for cancellation                          (39)                       –                      39                        –                        –               (2,013)              (2,013) 

Issue of equity                                                              243              12,694                        –                        –                        –                        –              12,937 

Cost of issue of equity                                                      –                  (254)                       –                        –                        –                        –                  (254) 

Reduction of share premium and  

capital redemption reserve                                              –             (43,061)                   (24)                       –                        –              43,085                        – 

Net dividends paid (note 9)                                            –                        –                        –                        –             (16,728)              (8,654)           (25,382) 

At 31 March 2022                                             1,369              10,047                      22                6,550                7,693              38,256              63,937 

At 1 April 2020                                                          1,148                39,477                           7                13,178                  6,549                10,269                70,628 

Return and total comprehensive income  

for the year                                                                         –                           –                           –                  1,831                  3,859                  1,468                  7,158 

Transfer of previously unrealised gains  

on realisations of investments                                       –                           –                           –              (11,421)              11,421                           –                           – 

Purchase of treasury shares                                            –                           –                           –                           –                           –                 (2,043)               (2,043) 

Issue of equity                                                                 17                  1,225                           –                           –                           –                           –                  1,242 

Cost of issue of equity                                                      –                       (34)                         –                           –                           –                           –                       (34) 

Net dividends paid (note 9)                                            –                           –                           –                           –                           –                 (4,263)               (4,263) 

At 31 March 2021                                                    1,165                40,668                           7                  3,588                21,829                  5,431                72,688 

* Included within these reserves is an amount of £26,804,000 (2021: £27,260,000) which is considered distributable. Over the next four years an 

additional £17,585,000 will become distributable. This is due to the HMRC requirement that the Company cannot use capital raised in the past three 

years to make a payment or distribution to shareholders. On 1 April 2022, £567,000 became distributable in line with this. 

The accompanying notes on pages 58 to 71 form an integral part of these Financial Statements. 

56

Albion Venture Capital Trust PLC

263764 Albion Capital pp54-pp57.qxp  29/06/2022  15:48  Page 57

Statement of cash flows

                                                                                                                                                                                                                 Year ended                     Year ended 
                                                                                                                                                                                                       31 March 2022             31 March 2021 
                                                                                                                                                                                                                          £’000                               £’000 

Cash flow from operating activities 

Loan stock income received                                                                                                                                                                            978                               2,985 

Deposit interest received                                                                                                                                                                                       4                                     14 

Dividend income received                                                                                                                                                                                     7                                     24 

Investment Manager’s fees paid                                                                                                                                                              (1,434)                            (1,337) 

Other cash payments                                                                                                                                                                                      (389)                                (378) 

UK Corporation tax paid                                                                                                                                                                                   (42)                                (204) 

Net cash flow from operating activities                                                                                                                                                (876)                              1,104 

Cash flow from investing activities 

Purchase of fixed asset investments                                                                                                                                                        (7,771)                            (5,040) 

Disposal of fixed asset investments                                                                                                                                                           4,649                             30,620 

Net cash flow from investing activities                                                                                                                                             (3,122)                           25,580 

Cash flow from financing activities 

Issue of share capital                                                                                                                                                                                    8,941                                   668 

Cost of issue of equity                                                                                                                                                                                       (35)                                  (17) 

Dividends paid*                                                                                                                                                                                          (21,589)                          (3,714) 

Purchase of own shares (including costs)                                                                                                                                                (2,213)                            (1,841) 

Net cash flow from financing activities                                                                                                                                          (14,896)                            (4,904) 

(Decrease)/increase in cash and cash equivalents                                                                                                                      (18,894)                           21,780 

Cash and cash equivalents at start of the year                                                                                                                                    43,562                             21,782 

Cash and cash equivalents at end of the year                                                                                                                               24,668                             43,562 

*The equity dividends paid shown in the cash flow are different to the dividends disclosed in note 9 as a result of the non-cash effect of the Dividend 

Reinvestment Scheme and the timing of unclaimed dividends. 

The accompanying notes on pages 58 to 71 form an integral part of these Financial Statements. 

Albion Venture Capital Trust PLC

57

 
 
 
 
263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 58

Notes to the Financial Statements

Basis of preparation 

1.
The  Financial  Statements  have  been  prepared  in  accordance 
with applicable United Kingdom law and accounting standards, 
including Financial Reporting Standard 102 (“FRS 102”), and with 
the Statement of Recommended Practice “Financial Statements 
of  Investment  Trust  Companies  and  Venture  Capital  Trusts” 
(“SORP”)  issued  by  The  Association  of  Investment  Companies 
(“AIC”). The Financial Statements have been prepared on a going 
concern basis and further details can be found in the Directors’ 
report on pages 33 and 34. 

requires 
The  preparation  of  the  Financial  Statements 
management to make judgements and estimates that affect the 
application of policies and reported amounts of assets, liabilities, 
income  and  expenses.  The  most  critical  estimates  and 
judgements  relate  to  the  determination  of  carrying  value  of 
investments  at  Fair  Value  Through  Profit  and  Loss  (“FVTPL”)  in 
accordance  with  FRS  102  sections  11  and  12.  The  Company 
values investments by following the International Private Equity 
and Venture Capital Valuation (“IPEV”) Guidelines as updated in 
2018  and  further  detail  on  the  valuation  techniques  used  are 
outlined below. 

Company information is shown on page 2. 

Accounting policies 

2.
Fixed asset investments 
The  Company’s  business  is  investing  in  financial  assets  with  a 
view to profiting from their total return in the form of income and 
capital growth. This portfolio of financial assets is managed and 
its  performance  evaluated  on  a  fair  value  basis,  in  accordance 
with  a  documented  investment  policy,  and  information  about 
the portfolio is provided internally on that basis to the Board. 

In  accordance  with  the  requirements  of  FRS  102,  those 
undertakings in which the Company holds more than 20 per cent. 
of  the  equity  as  part  of  an  investment  portfolio  are  not 
accounted for using the equity method. In these circumstances 
the investment is measured at FVTPL. 

Upon 
initial  recognition  (using  trade  date  accounting) 
investments, including loan stock, are classified by the Company 
as FVTPL and are included at their initial fair value, which is cost 
(excluding  expenses  incidental  to  the  acquisition  which  are 
written off to the Income statement). 

Subsequently, the investments are valued at ‘fair value’, which is 
measured as follows: 

•   Investments  listed  on  recognised  exchanges  are  valued  at 
their  bid  prices  at  the  end  of  the  accounting  period  or 
otherwise at fair value based on published price quotations. 

•   Unquoted  investments,  where  there  is  not  an  active  market, 
are  valued  using  an  appropriate  valuation  technique  in 
accordance with the IPEV Guidelines. Indicators of fair value 
are  derived  using  established  methodologies  including 
earnings multiples, the level of third party offers received, cost 
or  price  of  recent  investment  rounds,  net  assets,  discounted 
cash flows and industry valuation benchmarks. Where price of 
recent  investment  is  used  as  a  starting  point  for  estimating 
fair  value  at  subsequent  measurement  dates,  this  has  been 
benchmarked  using  an  appropriate  valuation  technique 
permitted by the IPEV guidelines. 

•   In situations where cost or price of recent investment is used, 
consideration  is  given  to  the  circumstances  of  the  portfolio 
company  since  that  date  in  determining  fair  value.  This 
includes  consideration  of  whether  there  is  any  evidence  of 
deterioration  or  strong  definable  evidence  of  an  increase  in 
value.  In  the  absence  of  these  indicators,  the  investment  in 
question  is  valued  at  the  amount  reported  at  the  previous 
reporting  date.  Examples  of  events  or  changes  that  could 
indicate a diminution include: 

     •      the  performance  and/or  prospects  of  the  underlying 
business  are  significantly  below  the  expectations  on 
which the investment was based; 

     •      a  significant  adverse  change  either  in  the  portfolio 
company’s  business  or  in  the  technological,  market, 
economic,  legal  or  regulatory  environment  in  which  the 
business operates; or 

     •      market  conditions  have  deteriorated,  which  may  be 
indicated  by  a  fall  in  the  share  prices  of  quoted 
businesses operating in the same or related sectors. 

Investments  are  recognised  as  financial  assets  on  legal 
completion of the investment contract and are de-recognised on 
legal completion of the sale of an investment. 

Dividend  income  is  not  recognised  as  part  of  the  fair  value 
movement  of  an  investment,  but  is  recognised  separately  as 
investment income through the other distributable reserve when 
a share becomes ex-dividend. 

Current assets and payables 
Receivables  (including  debtors  due  after  more  than  one  year), 
payables and cash are carried at amortised cost, in accordance 
with  FRS  102.  Debtors  due  after  more  than  one  year  meet  the 
definition of a financing transaction held at amortised cost, and 
interest will be recognised through capital over the credit period 
using  the  effective  interest  method.  There  are  no  financial 
liabilities other than payables. 

58

Albion Venture Capital Trust PLC

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 59

Notes to the Financial Statements continued 

Accounting policies (continued) 

2.
Investment income 
Equity income 
Dividend income is included in revenue when the investment is 
quoted ex-dividend. 

Unquoted loan stock  
Fixed  returns  on  non-equity  shares  and  debt  securities  are 
recognised  when  the  Company’s  right  to  receive  payment  and 
expect  settlement  is  established.  Where  interest  is  rolled  up 
and/or  payable  at  redemption  then  it  is  recognised  as  income 
unless there is reasonable doubt as to its receipt. 

Bank interest income 
Interest income is recognised on an accruals basis using the rate 
of interest agreed with the bank. 

Investment management fee, performance incentive fee 
and other expenses 
All  expenses  have  been  accounted  for  on  an  accruals  basis. 
Expenses  are  charged  through  the  other  distributable  reserve 
except  the  following  which  are  charged  through  the  realised 
capital reserve: 

•   90%  of  management  fees  and  100%  of  performance 
incentive  fees,  if  any,  are  allocated  to  the  realised  capital 
reserve. This has changed from 75% for both management 
fees  and  performance  incentive  fees  in  the  year  ended  31 
March 2021, to better align with the Board’s expectation that 
over the long term the majority of the Company’s investment 
returns will be in the form of capital gains; and 

•   expenses which are incidental to the purchase or disposal of 
an  investment  are  charged  through  the  realised  capital 
reserve. 

Taxation 
Taxation  is  applied  on  a  current  basis  in  accordance  with  FRS 
102.  Current  tax  is  tax  payable  (refundable)  in  respect  of  the 
taxable  profit  (tax  loss)  for  the  current  period  or  past  reporting 
periods using the tax rates and laws that have been enacted or 
substantively  enacted  at  the  financial  reporting  date.  Taxation 
associated  with  capital  expenses  is  applied  in  accordance  with 
the SORP.  

Deferred  tax  is  provided  in  full  on  all  timing  differences  at  the 
reporting  date.  Timing  differences  are  differences  between 
taxable profits and total comprehensive income as stated in the 
financial statements that arise from the inclusion of income and 
expenses  in  tax  assessments  in  periods  different  from  those  in 
which they are recognised in the financial statements. As a VCT 
the Company has an exemption from tax on capital gains. The 
Company intends to continue meeting the conditions required to 
obtain approval as a VCT in the foreseeable future. The Company 

therefore,  should  have  no  material  deferred  tax  timing 
differences  arising  in  respect  of  the  revaluation  or  disposal  of 
investments and the Company has not provided for any deferred 
tax.  

Reserves 
Called-up share capital 
This accounts for the nominal value of the Company’s shares. 

Share premium  
This accounts for the difference between the price paid for shares 
and the nominal value of the shares, less issue costs and transfers 
on  cancellation  of  share  premium  once  consent  of  the  court  is 
given. 

Capital redemption reserve 
This  reserve  accounts  for  amounts  by  which  the  issued  share 
capital is diminished through the repurchase and cancellation of 
the Company’s own shares, less any transfers on cancellation of 
share premium once consent of the court is given. 

Unrealised capital reserve 
Increases and decreases in the valuation of investments held at 
the year end against cost are included in this reserve. 

Realised capital reserve 
The following are disclosed in this reserve: 

•   gains  and  losses  compared  to  cost  on  the  realisation  of 
investments,  or  permanent  diminutions  in  value  (including 
gains  recognised  on  the  realisation  of  investment  where 
consideration is deferred that are not distributable as a matter 
of law); 

•   finance income in respect of the unwinding of the discount on 
deferred consideration that is not distributable as a matter of 
law; 

•   expenses, together with the related taxation effect, charged 

in accordance with the above policies; and 

•   dividends paid to equity holders where paid out by capital. 

Other distributable reserve 
The  special  reserve,  treasury  share  reserve  and  the  revenue 
reserve were combined in 2012 to form a single reserve named 
other distributable reserve. 

This reserve accounts for movements from the revenue column 
of  the  Income  statement,  the  payment  of  dividends,  the  buy-
back  of  shares,  transfers  from  the  share  premium  and  capital 
redemption reserve, and other non-capital realised movements.

Albion Venture Capital Trust PLC

59

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 60

Notes to the Financial Statements continued 

Accounting policies (continued) 

2.
Going concern 
The  Board  has  assessed  the  Company’s  operation  as  a  going  concern.  The  Company  has  sufficient  cash  and  liquid  resources,  its 
portfolio of investments is well diversified in terms of sector, and the major cash outflows of the Company (namely investments, buy-
backs and dividends) are within the Company’s control. Cash flow forecasts are discussed quarterly at Board level with regards to going 
concern. The cash flow forecasts have been updated and stress tested. Accordingly, after making diligent enquiries, the Directors have 
a reasonable expectation that the Company has adequate resources to continue in operational existence over a period of at least 
twelve months from the date of approval of the Financial Statements. For this reason, the Directors have adopted the going concern 
basis in preparing the accounts. The Directors do not consider there to be any material uncertainty over going concern. 

Dividends 
Dividends by the Company are accounted for when the liability to make the payment (record date) has been established.  

Segmental reporting 
The Directors are of the opinion that the Company is engaged in a single operating segment of business, being investment in smaller 
companies principally based in the UK. 

Gains on investments 

3.
                                                                                                                                                                                                         Year ended                            Year ended 
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                    £’000                                     £’000 

Unrealised gains on fixed asset investments                                                                                                                                    3,784                                      1,831 

Realised gains on fixed asset investments                                                                                                                                         2,546                                      4,626 

Finance income from deferred consideration                                                                                                                                       223                                           51 

                                                                                                                                                                                                                    6,553                                      6,508 

Investment income  

4.
                                                                                                                                                                                                         Year ended                            Year ended 
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                    £’000                                     £’000 

Loan stock interest                                                                                                                                                                                  1,026                                      2,432 

Dividend income                                                                                                                                                                                              7                                           24 

Bank interest                                                                                                                                                                                                     4                                           11 

                                                                                                                                                                                                                    1,037                                      2,467 

Investment Manager’s fees 

5.
                                                                                                                                                                                                         Year ended                            Year ended 
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                    £’000                                     £’000 

Investment management fee charged to revenue                                                                                                                             122                                         337 

Investment management fee charged to capital                                                                                                                            1,097                                      1,010 

                                                                                                                                                                                                                    1,219                                      1,347 

Further details of the Management agreement under which the investment management fee and any performance incentive fee is 
paid are given in the Strategic report on page 13. 

During the year, services of a total value of £1,274,000 (2021: £1,401,000), were purchased by the Company from Albion Capital 
Group LLP; this includes £1,219,000 (2021: £1,347,000) of investment management fee and £55,000 (2021: £54,000) of secretarial 
and administration fee. At the financial year end, the amount due to Albion Capital Group LLP in respect of these services disclosed 
within payables was £144,000 (2021: £359,000).

60

Albion Venture Capital Trust PLC

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 61

Notes to the Financial Statements continued 

Investment Manager’s fees (continued) 

5.
Albion Capital Group LLP is, from time to time, eligible to receive arrangement fees and monitoring fees from portfolio companies.  
During the year ended 31 March 2022, fees of £155,000 attributable to the investments of the Company were received by Albion 
Capital Group LLP pursuant to these arrangements (2021: £193,000). 

Albion Capital Group LLP, its partners and staff hold a total of 1,324,035 shares in the Company as at 31 March 2022. 

The Company entered into an offer agreement relating to the Offers with the Company’s investment manager Albion Capital Group 
LLP (“Albion”), pursuant to which Albion received a fee of 2.5 per cent. of the gross proceeds of the Offers and out of which Albion paid 
the costs of the Offers, as detailed in the Prospectus. 

Other expenses 

6.
                                                                                                                                                                                                         Year ended                            Year ended 
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                    £’000                                     £’000 

Directors’ fees (including NIC)                                                                                                                                                                 103                                         101 

Auditor’s remuneration for statutory audit services (excluding VAT)                                                                                                 39                                           37 

Secretarial and administration fee                                                                                                                                                             55                                           54 

Other administrative expenses                                                                                                                                                                 214                                         171 

                                                                                                                                                                                                                        411                                         363 

Directors’ fees  

7.
The amounts paid to and on behalf of Directors during the year are as follows: 

                                                                                                                                                                                                         Year ended                            Year ended 
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                    £’000                                     £’000 

Directors’ fees                                                                                                                                                                                                 95                                           93 

National insurance                                                                                                                                                                                           8                                              8 

                                                                                                                                                                                                                        103                                         101 

The Company’s key management personnel are the Directors. Further information regarding Directors’ remuneration can be found in 
the Directors’ remuneration report on page 46. 

Tax charge/(credit) on ordinary activities 

8.
                                                                                                  Year ended 31 March 2022                                   Year ended 31 March 2021 
                                                                                    Revenue                Capital                    Total               Revenue                   Capital
                                                                                                 £’000                   £’000                   £’000                   £’000                     £’000

UK corporation tax in respect of current year                       98                       (98)                          –                         332                       (192)

UK corporation tax in respect of prior year                             (1)                          –                          (1)                        (33)                             –

                                                                                                        97                       (98)                        (1)                       299                       (192)

Total 

£’000 

140 

(33) 

107 

Albion Venture Capital Trust PLC

61

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 62

Notes to the Financial Statements continued 

Tax (charge)/credit on ordinary activities (continued) 

8.
                                                                                                                                                                                                         Year ended                            Year ended 
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
Reconciliation of profit on ordinary activities to taxation charge                                                                                     £’000                                     £’000 

Return on ordinary activities before taxation                                                                                                                                    5,960                                      7,265 

Tax charge on profit at the standard rate of 19% (2021: 19%)                                                                                                 1,132                                      1,380 

Factors affecting the charge: 

Non-taxable gains                                                                                                                                                                                  (1,245)                                   (1,236) 

Income not taxable                                                                                                                                                                                        (1)                                           (4) 

Consortium relief in respect of prior years                                                                                                                                                  –                                          (33) 

Prior year refund                                                                                                                                                                                               1                                              – 

Excess management expenses carried forward                                                                                                                                   112                                              – 

                                                                                                                                                                                                                           (1)                                        107 

The tax charge for the year shown in the Income statement is lower than the standard rate of corporation tax in the UK of 19 per cent. 
(2021: 19 per cent.). The differences are explained above. 

Consortium relief is recognised in the accounts in the period in which the claim is submitted to HMRC and is shown as tax in respect 
of prior year. 

Notes  
(i)           Venture Capital Trusts are not subject to corporation tax on capital gains. 
(ii)          Tax relief on expenses charged to capital. has been determined by allocating tax relief to expenses by reference to the applicable corporation tax rate and 

allocating the relief between revenue and capital in accordance with the SORP. 

(iii)         The Company has excess management expenses of £582,000 (2021: £nil) that are available for offset against future profits. A deferred tax asset of £146,000 

(2021: £nil) has not been recognised in respect of these losses as they will be recoverable only to the extent that the Company has sufficient future taxable profits. 

Dividends 

9.
                                                                                                                                                                                                         Year ended                            Year ended 
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                    £’000                                     £’000 

First interim and first special dividend of 16.83p per share paid on 30 July 2021  

(31 July 2020: First interim dividend of 2.50p per share)                                                                                                            16,728                                      2,541 

Second special dividend of 7.00p per share paid on 31 December 2021                                                                                  7,141                                              – 

Second interim dividend of 1.47p per share paid on 31 January 2022  

(29 January 2021: Second interim dividend of 1.74p per share)                                                                                                 1,523                                      1,745 

Unclaimed dividends                                                                                                                                                                                   (10)                                         (23) 

                                                                                                                                                                                                                  25,382                                      4,263 

In addition to the dividends summarised above, the Board has declared a first dividend for the year ending 31 March 2023 of 1.33 
pence per share to be paid on 29 July 2022 to shareholders on the register on 8 July 2022. The total dividend will be approximately 
£1,614,000.  

During  the  year,  unclaimed  dividends  older  than  twelve  years  of  £10,000  (2021:  £23,000)  were  returned  to  the  Company  in 
accordance with the terms of the Articles of Association and have been accounted for on an accruals basis.

62

Albion Venture Capital Trust PLC

 
263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 63

Notes to the Financial Statements continued 

10. Basic and diluted return per share 
                                                                                                  Year ended 31 March 2022                                          Year ended 31 March 2021 
                                                                                    Revenue                Capital                    Total               Revenue                   Capital

Return attributable to equity shares (£’000)                      407                   5,554                   5,961                      1,468                      5,690
Weighted average shares in issue  
(adjusted for treasury shares)                                                                      103,265,706                                                                         100,836,952 
Return attributable per equity share (pence)                    0.39                      5.38                      5.77                        1.46                        5.64

Total 

7,158 

7.10 

The weighted average number of shares is calculated after adjusting for treasury shares of 17,153,431 (2021: 17,153,431). 

There are no convertible instruments, derivatives or contingent share agreements in issue so basic and diluted return per share are the 
same. 

Fixed asset investments  

11.
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
Investments held at fair value through profit or loss                                                                                                             £’000                                     £’000 

Unquoted equity                                                                                                                                                                                   24,388                                   17,563 

Unquoted loan stock                                                                                                                                                                            12,460                                   10,792 

Quoted equity                                                                                                                                                                                              756                                              – 

                                                                                                                                                                                                                  37,604                                   28,355 

                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                  £’000                                     £’000 

Opening valuation                                                                                                                                                              28,355                                   49,243 

Purchases at cost                                                                                                                                                                                     7,771                                      5,040 

Disposal proceeds                                                                                                                                                                                  (4,899)                                (31,883) 

Realised gains                                                                                                                                                                                           2,546                                      4,677 

Movement in loan stock accrued income                                                                                                                                                 47                                        (553) 

Unrealised gains                                                                                                                                                                                      3,784                                      1,831 

Closing valuation                                                                                                                                                                                37,604                                   28,355 

Movement in loan stock accrued income 

Opening accumulated loan stock accrued income                                                                                                                              199                                         752 

Movement in loan stock accrued income                                                                                                                                                 47                                        (553) 

Closing accumulated loan stock accrued income                                                                                                                         246                                         199 

Movement in unrealised gains 

Opening accumulated unrealised gains                                                                                                                                             3,588                                   13,178 

Transfer of previously unrealised gains to realised reserve on realisations of investments                                                       (822)                                (11,421) 

Unrealised gains                                                                                                                                                                                      3,784                                      1,831 

Closing accumulated unrealised gains                                                                                                                                          6,550                                      3,588 

Historic cost basis 

Opening book cost                                                                                                                                                                                24,568                                   35,313 

Purchases at cost                                                                                                                                                                                     7,771                                      5,040 

Disposals at cost                                                                                                                                                                                     (1,531)                                (15,785) 

Closing book cost                                                                                                                                                                               30,808                                   24,568 

Purchases and disposals detailed above may not agree to purchases and disposals in the Statement of cash flows due to restructuring 
of investments, conversion of convertible loan stock and settlement of receivables and payables. 

Albion Venture Capital Trust PLC

63

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 64

Notes to the Financial Statements continued 

Fixed asset investments (continued) 

11.
The Company does not hold any assets as a result of the enforcement of security during the period, and believes that the carrying 
values for both impaired and past due assets are covered by the value of security held for these loan stock investments.  

Unquoted fixed asset investments are valued at fair value in accordance with the IPEV guidelines as follows: 

                                                                                                                                                                                                 31 March 2022                    31 March 2021 
Valuation methodology                                                                                                                                                                     £’000                                     £’000 

Cost and price of recent investment (reviewed for impairment or uplift)                                                                                16,678                                   11,408 

Third party valuation – Discounted cash flow                                                                                                                                10,026                                      9,835 

Third party valuation – Earnings multiple                                                                                                                                          3,085                                      2,196 

Net assets                                                                                                                                                                                                  3,038                                      1,850 

Revenue multiple                                                                                                                                                                                     1,595                                      1,400 

Bid price                                                                                                                                                                                                        756                                              – 

Earnings multiple                                                                                                                                                                                     2,426                                      1,666 

                                                                                                                                                                                                                  37,604                                   28,355 

When using the cost or price of a recent investment in the valuations the Company looks to re-calibrate this price at each valuation 
point  by  reviewing  progress  within  the  investment,  comparing  against  the  initial  investment  thesis,  assessing  if  there  are  any 
significant events or milestones that would indicate the value of the investment has changed and considering whether a market-based 
methodology (i.e. using multiples from comparable public companies) or a discounted cashflow forecast would be more appropriate. 

The main inputs into the calibration exercise, and for the valuation models using multiples, are revenue, EBITDA and P/E multiples 
(based on the most recent revenue, EBITDA or earnings achieved and equivalent corresponding revenue, EBITDA or earnings multiples 
of comparable companies), quality of earnings assessments and comparability difference adjustments. Revenue multiples are often 
used, rather than EBITDA or earnings, due to the nature of the Company’s investments, being in growth and technology companies 
which are not normally expected to achieve profitability or scale for a number of years. Where an investment has achieved scale and 
profitability the Company would normally then expect to switch to using an EBITDA or earnings multiple methodology. 

In the calibration exercise and in determining the valuation for the Company’s equity instruments, comparable trading multiples are 
used. In accordance with the Company’s policy, appropriate comparable companies based on industry, size, developmental stage, 
revenue generation and strategy are determined and a trading multiple for each comparable company identified is then calculated. 
The multiple is calculated by dividing the enterprise value of the comparable group by its revenue, EBITDA or earnings. The trading 
multiple  is  then  adjusted  for  considerations  such  as  illiquidity,  marketability  and  other  differences,  advantages  and  disadvantages 
between the portfolio company and the comparable public companies based on company specific facts and circumstances. 

Fair value investments had the following movements between valuation methodologies between 31 March 2021 and 31 March 2022: 

                                                                                                                                       Value as at  
                                                                                                                               31 March 2022 

Change in valuation methodology (2021 to 2022)                                                      £’000            Explanatory note 

Cost and price of recent investment (reviewed for impairment or uplift)                              1,595             Revenue multiple more relevant based on  

to revenue multiple                                                                                                                                                    current trading 

Cost and price of recent investment (reviewed for impairment or uplift)                              1,292             More appropriate valuation methodology 

to net assets 

Cost and price of recent investment (reviewed for impairment or uplift) to bid price            756             IPO listing  

64

Albion Venture Capital Trust PLC

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 65

Notes to the Financial Statements continued 

Fixed asset investments (continued) 

11.
The valuation will be the most appropriate valuation methodology for an investment within its market, with regard to the financial 
health of the investment and the IPEV Guidelines. The Directors believe that, within these parameters, there are no other more relevant 
methods of valuation which would be reasonable as at 31 March 2022. 

FRS 102 and the SORP requires the Company to disclose the inputs to the valuation methods applied to its investments measured at 
FVTPL in a fair value hierarchy. The table below sets out fair value hierarchy definitions using FRS 102 s.11.27. 

Fair value hierarchy                                      Definition  

Level 1                                                                    The unadjusted quoted price in an active market 
Level 2                                                                    Inputs to valuations are from observable sources and are directly or indirectly derived from prices 
Level 3                                                                    Inputs to valuations not based on observable market data 

All fixed asset investments (unquoted equity, preference shares and loan stock) are valued according to Level 3 valuation methods. 

Investments held at fair value through profit or loss (Level 3) had the following movements: 

                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                  £’000                                     £’000 

Opening valuation                                                                                                                                                                                28,355                                   49,243 

Purchases at cost                                                                                                                                                                                     7,771                                      5,040 

Movement from Level 3 to Level 1*                                                                                                                                                       (356)                                             – 

Unrealised gains                                                                                                                                                                                      3,384                                      1,831 

Movement in loan stock accrued income                                                                                                                                                 47                                        (553) 

Realised net gains on disposal                                                                                                                                                              2,546                                      4,677 

Disposal proceeds                                                                                                                                                                                  (4,899)                                (31,883) 

Closing valuation                                                                                                                                                                                36,848                                   28,355 

* This relates to Arecor Therapeutics PLC, which listed on the AIM stock exchange during the period. 

FRS 102 requires the Directors to consider the impact of changing one or more of the inputs used as part of the valuation process to 
reasonable possible alternative assumptions. 79% of the portfolio of investments, consisting of equity and loan stock, is based on 
recent investment price, net assets and cost, which is considered and as such the Board believes that changes to reasonable possible 
alternative input assumptions (by adjusting the earnings and revenue multiples) for the valuation of the remainder of the portfolio 
could lead to a significant change in the fair value of the portfolio. Therefore, for the remainder of the portfolio, the Board has adjusted 
the  inputs  for  a  number  of  the  largest  portfolio  companies  (by  value)  resulting  in  a  total  coverage  of  88%  of  the  portfolio  of 
investments. The main inputs considered for each type of valuation is as follows: 

                                                                         Portfolio                

                                                                 fair value 

NAV  

                                                                         company               

Base                  Change                         of investments 

(pence 

Valuation technique                                     sector                     Input

Case*                in input                         (£’000)

 per share) 

                                                                 Change in 

Change in 

Third party valuation – Discounted                  Renewable               Discount rate  5.5%                  +0.5%                               144
cashflow                                                                 energy                      

                            -0.5%                                (131)

Third party valuation – Earnings multiple       Education                 Earnings
                                                                                                                   multiple

22.5x                  2.25x                                 186
                            -2.25x                                (186)

0.12 
(0.11) 

0.16 
(0.16) 

* As detailed in the accounting policies on page 58, the base case is based on market comparables, discounted where appropriate for marketability, in accordance with the 
IPEV guidelines. 

The impact of these changes could result in an overall increase in the valuation of the unquoted equity investments by £330,000 
(1.4%) or a decrease in the valuation of unquoted equity investments by £317,000 (1.3%).

Albion Venture Capital Trust PLC

65

                                                                                                         
263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 66

Notes to the Financial Statements continued 

Significant interests 

12.
The principal activity of the Company is to select and hold a portfolio of investments in unquoted securities. Although the Company, 
through the Manager, will, in some cases, be represented on the board of the portfolio company, it will not take a controlling interest 
or become involved in the management of a portfolio company. The size and structure of the companies with unquoted securities may 
result in certain holdings in the portfolio representing a participating interest without there being any partnership, joint venture or 
management consortium agreement.  

The  Company  has  interests  of  greater  than  20  per  cent.  of  the  nominal  value  of  any  class  (some  of  which  are  non-voting)  of  the 
allotted shares in the portfolio companies as at 31 March 2022 as described below.  

                                                                         Registered             

Aggregate  

                                                                         address and          Profit/(loss) 

capital and                                             % class

                                                                         country of             before tax

reserves            Results for                     and

Company                                                         incorporation        £’000

£’000               year ended                   share type

% total 

voting 

rights 

Kew Green VCT (Stansted) Limited                  EC1M 5QL, UK        n/a*

3,001                  31 December 2020        45.2% Ordinary 

45.2% 

*The company files filleted accounts which do not disclose this information.  

Trade and other receivables 

13.
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                    £’000                                     £’000 

Other receivables                                                                                                                                                                                         342                                         107 

UK corporation tax receivable                                                                                                                                                                       –                                           97 

Prepayments                                                                                                                                                                                                   24                                           21 

Deferred consideration over one year                                                                                                                                                 1,560                                      1,336 

                                                                                                                                                                                                                    1,926                                      1,561 

The  deferred  consideration  over  one  year  relates  to  the  sale  of  G.  Network  Communications  Limited  in  December  2020.  These 
proceeds  are  receivable  in  January  2024,  and  have  been  discounted  to  present  value  at  the  prevailing  market  rate,  including  a 
provision for counterparty risk. This constitutes a financing transaction, and has been accounted for using the policy disclosed in note 2. 

The Directors consider that the carrying amount of receivables is not materially different to their fair value. 

Trade and other payables 

14.
                                                                                                                                                                                                 31 March 2022                    31 March 2021 
                                                                                                                                                                                                                  £’000                                     £’000 

Trade payables                                                                                                                                                                                               27                                         219 

UK Corporation tax payable                                                                                                                                                                           –                                         140 

Accruals and deferred income                                                                                                                                                                  234                                         431 

                                                                                                                                                                                                                        261                                         790 

The Directors consider that the carrying amount of payables is not materially different to their fair value. 

66

Albion Venture Capital Trust PLC

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 67

Notes to the Financial Statements continued 

15. Called-up share capital 
Allotted, called-up and fully paid                                                                                                                                                                                  £’000 

116,549,525 Ordinary shares of 1 penny each at 31 March 2021                                                                                                                                              1,165 

24,297,674 Ordinary shares of 1 penny each issued during the year                                                                                                                                             243 

3,919,566 Ordinary shares of 1 penny each cancelled during the year                                                                                                                                           (39) 

136,927,633 Ordinary shares of 1 penny each at 31 March 2022                                                                                                                         1,369 

17,153,431 Ordinary shares of 1 penny each held in treasury at 31 March 2021                                                                                                                     (172) 

17,153,431 Ordinary shares of 1 penny each held in treasury at 31 March 2022                                                                                                (172) 

119,774,202 Ordinary shares of 1 penny each in circulation* at 31 March 2022                                                                                               1,198 

* Carrying one vote each 

The Company purchased 3,919,566 Ordinary shares to be cancelled (2021: 3,069,400 to be held in treasury) at a cost of £2,013,000 
(2021:  £2,043,000)  representing  2.9  per  cent.  (2021:  2.6  per  cent.)  of  its  issued  share  capital  as  at  31  March  2022.  The  shares 
purchased for treasury in the prior year were funded from the other distributable reserve.  

The Company holds a total of 17,153,431 shares (2021: 17,153,431) in treasury at a nominal value of £172,000, representing 12.5 
per cent. of the issued Ordinary share capital as at 31 March 2022.  

Under the terms of the Dividend Reinvestment Scheme Circular dated 10 July 2008, the following new Ordinary shares of nominal 
value 1 penny each were allotted during the year: 

                                                                                                                     Aggregate                                                                                 Opening market  

                                                                                                                         nominal                                                                                                price on  

                                                                                Number of          value of shares                 Issue price              Net invested          allotment date  

Date of allotment                                         shares allotted                          £’000       (pence per share)                         £’000       (pence per share) 

30 July 2021                                                                   4,358,920                                   44                              56.30                              2,437                              53.50 

31 December 2021                                                       2,065,224                                   21                              51.80                              1,052                              49.45 

31 January 2022                                                               508,281                                      5                              50.33                                 254                              47.40 

                                                                                         6,932,425                                69                                                               3,743 

During  the  year,  the  Company  issued  the  following  new  Ordinary  shares  of  nominal  value  1  penny  each  under  the  Albion  VCTs 
Prospectus Top Up Offers 2021/22: 

                                                                                                                     Aggregate                                                                   Net        Opening market  

                                                                                                                         nominal                                                 consideration                      price on  

                                                                                Number of          value of shares                 Issue price                      received          allotment date  

Date of allotment                                         shares allotted                          £’000       (pence per share)                         £’000       (pence per share) 

25 February 2022                                                          1,836,706                                   18                              52.30                                 946                              49.00 

25 February 2022                                                             760,552                                      8                              52.50                                 391                              49.00 

25 February 2022                                                       14,767,991                                 148                              52.80                              7,603                              49.00 

                                                                                       17,365,249                              174                                                               8,940 

Albion Venture Capital Trust PLC

67

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 68

Notes to the Financial Statements continued 

16. Basic and diluted net asset value per share 
                                                                                                                                                                                                 31 March 2022                    31 March 2021 

Basic and diluted net asset value per share (pence)                                                                                                                       53.38                                      73.13 

The basic and diluted net asset value per share at the year end are calculated in accordance with the Articles of Association and are 
based upon total shares in issue (adjusted for treasury shares) of 119,774,202 Ordinary shares (2021: 99,396,094). 

17. Capital and financial instruments risk management 
The Company’s capital comprises Ordinary shares as described in note 15. The Company is permitted to buy back its own shares for 
cancellation or treasury purposes, and this is described in more detail on page 33 of the Directors’ report. 

The Company’s financial instruments comprise equity and loan stock investments in quoted and unquoted companies, cash balances 
and  short  term  receivables  and  payables  which  arise  from  its  operations.  The  main  purpose  of  these  financial  instruments  is  to 
generate cash flow, revenue and capital appreciation for the Company’s operations. The Company has no gearing or other financial 
liabilities apart from short term payables. The Company does not use any derivatives for the management of its Balance sheet. 

The principal risks arising from the Company’s operations are: 

•   Market and investment risk (which comprises investment price and cash flow interest rate risk); 

•   credit risk; and 

•   liquidity risk. 

The Board regularly reviews and agrees policies for managing each of these risks. There have been no changes in the nature of the 
risks that the Company has faced during the past year and there have been no changes in the objectives, policies or processes for 
managing risks during the past year. The key risks are summarised below. 

Market risk 
As  a  Venture  Capital  Trust,  it  is  the  Company’s  specific  nature  to  evaluate  the  market  risk  of  its  portfolio  in  unquoted  companies. 
Market risk is the exposure of the Company to the revaluation and devaluation of investments as a result of macroeconomic changes. 
The main driver of market risk is the dynamics of market quoted comparators, as well as the financial and operational performance of 
portfolio companies. The Board seeks to reduce this risk by having a spread of investments across a variety of sectors. More details on 
the sectors the Company invests in can be found in the pie chart on page 9. 

The Manager and the Board formally review market risk, both at the time of initial investment and at quarterly Board meetings. 

The Board monitors the prices at which sales of investments are made to ensure that profits to the Company are maximised, and that 
valuations of investments retained within the portfolio appear sufficiently prudent and realistic compared to prices being achieved in 
the market for sales of unquoted investments. 

As required under FRS 102 the Board is required to illustrate by way of a sensitivity analysis the extent to which the assets are exposed 
to market risk. The Board considers that the value of the fixed asset investment portfolio is sensitive to a change of 10% based on the 
current economic climate. The impact of a 10% change has been selected as this is considered reasonable given the current level of 
volatility  observed.  When  considering  the  appropriate  level  of  sensitivity  to  be  applied,  the  Board  has  considered  both  historic 
performance and future expectations.  

The  sensitivity  of  a  10%  increase  or  decrease  in  the  valuation  of  the  fixed  asset  investment  portfolio  (keeping  all  other  variables 
constant) would increase or decrease the net asset value and return for the year by £3,760,000. Further sensitivity analysis on fixed 
asset investments is included in note 11.

68

Albion Venture Capital Trust PLC

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 69

Notes to the Financial Statements continued 

17. Capital and financial instruments risk management (continued) 
Investment risk (including investment price risk) 
Investment  risk  (including  investment  price  risk)  is  the  risk  that  the  fair  value  of  future  investment  cash  flows  will  fluctuate  due  to 
factors specific to an investment instrument or to a market in similar instruments. The management of risk within the venture capital 
portfolio  is  addressed  through  careful  investment  selection,  by  diversification  across  different  industry  segments,  by  maintaining  a 
wide  spread  of  holdings  in  terms  of  financing  stage  and  by  limitation  of  the  size  of  individual  holdings.  The  Manager  receives 
management  accounts  from  portfolio  companies  and  members  of  the  investment  management  team  often  sit  on  the  boards  of 
unquoted portfolio companies; this enables the close identification, monitoring and management of investment risk. The Directors 
monitor the Manager’s compliance with the investment policy, review and agree policies for managing this risk and monitor the overall 
level of risk on the investment portfolio on a regular basis.  

Valuations are based on the most appropriate valuation methodology for an investment within its market, with regard to the financial 
health of the investment and the IPEV Guidelines. Details of the industries in which investments have been made are contained in the 
pie chart in the Strategic report on page 9. 

The maximum investment risk on the balance sheet date is the value of the fixed asset investment portfolio which is £37,604,000 
(2021: £28,355,000). Fixed asset investments form 59 per cent. of the net asset value on 31 March 2022 (2021: 39 per cent.). 

Interest rate risk 
It is the Company’s policy to accept a degree of interest rate risk on its financial assets through the effect of interest rate changes. On 
the basis of the Company’s analysis, it was estimated that a rise of 1 per cent. in all interest rates would have increased total return 
before tax for the year by approximately £341,000 (2021: £327,000). Furthermore, it was considered that a fall of interest rates below 
current levels during the year would have been unlikely.  

The weighted average effective interest rate applied to the Company’s fixed rate assets during the year was approximately 7.3 per 
cent. (2021: 11.9 per cent.). The weighted average period to maturity for the fixed rate assets is approximately 6.0 years (2021: 6.9 
years). 

The Company’s financial assets and liabilities, all denominated in Sterling, consist of the following: 

                                                                                           31 March 2022                                                                         31 March 2021 
                                                                                                                Non-                                                                                                  Non- 
                                                              Fixed          Floating           interest                                                                 Floating              interest 
                                                                rate                  rate           bearing                Total         Fixed rate                    rate             bearing                  Total 
                                                             £’000              £’000              £’000              £’000               £’000                £’000                £’000                £’000 

Unquoted equity                                              –                       –            24,388            24,388                         –                         –              17,563              17,563 

Quoted equity                                                  –                       –                  756                  756                       –                         –                         –                         – 

Unquoted loan stock                           11,922                  233                  305            12,460              10,233                    247                    312              10,792 

Receivables *                                                     –                       –               1,902               1,902                         –                         –                 1,443                 1,443 

Payables*                                                           –                       –                 (261)               (261)                        –                         –                   (650)                 (650) 

Cash                                                                    –            24,668                       –            24,668                         –              43,562                         –              43,562 

                                                                 11,922            24,901            27,090            63,913              10,233              43,809              18,668              72,710 

* The receivables and payables do not reconcile to the Balance sheet as prepayments and tax receivable/(payable) are not included in the above table. 

Credit risk 
Credit risk is the risk that the counterparty to a financial instrument will fail to discharge an obligation or commitment that it has 
entered into with the Company. The Company is exposed to credit risk through its receivables, investment in unquoted loan stock, and 
through the holding of cash on deposit with banks.

Albion Venture Capital Trust PLC

69

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 70

Notes to the Financial Statements continued 

17. Capital and financial instruments risk management (continued) 
The  Manager  evaluates  credit  risk  on  loan  stock  and  other  similar  instruments  prior  to  investment,  and  as  part  of  its  ongoing 
monitoring of investments. In doing this, it takes into account the extent and quality of any security held. For loan stock investments 
made prior to 6 April 2018, which account for 78 per cent. of loan stock by value, typically loan stock instruments have a fixed or 
floating charge, which may or may not have been subordinated, over the assets of the portfolio company in order to mitigate the gross 
credit risk. 

The Manager receives management accounts from portfolio companies, and members of the investment management team often 
sit on the boards of unquoted portfolio companies; this enables the close identification, monitoring and management of investment-
specific credit risk. 

The Manager and the Board formally review credit risk (including receivables) and other risks, both at the time of initial investment 
and at quarterly Board meetings. 

The Company’s total gross credit risk as at 31 March 2022 was limited to £12,460,000 of unquoted loan stock instruments (2021: 
£10,792,000), £24,668,000 cash deposits with banks (2021: £43,562,000) and £1,926,000 of other receivables (2021: £1,561,000). 

At the Balance sheet date, the cash held by the Company was held with Lloyds Bank plc, Scottish Widows Bank plc (part of Lloyds 
Banking  Group),  Barclays  Bank  plc,  National  Westminster  Bank  plc  and  Société  Générale  S.A.  Credit  risk  on  cash  transactions  was 
mitigated  by  transacting  with  counterparties  that  are  regulated  entities  subject  to  prudential  supervision,  with  high  credit  ratings 
assigned by international credit-rating agencies. 

The Company has an informal policy of limiting counterparty banking and floating rate note exposure to a maximum of 20 per cent. 
of net asset value for any one counterparty. 

The credit profile of the unquoted loan stock is described under liquidity risk. 

Liquidity risk 
Liquid assets are held as cash on current account, on deposit or short term money market account. Under the terms of its Articles, the 
Company has the ability to borrow up to 10 per cent. of its adjusted capital and reserves of the latest published audited Balance sheet, 
which amounts to £6,232,000 as at 31 March 2022 (2021: £5,596,000). 

The Company has no committed borrowing facilities as at 31 March 2022 (2021: £nil) and had cash balances of £24,668,000 (2021: 
£43,562,000).  The  main  cash  outflows  are  for  new  investments,  buy-back  of  shares  and  dividend  payments,  which  are  within  the 
control of the Company. The Manager formally reviews the cash requirements of the Company on a monthly basis, and the Board on 
a quarterly basis as part of its review of management accounts and forecasts. All the Company’s financial liabilities are short term in 
nature and total £261,000 as at 31 March 2022 (2021: £790,000). 

The carrying value of loan stock investments as analysed by expected maturity dates is as follows: 

                                                                                                           31 March 2022                                                            31 March 2021 
                                                                                      Fully                                Valued                                      Fully                                    Valued 
                                                                           performing       Past due   below cost             Total   performing         Past due     below cost               Total 
Redemption date                                                     £’000           £’000           £’000           £’000            £’000             £’000             £’000             £’000 

Less than one year                                                            1,741               469               857            3,067                 864                 486                 916              2,266 

1-2 years                                                                                      –                    –                    –                    –                      –                 806                      –                 806 

2-3 years                                                                             1,395                    –                    2            1,397                      –                      –                      –                      – 

3-5 years                                                                             2,422                    –                    –            2,422              1,618                      –                      5              1,623 

5+  years                                                                             5,154               420                    –            5,574            5,649                 448                      –              6,097 

Total                                                                                 10,712               889               859          12,460              8,131              1,740                 921           10,792 

Loan stock can be past due as a result of interest or capital not being paid in accordance with contractual terms. The cost of loan stock 
valued below cost is £1,045,000 (2021: £1,045,000).

70

Albion Venture Capital Trust PLC

263764 Albion Capital pp58-pp71.qxp  29/06/2022  15:49  Page 71

Notes to the Financial Statements continued 

17. Capital and financial instruments risk management (continued) 
The Company does not hold any assets as the result of the enforcement of security during the period, and believes that the carrying 
values for both those valued below cost and past due assets are covered by the value of security held for these loan stock investments. 

In view of the availability of adequate cash balances and the repayment profile of loan stock investments, the Board considers that 
the Company is subject to low liquidity risk. 

Fair values of financial assets and financial liabilities 
All the Company’s financial assets and liabilities as at 31 March 2022 are stated at fair value as determined by the Directors, with the 
exception of receivables, payables and cash which are carried at amortised cost. There are no financial liabilities other than payables. 
The Company’s financial liabilities are all non-interest bearing. It is the Directors’ opinion that the book value of the financial liabilities 
is not materially different to the fair value and all are payable within one year. 

18. Commitments and contingencies 
The Company had no financial commitments in respect of investments at 31 March 2022 (2021: £nil). 

There are no contingent liabilities or guarantees given by the Company as at 31 March 2022 (2021: £nil). 

Post balance sheet events 

19.
Since 31 March 2022 the Company has had the following material post balance sheet events: 

•   Investment of £711,000 in an existing portfolio company, Gravitee TopCo Limited (T/A Gravitee.io), an API management platform; 

•   Investment of £565,000 in a new portfolio company which provides insights and analytics to pharmaceutical companies about 

therapeutic areas; 

•   Investment of £435,000 in an existing portfolio company, Cantab Research Limited (T/A Speechmatics), a provider of low footprint 

automated speech recognition which can be deployed in the cloud, on premise or on device across over 31 languages; and 

•   Investment of £433,000 in a new portfolio company which is an autonomous debt resolution platform. 

The  following  new  Ordinary  shares  of  nominal  value  1  penny  each  were  allotted  under  the  Albion  VCTs  Prospectus  Top  Up  Offers 
2021/22 after 31 March 2022: 

                                                                                                                     Aggregate                                                                   Net                     Opening 

                                                                                                                         nominal                                                 consideration        market price on  

                                                                                Number of          value of shares                 Issue price                      received          allotment date  

Date of allotment                                         shares allotted                          £’000       (pence per share)                         £’000       (pence per share) 

11 April 2022                                                                     446,260                                      4                              52.30                                 230                              48.60 

11 April 2022                                                                       23,806                                      –                              52.50                                   12                              48.60 

11 April 2022                                                                 1,126,685                                   11                              52.80                                 580                              48.60 

                                                                                         1,596,751                                16                                                                  822 

20. Related party transactions  
Other  than  transactions  with  the  Manager  as  disclosed  in  note  5,  and  the  Directors’  remuneration  disclosed  in  the  Directors’ 
remuneration report on page 46, there are no other related party transactions or balances requiring disclosure. 

Albion Venture Capital Trust PLC

71

263764 Albion Capital pp72-end.qxp  29/06/2022  15:49  Page 72

Notice of Annual General Meeting

SHAREHOLDERS  SHOULD  TAKE  NOTE  THAT  THIS  WILL  BE  A  VIRTUAL  AGM  AND  FURTHER  DETAILS  WILL  BE  MADE 
AVAILABLE AT WWW.ALBION.CAPITAL/VCT-HUB/AGMS-EVENTS. 

NOTICE  IS  HEREBY  GIVEN  that  the  Annual  General  Meeting  of  Albion  Venture  Capital  Trust  PLC  (the  “Company”)  will  be  held 
virtually  at  noon  on  6  September  2022  at  the  registered  office  of  the  Company  at  1  Benjamin  Street,  London,  EC1M  5QL  for  the 
purposes of considering and, if thought fit, passing the following resolutions, of which resolutions 1 to 8 will be proposed as ordinary 
resolutions and resolutions 9 and 10 will be proposed as special resolutions. 

Ordinary Business 
1.        To receive and adopt the Company’s accounts for the year ended 31 March 2022 together with the Strategic report and the 

reports of the Directors and Auditor. 

2.        To approve the Directors’ remuneration report for the year ended 31 March 2022.  

3.        To re-elect Richard Glover as a Director of the Company. 

4.        To re-elect Ann Berresford as a Director of the Company. 

5.        To re-elect Richard Wilson as a Director of the Company. 

6.        To re-appoint BDO LLP as Auditor of the Company to hold office from the conclusion of the meeting to the conclusion of the 

next meeting at which the accounts are to be laid. 

7.        To authorise the Directors to agree the Auditor’s remuneration.  

Authority to allot shares 

Special Business 
8.
           The  Directors  be  generally  and  unconditionally  authorised  in  accordance  with  section  551  of  the  Companies  Act  2006  (the 
“Act”)  to  allot  Ordinary  shares  of  nominal  value  1  penny  per  share  in  the  Company  up  to  a  maximum  aggregate  nominal 
amount of £277,049 (representing approximately 20 per cent. of the issued share capital as at the date of this Notice) provided 
that this authority shall expire 15 months from the date that this resolution is passed, or, if earlier, the conclusion of the next 
Annual General Meeting of the Company, but so that the Company may, before the expiry, make an offer or agreement which 
would or might require shares to be allotted or rights to subscribe for or convert securities into shares to be granted after such 
expiry and the Directors may allot shares or grant rights to subscribe for or convert securities into shares pursuant to such an 
offer or agreement as if the authority had not expired. 

Authority for the disapplication of pre-emption rights 

9.
           That, subject to the authority and conditional on the passing of resolution number 8 the Directors be empowered, pursuant to 
sections 570 and 573 of the Act, to allot equity securities (within the meaning of section 560 of the Act) for cash pursuant to 
the authority conferred by resolution number 8 and/or sell ordinary shares held by the Company as treasury shares for cash as 
if section 561(1) of the Act did not apply to any such allotment or sale. 

           Under this power the Directors may impose any limits or restrictions and make any arrangements which they deem necessary 
or expedient to deal with any treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or 
laws of, any territory or other matter, arising under the laws of, or the requirements of any recognised regulatory body or any 
stock exchange in, any territory or any other matter. 

           This power shall expire 15 months from the date that this resolution is passed or, if earlier, the conclusion of the next Annual 
General Meeting of the Company, save that the Company may, before such expiry, make an offer or agreement which would or 
might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any 
such offer or agreement as if this power had not expired. 

72

Albion Venture Capital Trust PLC 

263764 Albion Capital pp72-end.qxp  29/06/2022  15:49  Page 73

Notice of Annual General Meeting continued

10. Authority to purchase own shares 
           That, subject to and in accordance with the Company’s Articles of Association, the Company be generally and unconditionally 
authorised,  pursuant  to  and  in  accordance  with  section  701  of  the  Act,  to  make  market  purchases  (within  the  meaning  of 
Section 693(4) of the Act) of Ordinary shares on such terms as the Directors think fit, provided always that: 

           (a)      the maximum aggregate number of Ordinary shares hereby authorised to be purchased is 18,193,506 or, if lower, such 
number of Ordinary shares as shall equal 14.99% of the issued Ordinary share capital of the Company at the date of the 
passing of this resolution; 

           (b)      the minimum price, exclusive of any expenses, which may be paid for an Ordinary share is 1 penny; 

           (c)       the maximum price, exclusive of any expenses, which may be paid for each Ordinary share is an amount equal to the 
higher of (a) 105% of the average of the middle market quotations for an Ordinary share, as derived from the London 
Stock Exchange Daily Official List, for the five business days immediately preceding the day on which the Ordinary share 
is purchased; and (b) the amount stipulated by Article 5(1) of the Buy-back and Stabilisation Regulation 2003; 

           (d)      the authority hereby conferred shall, unless previously revoked, varied or renewed, expire 15 months from the date that 

this resolution is passed or, if earlier, at the conclusion of the next Annual General Meeting; and  

           (e)      the Company may make a contract or contracts to purchase Ordinary shares under this authority before the expiry of the 
authority which will or may be executed wholly or partly after the expiry of the authority, and may make a purchase of 
shares in pursuance of any such contract or contracts as if the authority conferred hereby had not expired. 

By Order of the Board 

Albion Capital Group LLP 
Company Secretary 
Registered office 
1 Benjamin Street, 
London, EC1M 5QL  
29 June 2022 

Albion Venture Capital Trust PLC is registered in England and Wales with number 03142609 

Albion Venture Capital Trust PLC 

73

 
 
 
 
 
263764 Albion Capital pp72-end.qxp  29/06/2022  15:49  Page 74

Notice of Annual General Meeting continued

Notes 
1.        Members entitled to participate in, speak and vote at the Annual General Meeting (“AGM”) may appoint a proxy or proxies (who 
need not be a member of the Company) to exercise these rights in their place at the AGM. A member may appoint more than 
one  proxy,  provided  that  each  proxy  is  appointed  to  exercise  the  rights  attached  to  different  shares.  Proxies  may  only  be 
appointed by: 

       •         completing  and  returning  the  Form  of  Proxy  enclosed  with  this  Notice  to  Computershare  Investor  Services  PLC,  The 

Pavilions, Bridgwater Road, Bristol BS99 6ZY; or 

       •         going to www.investorcentre.co.uk/eproxy and following the instructions provided there; or 
       •         by having an appropriate CREST message transmitted, if you are a user of the CREST system (including CREST personal 

members). 

           Return of the Form of Proxy will not preclude a member from participating in the meeting and voting in person. A member may 
not use any electronic address provided in the Notice of this meeting to communicate with the Company for any purposes other 
than those expressly stated. 

           To be effective the Form of Proxy must be completed in accordance with the instructions and received by the Registrars of the 

Company by noon on 2 September 2022. 

          In accordance with good governance practice, the Company is offering shareholders use of an online service, offered 
by the Company’s registrar, Computershare Investor Services, at www.investorcentre.co.uk/eproxy. Shareholders can 
use this service to vote or appoint a proxy online. The same voting deadline of noon on 2 September 2022 applies as 
if you were using your Personalised Voting Form to vote or appoint a proxy by post to vote for you. Shareholders who 
hold  their  shares  electronically  may  submit  their  votes  through  CREST,  by  submitting  the  appropriate  and 
authenticated CREST message so as to be received by the Company's registrar not later than two business days before 
the start of the meeting. Instructions on how to vote through CREST can be found by accessing the following website: 
www.euroclear.com/CREST. Shareholders should not show this information to anyone unless they wish to give proxy 
instructions on their behalf. 

2.        Any person to whom this Notice is sent who is a person nominated under section 146 of the Companies Act 2006 (“the Act”) to 
enjoy information rights (a “Nominated Person”) may, under an agreement between him or her and the member by whom he 
or  she  was  nominated,  have  a  right  to  be  appointed  (or  to  have  someone  else  appointed)  as  a  proxy  for  the  AGM.  If  a 
Nominated  Person  has  no  such  proxy  appointment  right  or  does  not  wish  to  exercise  it,  he  or  she  may,  under  any  such 
agreement, have a right to give instructions to the member as to the exercise of voting rights.  

           The statement of rights of members in relation to the appointment of proxies in note 1 above does not apply to Nominated 

Persons. The rights described in that note can only be exercised by members of the Company. 

3.        To be entitled to participate and vote at the AGM (and for the purpose of the determination by the Company of the votes they 
may cast), members must be registered in the register of members of the Company at noon on 2 September 2022 (or, in the 
event of any adjournment, on the date which is two business days before the time of the adjourned meeting). Changes to the 
register of members after the relevant deadline shall be disregarded in determining the rights of any person to participate and 
vote at the meeting. 

4.        CREST members who wish to appoint a proxy or proxies through the CREST electronic proxy appointment service may do so for 
this AGM and any adjournment(s) by using the procedures described in the CREST Manual. CREST personal members or other 
CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their 
CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf. 

           In order for a proxy appointment or instruction made using the CREST service to be valid, the appropriate CREST message (a 
“CREST Proxy Instruction”) must be properly authenticated in accordance with Euroclear UK and Ireland Limited’s specifications, 
and  must  contain  the  information  required  for  such  instruction,  as  described  in  the  CREST  Manual  (available  via 
www.euroclear.com/CREST). The message, regardless of whether it constitutes the appointment of a proxy or is an amendment 
to the instruction given to a previously appointed proxy must, in order to be valid, be transmitted so as to be received by the 
issuer's agent by noon on 2 September 2022. For this purpose, the time of receipt will be taken to be the time (as determined 
by the time stamp applied to the message by the CREST Application Host) from which the issuer's agent is able to retrieve the 
message  by  enquiry  to  CREST  in  the  manner  prescribed  by  CREST.  After  this  time  any  change  of  instructions  to  proxies 
appointed through CREST should be communicated to the appointee through other means.  

           CREST members and, where applicable, their CREST sponsors or voting service provider(s) should note that Euroclear UK and 
Ireland Limited does not make available special procedures in CREST for any particular message. Normal system timings and 

74

Albion Venture Capital Trust PLC 

263764 Albion Capital pp72-end.qxp  29/06/2022  15:49  Page 75

Notice of Annual General Meeting continued

limitations will, therefore, apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member 
concerned  to  take  (or,  if  the  CREST  member  is  a  CREST  personal  member  or  sponsored  member  or  has  appointed  a  voting 
service provider, to procure that his or her CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary 
to  ensure  that  a  message  is  transmitted  by  means  of  the  CREST  system  by  any  particular  time.  In  this  connection,  CREST 
members and, where applicable, their CREST sponsors or voting service provider(s) are referred, in particular, to those sections 
of the CREST Manual concerning practical limitations of the CREST system and timings. 

           The  Company  may  treat  as  invalid  a  CREST  Proxy  Instruction  in  the  circumstances  set  out  in  Regulation  35(5)(a)  of  the 

Uncertificated Securities Regulations 2001. 

5.       Any corporation which is a member can appoint one or more corporate representatives who may exercise on its behalf all of its 

powers as a member provided that they do not do so in relation to the same shares. 

6.       A copy of this Notice, and other information regarding the meeting, as required by section 311A of the Act, is available from 

www.albion.capital/funds/AAVC under the ‘Fund reports’ section. 

7.       Any member participating in the meeting has the right to ask questions. The Company must cause to be answered any such 
question relating to the business being dealt with at the meeting but no such answer need be given if (a) to do so would interfere 
unduly with the preparation for the meeting or involve the disclosure of confidential information, (b) the answer has already 
been given on a website in the form of an answer to a question, or (c) it is undesirable in the interests of the Company or the 
good order of the meeting that the question be answered. 

8.       Copies of contracts of service and letters of appointment between the Directors and the Company, together with the Register 
of Directors’ Interests in the Ordinary shares of the Company, will be available for inspection at the Registered Office of the 
Company during normal business hours from the date of this Notice until the conclusion of the meeting, and at the place of the 
meeting for at least 15 minutes prior to the meeting until its conclusion. In addition, a copy of the Articles of Association will be 
available for inspection at the Company’s registered office from the date of this Notice until the conclusion of the meeting, and 
at the place of the meeting for at least 15 minutes prior to the meeting until its conclusion.  

9.       Under section 527 of the Act members meeting the threshold requirements set out in that section have the right to require the 
Company  to  publish  on  a  website  a  statement  setting  out  any  matter  relating  to:  (i)  the  audit  of  the  Company’s  accounts 
(including  the  Auditor’s  report  and  the  conduct  of  the  audit)  that  are  to  be  laid  before  the  AGM:  or  (ii)  any  circumstances 
connected with an Auditor of the Company ceasing to hold office since the previous meeting at which the annual accounts and 
reports were laid in accordance with section 437 of the Act. The Company may not require the members requesting any such 
website publication to pay its expenses in complying with section 527 and 528 of the Act. Where the Company is required to 
place a statement on a website under section 527 of the Act, it must forward the statement to the Company’s Auditor not later 
than the time when it makes the statement available on the website. The business which may be dealt with at the AGM includes 
any statement that the Company has been required under section 527 of the Act to publish on a website.  

10.     Members satisfying the thresholds in Section 338 of the Companies Act 2006 may require the Company to give, to members 
of the Company entitled to receive notice of the AGM, notice of a resolution which those members intend to move (and which 
may properly be moved) at the AGM. A resolution may properly be moved at the AGM unless (i) it would, if passed, be ineffective 
(whether by reason of any inconsistency with any enactment of the Company’s constitution or otherwise); (ii) it is defamatory 
of any person; or (iii) it is frivolous or vexatious. The business which may be dealt with at the AGM includes a resolution circulated 
pursuant to this right. A request made pursuant to this right may be in hard copy or electronic form, must identify the resolution 
of which notice is to be given, must be authenticated by the person(s) making it and must be received by the Company not later 
than 6 weeks before the date of the AGM.  

11.     Members satisfying the thresholds in Section 388A of the Companies Act 2006 may request the Company to include in the 
business to be dealt with at the AGM any matter (other than a proposed resolution) which may properly be included in the 
business at the AGM. 

           A matter may properly be included in the business at the AGM unless (i) it is defamatory of any person or (ii) it is frivolous or 
vexatious. A request made pursuant to this right may be in hard copy or electronic form, must identify the matter to be included 
in the business, must be accompanied by a statement setting out the grounds for the request, must be authenticated by the 
person(s) making it and must be received by the Company not later than 6 weeks before the date of the AGM. 

12.     As at 28 June 2022 being the latest practicable date prior to the publication of this Notice, the Company’s issued share capital 
consists of 138,524,384 Ordinary shares with a nominal value of 1 penny each. The Company also holds 17,153,431 Ordinary 
shares in treasury. Therefore, the total voting rights in the Company as at 28 June 2022 are 121,370,953. 

Albion Venture Capital Trust PLC 

75

Albion Venture Capital Trust PLC

Albion Venture Capital Trust PLC

Annual Report and Financial 
Statements for the year 
ended 31 March 2022

l

i

A
b
o
n
V
e
n
t
u
r
e
C
a
p
i
t
a

A member of the Association 
of Investment Companies

This report is printed on Amadeus offset a totally recycled paper 
produced using 100% recycled waste at a mill that has been 
awarded the ISO 14001 certificate for environmental management. 
The pulp is bleached using a totally chlorine free (TCF) process. 

l

T
r
u
s
t

P
L
C

2
0
2
2

2022